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TTTR time-tagged time-resolved 
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List of symbols 
B brightness 
Bg B of the green particle in green 
channel 
Br B of the red particle in red channel 
Bc B of the green particle in red channel 
D diffusion coefficient (µm²/s) 
Dr rotational diffusion coefficient 
E FRET efficiency 
F fraction 
[G] free concentration of protein G 
[G]0 total concentration of protein G 
[GR] concentration of the G-R complex 
G(τ) normalized fluorescence (fluctuation) 
autocorrelation function 
Gg(τ) green ACF 
Gr(τ) red ACF 
G(0) correlation function amplitude 
GCC(τ) normalized fluorescence (fluctuation) 
cross-correlation function 
GD(τ) diffusion term of the ACF  
I(τ) normalized fluorescence intensity 
autocorrelation function 
Kass equilibrium constant for association 
Kdiss equilibrium constant for dissociation 
koff rate constant for dissociation 
kon rate constant for association 
k*on =kon[sites]0; pseudo first-order rate 
constant for association 
M molar 
 µM micromolar 
 nM nanomolar 
Mr relative molecular mass 
n refractive index 
N average particle number 
Ng average ‘only-green’ particles  
Nr  average ‘only-red’ particles 
Ngr  average ‘green-and-red’ particles 
Ng,total = Ng + Ngr 
Nr,total = Nr + Ngr 
NCC  = 1/GCC(0) 
NA = 6.022×1023; Avogadro’s number 
Q cross-talk parameter 
[R] free concentration of protein R 
[R]0 total concentration of protein R 
r (Å) intermolecular distance (Angström) 
R = 8.314472 JK−1mol−1; gas constant 
R0 (nm) Förster distance 
rH hydrodynamic radius 
s second 
 µs microsecond 
 ms millisecond 
 ns nanosecond 
 h hours 
S = ω2/ω1; structure parameter 
T (K) temperature (Kelvin) 
tbound =1/koff; the bound time before 
dissociation 
tfree =1/kon; the free time before 
association 
V (fL) volume (femtoliter, 10-15 L) 
VG green volume 
VR red volume 
VCC  cross-correlation volume 
w/w mass fraction, weight percent 
α anomaly parameter  
∆325 LEDGF/p75 lacking residues 1-325 
η (cP) viscosity (centipoises; mPa·s) 
θ  rotational correlation time 
λ (nm) wavelength (nanometer) 
ρ density (kg/dm³) 
τ (ms) correlation time (milliseconds) 
τdiff diffusion time 
τD fluorescence lifetime of the donor 
τDA fluorescence lifetime of the donor in 
the presence of the acceptor 
ω1 radial radius of the confocal volume 
ω2 axial radius of the confocal volume 
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Samenvatting 
Infectie met het humaan immuundeficiëntie virus (HIV), het virus dat het verworven 
immuundeficiëntie syndroom (AIDS) veroorzaakt, is ongeneeslijk; de zeer actieve 
antiretrovirale therapie is daarom een levenslange behandeling die gepaard gaat met een 
vermindering van de levenskwaliteit van de patiënt en met aanzienlijke ziektekosten. Het 
merendeel van geïnfecteerde mensen woont in ontwikkelingslanden en kan zich geen duur en 
doeltreffend therapeutisch regime veroorloven. Bovendien brengt antivirale resistentie alle 
doeltreffende behandelingen in gevaar. Basisonderzoek blijft dus nodig om de replicatiecyclus 
van HIV volledig te verstaan en om nieuwe doelwitten en nieuwe therapeutische strategieën 
te identificeren. LEDGF/p75, een menselijke transcriptionele co-activator, is belangrijk voor 
een efficiënte HIV-replicatie, door zijn directe en specifieke interactie met HIV-1 integrase, 
het virale enzym dat de insertie van het virale genoom in dat van de geïnfecteerde immuuncel 
katalyseert.  
De grondreden voor dit doctoraal onderzoeksproject is het inzicht scheppen in de cellulaire 
functie van LEDGF/p75, zijn intracellulaire interactie met HIV-1 integrase en zijn rol voor 
de replicatie van het HIV-1. Om dit onderzoek uit te voeren hebben we een uitdagende 
interdisciplinaire aanpak gevolgd; kwantitatieve fluorescentietechnieken worden toegepast om 
het gedrag van eiwitten in levende menselijke cellen te bestuderen. Op die manier kunnen 
bepaalde moleculaire eigenschappen van LEDGF/p75 worden bepaald, die onmogelijk met 
normale biochemische onderzoekstechnieken kunnen worden onderzocht. 
Fluorescentie is het fenomeen waarbij sommige stoffen licht kunnen uitzenden wanneer ze 
beschenen worden met licht van een lagere golflengte. Op die manier kan fluorescentie 
gebruikt worden als een ‘markeerstift’ voor biomoleculen. Confocale microscopische 
fluorescentietechnieken zijn het ‘vergrootglas’ dat we gebruiken om het gedrag van één soort 
biomolecule te onderzoeken in een levende cel die talloze andere biomoleculen bevat. 
Bijvoorbeeld, fluorescentiecorrelatiespectroscopie (FCS) is een biofysische techniek waarmee 
de concentratie en de dynamische eigenschappen van biomoleculen kan worden gemeten. 
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Fluorescentiecrosscorrelatiespectroscopie (FCCS) laat toe de interactie van specifieke eiwitten 
te bestuderen, en hun bindingsaffiniteit te bepalen. 
Het experimentele gedeelte van dit project start met een reeks in vitro controleëxperimenten. 
De FCS-techniek, die origineel ontwikkeld werd om de concentratie en dynamica van 
eiwitten te bepalen in een waterige oplossing, wordt dan toegepast in een aantal verschillende 
experimentele omstandigheden. Het effect van de cellulaire brekingsindex, de temperatuur 
van de oplossing, de dikte van het dekglaasje, detector en fluorochroom gerelateerde 
artefacten op de experimentele FCS-metingen wordt nagegaan en een geschikte methode om 
een tweekleuren opstelling te kalibreren wordt ontwikkeld. In dit deel van de thesis zal 
worden nagegaan onder welke omstandigheden de techniek goed presteert wanneer 
kwantitatieve metingen moeten worden uitgevoerd in levende cellen. 
Daarna wordt de transcriptionele co-activator LEDGF/p75 voor de eerste keer bestudeerd in 
real-time in zijn natuurlijke omgeving, in een levende menselijke celkern. Dit is mogelijk door 
LEDGF/p75 genetisch te merken met een groenfluorescent eiwit, eGFP, en de FCS-techniek 
toe te passen in cellen. We wijzen het dynamische gedrag van LEDGF/p75 toe aan 
interacties met het chromatine en geven een gedetailleerde mechanistische beschrijving van 
de kinetica van in vivo chromatinebinding. Wij zijn de eersten die zulke ultrasnelle kinetica van 
chromatinebinding rapporteren voor een transcriptiefactor. Het merendeel van de tijd is 
LEDGF/p75 op zoek naar mogelijke specifieke bindingsplaatsen op het chromatine, door 
middel van een dynamische genoomscanning. Tot slot geven we een betrouwbaar in vivo 
bewijs dat het PWWP-domein van LEDGF/p75, een gekend DNA/chromatine-bindend 
domein, een belangrijke bijdrage levert aan de associatie van LEDGF/p75 met chromatine.  
In een volgend deel van de thesis werd de interactie tussen LEDGF/p75 en HIV-1 integrase 
bestudeerd in levende cellen door middel van de FCCS-techniek. Aangezien het intranucleaire 
complex van de twee eiwitten sterk aan het chromatine verankerd is, werden verschillende 
strategieën gevolgd om hun interactie toch te kwantificeren met FCCS: de chromatine-
bindende domeinen van LEDGF/p75 werden verwijderd terwijl de interactie met IN werd 
verzekerd, het interactiecomplex werd verplaatst naar het cytoplasma van de cellen, of het 
belangrijkste chromatine-bindend domein werd op een specifieke manier gewijzigd. In de drie 
gevallen werd er een zodanige stijging in de mobiliteit van het complex waargenomen dat de 
interactie kon worden waargenomen met FCCS.  
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Heden worden deze interactietesten gebruikt om te screenen naar potentiële inhibitoren van 
deze interactie. Tot slot werden ook studies op de stoichiometrie van het interactiecomplex 
uitgevoerd en werd een eerste mechanistisch model opgebouwd, dat paradoxale meningen 
over transcriptionele co-activatie and targeting van HIV-1 door LEDGF/p75 verenigt. 
Metingen op een eiwit door middel van fluorescentie heeft logischerwijs als vereiste dat het 
eiwit fluorescent gemerkt wordt. In het laatste deel van de thesis werd de nadruk gelegd op de 
fotofysica van de fluorescente merkers die in het onderzoek werden gebruikt, zijnde 
fluorescente eiwitten. De mate waarin de fotofysica van deze eiwitten de metingen van de 
eigenschappen van biomoleculen beïnvloedt werd onderzocht. Daartoe voerden we 
kwantitatieve FCCS-metingen uit op een translatiefusie van twee fluorescente eiwitten. 
Hierdoor kregen we meer inzicht in de biofysische mogelijkheden en beperkingen van de 
techniek, en we overdenken hoe de FCCS-techniek zou kunnen worden geoptimaliseerd in de 
toekomst. Tot slot hebben we de monomerische rood-fluorescerende eiwitten, die gebruikt 
werden voor de kwantitatieve FCCS-metingen, onderworpen aan een gedetailleerde 
spectroscopische in vitro analyse. We relateren onze observaties met kristallografische 
informatie en dragen bij aan de kennis over de vorming van donkere toestanden in deze 
eiwitten. Dit deel van het project zal bijdragen aan de toekomstige doelgerichte constructie 
van nieuwe stabiele rood fluorescerende eiwitten. 
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Summary 
Infection with the human immunodeficiency virus (HIV), the virus that causes the Acquired 
immunodeficiency syndrome (AIDS), cannot be cured; the highly active antiretroviral therapy 
(HAART) is therefore lifelong and associated with a reduction in quality-of-life and 
considerable health care costs. Most infected people live in developing countries and cannot 
afford costly therapeutic regimens with effective antivirals. Moreover, emergence of antiviral 
resistance jeopardizes all effective treatment. Basic research thus remains necessary to fully 
understand the HIV replication cycle and to identify novel targets and novel therapeutic 
strategies. LEDGF/p75, a human transcriptional co-activator, is important for efficient HIV 
replication, through a direct and specific interaction with HIV-1 integrase (IN), the viral 
enzyme that catalyzes the insertion of the viral genome into that of the infected immune cell.   
The rationale of this doctoral research project is to gain insight into the cellular function of 
LEDGF/p75, its intracellular interaction with HIV-1 integrase and its role for HIV-1 
replication. A challenging interdisciplinary approach is followed; quantitative fluorescence 
techniques are applied to study the behaviour of proteins inside living human cells. This 
approach allows to determine molecular properties of LEDGF/p75 that are impossible to 
determine with standard biochemistry research tools.   
Fluorescence is the phenomenon by which some substances emit light when irradiated with 
light of shorter wavelength. As such, it can be used as a ‘magic marker’ for biomolecules. 
Confocal microscopic fluorescence techniques are the ‘magnifying glass’ to visualize the 
intracellular behaviour of one type of biomolecule inside a living cell containing numerous 
other biomolecules. For example, fluorescence correlation spectroscopy (FCS) is a 
biophysical technique for measuring the concentration and the dynamic properties of 
biomolecules. Fluorescence cross-correlation spectroscopy (FCCS) allows to study the 
interaction of specific proteins and determine their binding affinity.  
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The experimental part of the project starts with a series of in vitro control experiments. The 
FCS technique, originally developed to measure protein concentrations and dynamics in 
aqueous environment, is applied in a range of different experimental conditions. The effects  
of  the  cellular  refractive  index,  temperature  of  the  solute, cover glass thickness, detector 
and fluorochrome related artefacts on the experimental measurements are verified and an 
adequate method for calibrating a two-color setup is developed. In this part of the thesis, we 
verify under which circumstances the technique performs well for quantitative measurements 
inside living cells. 
Then, transcriptional co-activator LEDGF/p75 is studied for the first time in real-time in its 
natural condition, inside a living human cell nucleus. This is done by genetically labelling 
LEDGF/p75 with a green fluorescent protein, eGFP, and applying FCS in cells. We pinpoint 
the dynamic behaviour of the protein to chromatin binding and provide a detailed 
mechanistic description of the kinetics of in vivo chromatin binding. We are the first to report 
ultrafast kinetics of chromatin binding (k*on > 1.9×103 s-1 and koff > 38.6 s-1) for a 
transcription factor. During the majority of its nuclear residence, LEDGF/p75 is thus 
dynamically scanning the genome, in search for possible specific binding sites.  Finally, we 
provide solid in vivo evidence that the PWWP-domain of LEDGF/p75, a known 
DNA/chromatin binding motif, contributes strongly to chromatin association of 
LEDGF/p75.  
In a next part of the project, we study the IN-LEDGF/p75 interaction in living cells with the 
FCCS technique. Since their intranuclear complex is strongly tethered to chromatin, different 
strategies are followed to probe the interaction with FCCS: the chromatin binding domains of 
LEDGF/p75 are removed while conserving the interaction with IN, the interaction complex 
is retargeted to the cytoplasm, or the major chromatin binding domain of LEDGF/p75 is 
specifically altered. In every case, the increase in mobility of the complex allowed to quantify 
the interaction with FCCS. Currently, this assay is used to screen for possible inhibitors of the 
interaction. Finally, we also performed interaction studies on the stoichiometry of the 
complex, and built a first mechanistic model that unifies paradoxical notions of 
transcriptional co-activation and HIV-1 targeting by LEDGF/p75. 
Fluorescence measurements logically require the protein of interest to be fluorescently 
labelled. In the last part of the thesis, we focus on the photophysics of the fluorescent labels 
that were used throughout the project, i.e. fluorescent proteins, and try to assess to what 
 xxi 
extent the photophysics influences measurements on actual biological molecules. We 
performed a quantitative FCCS analysis of a genetic fusion of two fluorescent proteins. We 
gained more insight in the biophysical possibilities and limitations of the method, and we 
speculate on how the method could be improved in the future. Finally, we subjected 
monomeric red fluorescent proteins (mRFPs), that are used for quantitative FCS and FCCS 
measurements, to a detailed spectroscopical analysis in vitro, related our results with structural 
information on RFPs and contributed to the knowledge on dark state formation. This part of 
the project will hopefully lead to the goal-oriented engineering of RFPs towards more stable 
fluorescence. 
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Part I – Rationale and objectives 
The rationale of this doctoral research project is to gain insight into the intracellular function 
of human transcriptional co-activator LEDGF/p75, its interaction with HIV-1 integrase and 
its role for HIV-1 replication. To investigate this, we apply confocal spectroscopy techniques 
such as fluorescence correlation (FCS) and cross-correlation spectroscopy (FCCS), but also 
other quantitative fluorescence techniques inside living cells.  
A first objective is to investigate the performance of the FCS technique, originally designed to 
measure protein concentrations and dynamics in aqueous environment, for quantitative 
measurements inside living cells. We will do this by exploring experimental conditions in a 
controlled in vitro environment. Possible methodological artefacts, that would be left 
unnoticed when measuring directly inside living cells, can in this way be identified, controlled 
for or even eliminated. 
A second objective is to characterize the known chromatin binding properties of 
LEDGF/p75 for the first time in real-time inside living cells, with FCS. By labelling 
LEDGF/p75 with a green fluorescent protein, eGFP, we can monitor dynamics of the 
protein in the cell with FCS. The kinetics of chromatin binding will be characterized by 
customizing the experimental setup. Finally, the role of a major chromatin interacting domain 
for targeting HIV-1 integrase to chromatin will be investigated, both with FCS, as with a 
complementary technique for measuring protein dynamics in the slow time scale. 
A third objective is to apply the FCCS technique for probing the interaction of HIV-1 
integrase and LEDGF/p75 for the first time in living cells. Since their intranuclear complex is 
strongly tethered to chromatin, different strategies are followed to probe the interaction with 
FCCS: the chromatin binding domains of LEDGF/p75 will be removed, LEDGF/p75 will 
be retargeted to the cytoplasm, or the major chromatin binding domain of LEDGF/p75 will 
be altered. Finally, the FCCS technique will be used in a quantitative manner to determine 
and compare protein-protein interaction affinities.   
 2 
A fourth objective is to evaluate the FCCS technique for measuring protein-protein 
interactions quantitatively in living cells. By combining FCCS measurements on a control 
system, a genetic fusion construct of two fluorescent proteins, with complementary 
measurements performed by another technique for quantifying protein-protein interactions, 
we gain more insight in the biophysical fundamentals of FCCS. Finally, the experimental 
setup and the fluorochromes used for FCCS are critically evaluated and limitations and 
possible optimizations are discussed. 
Finally, a last objective is the characterization of monomeric red fluorescent protein 
photophysics with FCS, in combination with other spectroscopical methods. We provide 
structural-functional insight in this matter by linking our observations with crystallographic 
information. 
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Part II – Introduction 
Chapter 1. HIV-1 integrase and human transcriptional co-activator LEDGF/p75 
This thesis starts with the biological background of the doctoral research project. The human 
immunodeficiency virus is introduced and explained in detail with an emphasis on HIV-1 
integrase and human LEDGF/p75, the two main proteins that were studied during the 
project. 
 
Chapter 2. Fluorescence correlation and cross-correlation spectroscopy 
The interdisciplinary character of the project will become clear in the second chapter, when 
the two principal techniques that were used, fluorescence correlation and cross-correlation 
spectroscopy, are introduced. This detailed introductory chapter gives an overview of the 
biophysical and mathematical basics of these techniques, and novel trends in this field are 
also compared.  
 6 
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Chapter 1. HIV-1 integrase and 
human transcriptional co-activator 
LEDGF/p75 
1.1. The HIV/AIDS pandemic 
In 1981 the CDC (U.S. Centers for Disease Control and Prevention) was alarmed by an 
unusually high prevalence of rare opportunistic infections such as Pneumocystis carinii 
pneumonia and Kaposi’s sarcoma among young homosexual men. This condition was named 
Acquired Immunodeficiency Syndrome (AIDS). In 1983, the group of Luc Antoine 
Montagnier identified a previously unknown retrovirus to be the causative agent of AIDS 
(Barre-Sinoussi et al., 1983). Later the virus was named Human Immunodeficiency Virus type 
1 (HIV-1). Between 1983 and 2007, 25 million people have died from the consequences of 
HIV-1 infection. In 2007 there were an estimated 33 million people in the world living with 
HIV-1, two-thirds of whom lived in Southern Africa (Figure 1.1). While the prevalence of 
HIV-1 has stabilized since 2000, the total number of people living with HIV-1 continues to 
increase.  
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Figure 1.1 Prevalence of HIV in the world (reproduced from the 2008 UNAIDS report). 
The HIV/AIDS pandemic has caused history’s single sharpest reversal in human 
development. In the most heavily affected countries, it has reduced life expectancy 
considerably, increased poverty, shifted the size of populations, undermined national systems 
and weakened institutional structures. The epidemic cannot be reversed without reducing the 
rate of infections, therefore global HIV-1 prevention efforts, both on the economical, social 
and technical level, are essential. Recently though, a vaccine that lowered the chance of HIV 
infection with 26% has been reported, which holds promise for an effective prevention of 
HIV-1 in the future (Rerks-Ngarm et al., 2009).  
HIV-1  is  transmitted  through  the  contact  with  bodily  fluids.  Heterosexual intercourse, 
injecting drug use, sex between men and mother-to-child transmission are the main driving 
forces of the epidemic. HIV-1 infection can be treated but still is incurable. The virus 
becomes irreversibly incorporated in the genetic material of the patient. A proof-of-principle 
study recently reported the possibility of excising HIV-1 from the genome (Sarkar et al., 
2007), which might be a first step to a cure for HIV-1. Untreated, HIV infected patients 
usually progress to AIDS 9-10 years after the initial infection. Without treatment the survival 
time after progression to AIDS is less than one year. Clinical treatment of HIV-1 infection 
nowadays consists of the so-called highly active antiretroviral therapy (HAART). In this 
therapy patients are given a combination of different HIV targeting drugs in a strict schedule. 
HAART can extend the life expectancy of a patient by 20-50 years, but a large discrepancy 
with the life expectancy of HIV-1 negative individuals still exists. Moreover, side effects of 
the treatment can compromise the quality of life considerably. Continuous academic research 
on the biology and virology of HIV-1 is necessary, because it will aid the development of new 
1.2. Virion and genomic structure of HIV-1 
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HIV-1 drugs or vaccines. Moreover, current treatment is complicated by drug toxicity and 
HIV-1 resistance development.    
1.2. Virion and genomic structure of HIV-1 
HIV-1 is a lentivirus of the family of retroviruses. The spherical ~145-nm virion (Briggs et 
al., 2003)(Figure 1.2) has an envelope consisting of a phopholipid bilayer with embedded 
complexes of a trimeric transmembrane protein (TM/gp41) tightly anchored to a trimeric 
surface protein (SU/gp120). The matrix protein (MA/p17) lines the inner part of the virion, 
providing an anchor for the gp120/gp41 complex and giving structural integrity to the virion.  
 
Figure 1.2 Schematic structure of the HIV genome and virion – the 
abbreviations are explained in the text (Frankel and Young, 1998). 
A cone-shaped core consisting of 2000 copies of the capsid protein (CA/p24) is present in 
the virus. The virion contains the three viral enzymes, integrase (IN/p32), reverse 
transcriptase (RT/p51-p66) and protease (PR/p10) and the viral accessory proteins Vpr, Nef 
and Vif. Next to this, cellular proteins like BAF, Ini1 and cyclophilin A have been identified 
in the virion. The genome of HIV consists of two identical linear single stranded 9.2 kilobase 
(+)RNA strands, tightly associated with the nucleocapsid protein (NC/p6-p7) in the virion. 
Two copies of tRNALys3, a primer for the  reverse transcription of the genome, are hybridized 
with the genome in the virion. Structurally the genome consists of three large genes (gag, pol 
and env) and a number of smaller genes (vif, vpr, vpu, tat, rev and nef). The gag gene encodes for 
MA, CA and the NC proteins, the pol gene encodes for PR, RT and IN and the env gene 
encodes for the envelope proteins gp41 and gp120.  
  
Chapter 1. HIV-1 integrase and human transcriptional co-activator LEDGF/p75 
10 
1.3. The HIV-1 replication cycle 
HIV infects differentiated immune cells such as CD4+ T cells and non-dividing macrophages 
and dendritic cells. The gp120 surface protein of HIV-1 specifically recognizes the CD4 
receptor and a chemokine co-receptor on the immune cell. The type of chemokine receptor 
that is recognized by the virus, CCR5 or CXCR4, determines the tropism of the virus. After 
binding the gp41 protein undergoes a conformational change, triggering the fusion of the 
viral envelope with the host cell membrane and releasing the capsid into the cytoplasm 
(Figure 1.3). HIV can also enter the cell via receptor-mediated endocytosis and fusion of 
endosomes (Miyauchi et al., 2009). After uncoating of the capsid in the cytoplasm, reverse 
transcription of the RNA genome initiates. During this enzymatic reaction, the viral RNA is 
copied to double stranded copy DNA, flanked by two long terminal repeats (LTR’s). This 
newly synthesized cDNA forms a complex with IN, RT, MA and Vpr and cellular proteins, a 
so-called pre-integration complex (PIC), which is transported actively into the nucleus by 
cellular transportin-SR2 (Christ et al., 2008) after being processed by IN in the first of two 
catalytic steps called 3’-processing. In the nucleus the viral genome is integrated into that of 
the host cell by IN in a second catalytic step referred to as strand transfer. Cellular repair 
mechanism finally repair the gaps flanking the integrated provirus. 
The cellular transcription machinery transcribes the integrated provirus to mRNA starting at 
the promoter region in the 5’-LTR. Tat greatly enhances this process. In a next step the full-
length RNA is either spliced and transported to the cytoplasm or directly transported to the 
cytoplasm, where new viral proteins are synthesized. This transport step is regulated by Rev. 
The Env transmembrane protein is synthesized in the endoplasmatic reticulum and directed 
to the cell membrane by vesicular transport. The Gag and Gag-Pol polyproteins are directly 
targeted to the cell membrane through the N-terminal, myristoylated MA protein. At the cell 
membrane, new viral particles are assembled. These new virions contain the polyproteins Gag 
and Gag-Pol, Vif, Vpr, Nef and the genomic RNA. Vpu promotes CD4 receptor 
downregulation, to prevent association with the viral receptor upon translation in the 
endoplasmatic reticulum. Nef promotes endocytosis and degradation of cell surface CD4 
receptors. The exact function of Vif is less well known although it is important for the 
production of highly infectious mature virions. Vpr has a function in the nuclear uptake of 
the viral complex and induces cell cycle arrest in G2 phase. After budding from the cell, Gag 
1.3. The HIV-1 replication cycle 
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and Gag-Pol are proteolytically cleaved to MA, CA, NC, PR, RT and IN during maturation 
and the virion obtains its typical morphology and becomes infectious.  
 
 
Figure 1.3 The replication cycle of HIV – (1) After binding to the host cell membrane, (2) 
the content of the virus is released in the cytplasm. (3) Reverse transcription converts the 
ssRNA viral genome into a cDNA copy. (4) After nuclear import, the viral genome is 
integrated into the host genome. (5) Transcription of the provirus allows for new viral 
genetic material and viral proteins to be synthesized. (6) New virions assemble at and bud 
from the cell membrane and (7) after maturation, infectious viruses are formed (credit: 
NIAID). 
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1.4. HIV-1 integrase 
HIV-1 integrase (IN) is one of three essential retroviral enzymes present in the HIV-1 virion. 
IN (relative molecular mass 32 kDa) belongs to the nucleotidyl transferases (E.C.2.7.7.), 
enzymes that cut and paste DNA by direct transesterification. During HIV-1 replication, IN 
performs the enzymatic integration of the viral genome into the host genome. Mechanically 
and structurally, retroviral integrases resemble bacteriophage Mu and Tn5 transposases 
(Ljungquist et al., 1979; Reznikoff, 2003). During the transcription of new viral RNA, the 
mRNA of IN is part of the gag-pol mRNA. Translation is only possible when an occasional -
1 frame shift occurs during translation of the gag gene. The viral enzyme protease finally 
releases IN by cleaving the Gag-pol polyprotein.  
1.4.1. Enzymatic activity 
IN catalyzes the integration of the HIV-1 genome in two enzymatic steps called the 3’-
processing reaction and the strand transfer reaction (Figure 1.4). After reverse transcription in 
the cytoplasm, the double stranded viral cDNA in the pre-integration complex (PIC) is 
flanked by two identical Long Terminal Repeats (LTR’s). IN now recognizes the two 5’-
CAGT-3’ consensus sequences at the cDNA termini and cleaves off the pGT dinucleotide, 
creating a recessed 3’-OH. This reaction is a nucleophilic substitution  with  either  H2O  or  
the terminal 3’-OH as the attacking nucleophile.  After nuclear import of the PIC, the two 
recessed 3’-OH groups perform a nucleophilic attack on the host chromosomal DNA, 
catalysed by IN. More specifically, the two complementary strands of the target DNA are 
linearized at a five base pair distance by the reaction and the integrated viral DNA becomes 
flanked by two single stranded 5-base gaps. These gaps are finally repaired by host DNA 
repair mechanisms after which a stably integrated provirus is formed.  
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Figure 1.4 Enzymatic steps catalysed by HIV-1 integrase during HIV replication – 
In the first the 3’-processing step, IN binds to the consensus 5’-CAGT sequences at the 
LTR termini of the viral cDNA and cleaves off 5’-CA. During the second strand transfer 
step, IN inserts the two recessed LTR-ends at a 5-bp distance into the host genome. Host 
cell mechanisms repair the nicked ssDNA (Poeschla, 2008). 
1.4.2. Structure 
Like all retroviral integrases, IN contains three domains: an N-terminal domain (NTD), a 
catalytic core domain (CCD) and a C-terminal domain (CTD) (Figure 1.5). Crystallographic 
information is available for the NTD, CCD and CTD, for the fusion NTD-CCD and for the 
fusion CCD-CTD, but not for the full-length protein (Dyda et al., 1994; Lodi et al., 1995; Cai 
et al., 1997; Chen et al., 2000; Wang et al., 2001). The NTD (residues 1-52) forms a zinc-
finger motif by complexation of His-12, His-16, Cys-40 and Cys-43 with a Zn2+ ion and 
forms a stable dimer. This motif is very well conserved among retroviral integrases and often 
makes up the DNA binding part of transcription activators. In the crystal of the NTD the 
helix normally used for DNA binding lies at the dimer interface (Cai et al., 1997) and is likely 
involved in forming the quaternary structure of IN. The CCD (residues 53-212) contains the 
triad of catalytic residues, Asp-64, Asp-116 and Glu-152, that bind a divalent metal ion such 
as Mg2+ or Mn2+ (Dyda et al., 1994; Jenkins et al., 1995) and that make up the catalytic site of 
the enzyme. The CCD is dimeric in solution.  The CTD (residues 213-288) is least conserved 
among retroviral integrases. It shows homology with Src Homology 3 (SH3) domains, which 
play a role in protein-protein interactions in signal transduction pathways (Eijkelenboom et 
al., 1995). The CTD has been proposed to play a role in the oligomerization of IN (Lutzke 
and Plasterk, 1998). 
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Figure 1.5 Stereo representations of the crystallographic structures of the three 
domains of HIV-1 IN (top) The dimeric N-terminal domain (residues 1-52), with a Zn2+ 
ion (in blue) bound to residues His-12, His-16, Cys-40 and Cys-43, shown as sticks (PDB id. 
1WJC). (middle) The dimeric catalytic core domain (residues 53-212), with a Mg2+ ion (in 
green) bound to residues Asp-64, Asp-116 and Glu-152, shown as sticks (PDB id. 1BIU). 
(bottom) The dimeric C-terminal domain (residues 213-288) (PDB id. 1IHV)(produced with 
PyMOL Molecular Graphics System (2002, DeLano Scientific, Palo Alto, CA, USA)). 
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1.4.3. Stoichiometry 
The individual domains of IN dimerize in vitro, as observed by crystallography. Moreover, the 
distance between two active sites in a IN-CCD dimer is larger than the five base pair spacing 
between the adjacent integration sites of the two ends of the viral cDNA (Dyda et al., 1994). 
This would imply that the active form of IN capable of concerted strand transfer contains a 
higher order stoichiometry or an equilibrium between forms with different stoichiometries 
(Craigie, 2001). Indeed, in vitro at µM concentration IN is present as a dimer (Jenkins et al., 
1996). Recently, it has been claimed, based on FRET studies that the affinity of two 
monomers in a IN dimer is extremely strong, with an equilibrium dissociation constant of 
about 66 pM (Tsiang et al., 2009). In addition, IN can multimerize in solution (Jenkins et al., 
1996; Delelis et al., 2008). This multimerization  can be shifted to a dimer-tetramer 
equilibrium with an equilibrium dissociation constant of 22 µM by introducing the F185K-
C280S solubility mutations.  Furthermore, an oligonucleotide dsDNA substrate mimicking 
the LTR ends can either increase the solubility of IN by overtitrating with the DNA or 
increase IN multimerization by overtitrating the DNA with IN (Deprez et al., 2000; 
Vercammen et al., 2002). Furthermore it is known from cross-linking studies that in vitro full-
site concerted integration of a 2-LTR substrate can only be performed by a tetrameric IN, 
while the dimeric form of IN can only perform half-site integration, the processing and 
integration of only one viral end (Faure et al., 2005; Guiot et al., 2006). The IN tetramer 
moreover does not show strand activity when the substrate contains only one viral LTR, 
implying a sequential binding of a monomer or dimer of IN to each cDNA end, subsequent 
3’ processing and finally tetramerization of IN and strand transfer (Figure 1.6).   
Palindromic DNA sequences stabilize the IN tetramer due to their inherent symmetry 
(Delelis et al., 2007). Finally, molecular modeling attempts and a single particle reconstruction 
of electron microscopy data from DNA-IN complexes provide suggestions for the 3-
dimensional structure of the complex (Podtelezhnikov et al., 2003; Karki et al., 2004; Ren et 
al., 2007), although the real quaternary structure of IN to date remains elusive. In summary, 
the smallest stoichiometry of free IN likely is a dimer but for strand transfer at least a 
tetrameric IN is necessary.  
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Figure 1.6 IN sequential binding (A) IN is present in a monomer-dimer equilibrium in 
solution. (B) the IN dimer binds to and (C) 3’-processes the viral cDNA. (D) Still bound to 
the cDNA IN tetramerizes and (E) integrates the viral genome into that of the host cell. (F) 
Finally, host cells mechanisms repair the 5’ and 3’ single stranded gaps in the integrated 
DNA (Faure et al., 2005). 
1.5. HIV-1 integration and cellular components 
Multiple steps in HIV-1 replication depend on human cell components. The CD4 immune 
receptor and some co-receptors are needed for entry, human tRNA primers for reverse 
transcription, the cytoskeleton for intracellular transport of the PIC (McDonald et al., 2002), 
TRN-SR2 for nuclear import of the PIC (Christ et al., 2008) and the cellular transcription 
machinery for proviral gene expression, to give a few examples. Specifically for HIV-1 
integration, a number of human proteins have been proposed to play a role. Barrier-to-
autointegration factor (BAF), a highly conserved protein with a role in nuclear structure 
organization and assembly, associates with PICs in cells, protects retroviral DNA against 
autointegration and has been shown to have a role in HIV-1 integration (Lee and Craigie, 
1998; Lin and Engelman, 2003; Violot et al., 2003; Margalit et al., 2005). High Mobility 
Group Chromosomal protein A1 (HMGA1), a protein involved in transcription regulation by 
chromatin remodeling, can restore in vitro integration activity of salt stripped PICs (Farnet 
and Bushman, 1997; Reeves, 2001). Integrase interactor 1 (INI1/hSNF5), a component of 
the ATP-dependent chromatin remodeling mammalian SWI/SNF complex, interacts directly 
with IN, stimulates IN in vitro and is incorporated in HIV-1 virions (Kalpana et al., 1994; 
Muchardt and Yaniv, 1999; Yung et al., 2004). Moreover, overexpression of the IN binding 
domain of INI1 inhibits HIV-1 replication (Yung et al., 2001). Finally, Lens epithelium 
derived growth factor (LEDGF/p75), a human transcriptional co-activator (Ge et al., 1998a), 
was identified as an IN co-factor in a co-immunoprecipitation experiment (Cherepanov et al., 
2003). We will discuss LEDGF/p75 in more detail in the following section. 
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1.6. The transcriptional co-activator LEDGF/p75 
1.6.1. Discovery of LEDGF/p75 
Lens epithelium derived growth factor (LEDGF) was originally identified as a 75-kDa growth 
and survival factor in human lens epithelial cells (Singh et al., 1998). Concurrently it was 
identified as a 75-kDa protein (p75) during purification of the PC4 transcriptional co-
activator and was shown to interact with the VP16 activation domain and with components 
of the general transcription machinery (Ge et al., 1998a). Its alternative splice variant, p52, is a 
333 amino acid protein that shares the first 325 amino acids with LEDGF/p75. 
LEDGF/p75 and p52 localize in different compartments in the nucleus (Nishizawa et al., 
2001). Next to a broader range of interactions with transcription activators, p52 also 
functionally interacts with ASF/SF2 (alternative splicing factor/splicing factor 2), also known 
as SFRS1 (splicing factor, arginine/serine-rich 1) (Ge et al., 1998a; Ge et al., 1998b). 
LEDGF/p75 is a 530 amino acid protein derived from the ledgf gene, which is also known as 
the psip1 gene, for PC4- and SF2-interacting protein 1 (Figure 1.7). Finally, LEDGF was also 
referred to as dense fine speckles 70-kDa (DFS70) protein in autoimmune diseases (Ochs et 
al., 2000). Since LEDGF is an abundant protein that stimulates survival in a wide range of 
cell types, its name is not well chosen (Singh et al., 2000b). Nonetheless, the currently 
accepted and unique acronym is LEDGF/p75.  
LEDGF/p75 also has a function in oncogenesis. Through a direct interaction with the 
MLL/menin complex, LEDGF/p75 has been shown to be indispensable for MLL (mixed 
lineage leukemia) histone methyltransferase (HMT) dependent transcription and for 
MLL/menin dependent leukemic transformation (Yokoyama and Cleary, 2008). 
Furthermore, LEDGF/p75 is targeted by chromosomal translocations in leukemia that result 
in fusion with the nucleoporin NUP98 (Ahuja et al., 2000; Hussey et al., 2001; Grand et al., 
2005; Morerio et al., 2005). Autoantibodies against LEDGF/p75 are present in certain 
autoimmune diseases and prostate cancer (Ganapathy et al., 2003; Daniels et al., 2005). 
During apoptosis LEDGF/p75 undergoes caspase-3 and -7 dependent cleavage, which 
abrogates the pro-survival function and enhances its immunogenicity (Wu et al., 2002). The 
function of LEDGF/p75 during HIV-1 replication will be discussed later. 
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Figure 1.7 The location and organization of the ledgf gene – The ledgf gene is located on 
chromosome 9 area 9p22.2, contains 15 exons and 14 introns and encodes for two proteins, 
LEDGF/p75 and its alternative splice variant p52 (Ge et al., 1998a; Singh et al., 2000a) A. 
Organization of chromosome 9. Black arrow = position of the ledgf gene. B. Organization 
of the ledgf gene and the LEDGF/p75 and p52 mRNA. Ledgf gene: exons and introns are 
represented by resp. black and white colors, the exons are numbered. E, B and H indicate 
restriction sites for resp. EcoRI, BamHI and HindIII. Polyadenylation signals are indicated 
with AATAAA. LEDGF/p75 and p52 mRNA: coding and non-coding parts are represented 
by resp. gray and white colors. AUG: start codon; UAA: stop codon (Singh et al., 2000a). 
1.6.2. Chromatin binding domains in LEDGF/p75 
LEDGF/p75 belongs to the family of Hepatoma derived growth factor (HDGF) related 
proteins (HRP’s), which includes p52, HRP-1, -2, -3 and -4 (Izumoto et al., 1997; Ikegame et 
al., 1999; Dietz et al., 2002). Hepatoma derived growth factor (HDGF) is a protein with 
mitogenic properties originally identified in human hepatoma derived cell lines but 
ubiquitously expressed in several other cell lines (Nakamura et al., 1994). Besides the presence 
of a well-conserved N-terminal PWWP-domain, HRPs show very little homology (Izumoto 
et al., 1997; Stec et al., 2000; Singh et al., 2006). Characteristic of PWWP domains is a 
conserved although not invariant Pro-Trp-Trp-Pro motif (Stec et al., 2000). PWWP domains 
are generally involved in protein-protein interactions regulating the chromatin structure (Stec 
et al., 2000). Although structural information on the PWWP domain of LEDGF/p75 is not 
known, a comparison of the known structures of the  PWWP  domains of HDGF, Dnmt3b 
and mouse HRP-3 showed a high degree of similarity (Qiu et al., 2002b; Sue et al., 2004; 
Nameki et al., 2005; Lukasik et al., 2006). In addition, it has been shown that the PWWP 
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domain of HDGF can form domain swapped dimers in vitro (Sue et al., 2007) and that 
SUMO (small ubiquitin like modification) of HDGF occurs in cells (Thakar et al., 2008). In 
LEDGF/p75 a tripartite element consisting of the two AT-hooks and the NLS cooperates 
with the PWWP-domain when binding to DNA/chromatin, as has been shown in vitro (Llano 
et al., 2006b) and in vivo (Turlure et al., 2006) (Figure 1.8). In addition, eGFP-PWWP can 
interact with mitotic chromosomes and deletion of only this domain from full-length 
LEDGF/p75 weakens its affinity for chromatin in vitro (Llano et al., 2006b) and in vivo 
(Turlure et al., 2006; Llano et al., 2006b), underlining its contribution to chromatin-binding. 
Finally, PWWP domain residues important for binding to an in vitro chromatinized template 
were recently identified (Shun et al., 2008).  
 
 
Figure 1.8 Schematic representation of LEDGF/p75 – LEDGF/p75, its alternative splice 
variant LEDGF/p52 (Singh et al., 2000a) and a deletion mutant of LEDGF/p75 lacking 
residues 1-325 (∆325)(De Rijck et al., 2006). NLS = nuclear localisation signal, AT = AT-
hook domains, HTH = predicted Helix-Turn-Helix motifs (Llano et al., 2006b). 
 
Next, LEDGF/p75 directly interacts with heat shock elements (HSE) and stress related 
regulatory elements (STRE) to promote expression of stress-related genes, such as Hsp27, 
αB-crystallin, alcohol dehydrogenase (ADH), anti-oxydant protein 2 (AOP2) (Fatma et al., 
2001; Singh et al., 2001; Shinohara et al., 2002; Sharma et al., 2003; Fatma et al., 2004). It 
activates stress-response genes by virtue of the N-terminal PWWP domain binding to a 
STRE in the promotor of this gene. Furthermore it can activate stress-response genes by 
binding of its C-terminus (418-530), containing two predicted helix-turn-helix domains, to 
the HSE’s of the same promotor (Singh et al., 2001; Singh et al., 2006). Finally, LEDGF/p75 
contains a large percentage of charged residues (39.4%) and contains two defined regions 
with positively charged residues, that are involved in electrostatic interactions with 
DNA/chromatin (Llano et al., 2006b). 
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1.6.3. A protein-protein interaction domain in LEDGF/p75 
Next to the PWWP domain, LEDGF/p75 contains another conserved structural domain that 
was originally identified as the IN binding domain (IBD) (Cherepanov et al., 2004). Indeed, 
this domain of LEDGF/p75 strongly and specifically interacts with IN (Cherepanov et al., 
2005a). NMR studies provided structural details on the IBD; it consists of 5 alpha helices that 
form a superhelical domain. The IBD is structurally homologous to HEAT (Huntingin, 
elongation factor 3, subunit A of phosphatase 2A, yeast PI3 kinase TOR) or ARM (Drosophila 
melanogaster protein Armadillo) repeats of various proteins, which usually are responsible for 
mediating protein-protein interactions (Cherepanov et al., 2005b). A co-crystal of IBD and 
IN-CDD showed that the IBD of LEDGF/p75 interacts specifically with IN by binding at 
the interface of the IN-CCD dimer (Cherepanov et al., 2005a) (Figure 1.9). Other human 
proteins have been identified that bind to the IBD. Firstly, JPO2, also known as RAM2, 
represses transcription of the gene encoding monoamine oxidase (MAO) by binding to SP1 
sites in the core promoter of MAO (Chen et al., 2005a) and was independently identified in a 
yeast two hybrid screen for interactors of the Myc transcription factor (Huang et al., 2005). 
JPO2 interacts with LEDGF/p75 via the IBD and can compete with IN (Maertens et al., 
2006). LEDGF/p75 colocalizes with JPO2 in interphase cells, tethers JPO2 to mitotic 
chromosomes and stabilizes intracellular levels of JPO2 (Maertens et al., 2006). The 
JPO2/IBD interaction surface is different from the IN-CCD/IBD interface 
(Bartholomeeusen et al., 2007). Secondly, the menin tumor suppressor, product of the men1 
gene and implicated in cancer and transcriptional regulation as a component of the MLL-
HMT complex (section 1.6.1) interacts specifically with LEDGF/p75. The IBD and adjacent 
HTH-motif are necessary and sufficient to target LEDGF/p75 to the MLL/menin complex 
(Yokoyama and Cleary, 2008). Thirdly, PogZ (pogo transposable element derived protein 
with a Zinc finger), also interacts specifically with LEDGF/p75 through the IBD. PogZ is a 
domesticated transposase and carries a DDE-domain similar to the IN-CCD 
(Bartholomeeusen et al., 2009). PogZ also competes with IN for binding to LEDGF/p75, 
although the affinity is likely weaker (Bartholomeeusen et al., 2009). Finally, Cdc7 is a 
Ser/Thr kinase essential for the initiation of DNA replication throughout the S-phase. Its 
activity is controlled via interaction with a regulatory subunit, activator of S-phase kinase 
(ASK). LEDGF/p75 interacts with heterodimeric Cdc7/ASK via the IBD and stimulates 
Cdc7 kinase activity (Hughes et al., 2010). In summary, the IBD is a well conserved motif in 
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LEDGF/p75 that seems to function as an adaptor for interacting with multiple cellular target 
proteins. 
 
Figure 1.9 The crystal structure  of the dimeric catalytic core domain of IN (white) 
complexed to the IN-binding domain of LEDGF/p75 (gray) – Residues important for 
the enzymatic activity of IN are shown as sticks (PDB id. 2B4J)(Cherepanov et al., 
2005a)(produced with PyMOL). 
1.7. LEDGF/p75 and HIV-1 replication 
LEDGF/p75 is important for HIV replication. Potent knock-down or knock-out of 
LEDGF/p75 interferes with efficient HIV replication (Vandekerckhove et al., 2006; Zielske 
and Stevenson, 2006; Llano et al., 2006a; Marshall et al., 2007). Virus clones carrying 
mutations at the integrase-LEDGF/p75 interface are defective for HIV replication (Emiliani 
et al., 2005; Busschots et al., 2007). Overexpression of C-terminal fragments of LEDGF/p75 
drastically inhibits HIV replication (De Rijck J. et al., 2006a). Resistant HIV strains selected in 
cells overexpressing those fragments, carry mutations which lie at the integrase-LEDGF 
interface but remain dependent on the co-factor (Hombrouck et al., 2007). 
1.7.1. A tethering function of LEDGF/p75 
Upon identification of LEDGF/p75 by co-immunoprecipitation of HIV-1 IN, it was shown 
to enhance the strand transfer activity of IN in vitro (Cherepanov et al., 2003). This effect is 
lentivirus specific (Busschots et al., 2005; Cherepanov, 2007). In section 1.6.2 we already 
discussed the literature on the chromatin binding of LEDGF/p75. In addition, LEDGF/p75 
has been shown to greatly enhance the DNA binding of IN in vitro (Busschots et al., 2005). In 
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the living cell, IN and LEDGF/p75 co-localise in the nucleus and remain stably bound to 
chromosomes during mitosis (Maertens et al., 2003). Mutation of the NLS of LEDGF/p75 
disrupts the nuclear localization of IN and RNAi-mediated knock-down of LEDGF/p75 
results in a disappearance of the preferential nuclear localization of IN (Maertens et al., 2004; 
Llano et al., 2004b; Vandekerckhove et al., 2006). Based on all these experiments, a tethering 
function of LEDGF/p75 for the PIC was put forward. The N-terminal p52-part mediates 
DNA/chromatin-binding and the C-terminal ∆325-part can bind to IN through the 
conserved IBD, as such forming a molecular bridge between IN and the chromatin 
(Maertens et al., 2003; De Rijck J. et al., 2006b; Hombrouck et al., 2007). The apparent effect 
of LEDGF/p75 on the nuclear import of the pre-integration complex is most likely an 
indirect consequence of tethering (Maertens et al., 2004). Independent from the appreciable 
amount of research that has been performed on LEDGF/p75, to date no information is 
available on the strength of chromatin binding/tethering of LEDGF/p75 and if strong 
tethering of IN is a prerequisite of efficient integration. This is merely due to the fact that 
common in vitro techniques cannot assess interactions with chromatin quantitatively inside the 
cell.   
1.7.2. A targeting function of LEDGF/p75 
When LEDGF/p75 tethers IN to the chromatin, an entropic advantage for strand transfer is 
observed in vitro. In a cellular context however, integration is moreover targeted to actively 
transcribed regions in the genome. IN is the principle viral component responsible for this 
(Lewinski et al., 2006). LEDGF/p75 interacts with different components of the cellular 
transcription machinery and has even been shown to bind to specific sequences in promoter 
regions of certain genes (sections 1.6.1 and 1.6.2). Upon knockdown of LEDGF/p75 using 
RNAi, the integration pattern of HIV is perturbed (Ciuffi et al., 2005; Marshall et al., 2007; 
Shun et al., 2007). Furthermore, LEDGF/p75 responsive genes were identified by 
transcriptional profiling and found to be favored integration targets for HIV (Berry et al., 
2006). LEDGF/p75 is thus an important human factor that targets HIV replication. In the 
absence of LEDGF/p75, however, through knockdown or knockout, integration is still 
biased towards actively described regions (Ciuffi et al., 2005; Marshall et al., 2007; Shun et al., 
2007). Merely the more efficient integration in transcriptionally active and decondensed 
euchromatin in the nucleus could partially explain this; alternatively, another human or viral 
targeting factor for HIV-1 could exist. Hrp-2, for example, has been shown to be able to 
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interact specifically with HIV-1 integrase (Cherepanov et al., 2004). Its possible function in 
targeting HIV in the absence of LEDGF/p75 remains to be shown. 
1.7.3. A coordinating function of LEDGF/p75 
LEDGF/p75 was originally discovered during co-immunoprecipitation of HIV-1 IN. It 
bound with two copies to a tetramer of IN (Cherepanov et al., 2003). Later work showed that 
LEDGF/p75, and the IBD, could indeed promote IN tetramerization, which positively 
influences the strand transfer activity of IN (McKee et al., 2008). LEDGF/p75 IBD derived 
peptides that had an effect on the oligomerization of IN were shown to inhibit IN enzymatic 
activity (Hayouka et al., 2007). Structurally, the IBD of LEDGF/p75 binds at the dimer 
interface of an IN-CCD dimer (Cherepanov et al., 2005a). Importantly, contacts between the 
IN-NTD and the IBD have been suggested from a co-crystal of HIV-2 IN-NTD-CCD and 
IBD (Hare et al., 2009b). Since the function of the NTD has been shown to be promoting 
tetramerization and increasing enzymatic activity of IN, the effect of the IBD on the IN 
stoichiometry could be related to these contacts (Zheng et al., 1996; Lee et al., 1997). Cryo-
EM studies provided a first in vitro model of a tetrameric IN complexed with two 
LEDGF/p75 molecules (Michel et al., 2009). Finally, a crystal structure of maedi-visna virus 
IN NTD-CCD in complex with the IBD finally suggested that a catalytically active IN 
tetramer can be formed by domain swapping of the NTD’s of two monomers that are closest 
to each other in a IN tetramer (Figure 1.10)(Hare et al., 2009a). Important in this crystal is the 
presence of 4 unidentical binding sites for the IBD, two with strong affinity at the tetramer 
interface that make contacts both with the NTD as with the CCD, and two on the outside of 
the tetramer, of weaker affinity.   
In conclusion, although a crystal structure of full-length HIV-1 IN in complex with 
LEDGF/p75 has not yet been resolved, the CCD of IN likely induces a dimer of IN, and 
these dimers then constitute a tetramer by domain swapping of NTDs, interaction which are 
stabilized by LEDGF/p75.  
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Figure 1.10 Co-crystal structure of maedi-visna IN (NTD-CCD) and LEDGF/p75 
(IBD) in stereo view – A tetrameric IN is shown, of which one dimer is shown in 
red/green and one dimer in gray. Two of four IBDs are shown in blue. The small domain 
swapped colored NTDs of the top dimer make extensive contacts with the lower dimer. 
Whereas the bottom IBD is bound to both the IN-CCD dimer as the IN-NTD from 
another IN dimer, the top IBD is only bound to the IN-CDD dimer (Hare et al., 2009a) 
(produced with PyMOL). 
1.7.4. A protective function of LEDGF/p75 
Finally, IN expression in cells is stabilized by the presence of LEDGF/p75. LEDGF/p75 
was shown to protect IN against proteasomal degradation (Llano et al., 2004a) and has 
recently also been shown to have a protective function for other proteins (Maertens et al., 
2006). This protection seems independent from nuclear relocalisation or chromatin tethering. 
Likely, the higher order stoichiometry of the LEDGF/p75-IN complex prevents IN from 
being targeted for degradation in cells. 
1.8. Novel ways to inhibit HIV-1 replication 
Treatment of HIV infection is possible with highly active anti-retroviral therapy (HAART). 
Patients following HAART treatment take ‘cocktails’ of antiretroviral drugs that target 
different steps in the HIV replication cycle; viral fusion, reverse transcription, integration and 
proteolytic cleavage of newly synthesized viral polyproteins. However, due to the high error 
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rate of the viral reverse transcriptase enzyme, on average about 1 error per 2000 synthesized 
bases, and the high turnover of viral particles, 109 to 1010 new particles are produced each day 
in a patient, the genotype of the virus can change remarkably easy. This genotypic change 
allows for the virus to become resistant against the therapy, if viral proteins targeted by the 
drugs are modified by the genotypic change. Currently, FDA approved HIV drugs can be 
divided into six classes, the nucleoside analog, nucleotide analog and non-nucleoside reverse 
transcriptase inhibitors (resp. NRTIs, NtRTIs and NNRTIs), protease inhibitors (PIs), entry 
or fusion inhibitors and the most recent class, the integrase inhibitors. LEDGF/p75 is 
important for efficient HIV replication and has been put forward as a novel target for HIV 
treatment.  
 
 
Figure 1.11 Stereo zoom on the contact surface of a co-crystal of the IN-CCD dimer 
and LEDGF/p75-IBD – Monomers in the IN-CCD dimer are shown in yellow and blue, 
the IBD is shown in green. Important residues are shown as sticks. Important H-bonds are 
indicated (produced with PyMOL). 
Generally, drugs target small sites on a protein, such as an active site in an enzyme. Protein-
protein interactions, such as the LEDGF/p75-IN interaction, generally have large contact 
surfaces, making it unattractable for the development of small-molecule inhibitors. In the 
particular case of the LEDGF/p75-IN interaction, however, the interhelical loop of the IBD 
protrudes into the IN-CCD dimer interface (Figure 1.11), creating a rather small contact 
Chapter 1. HIV-1 integrase and human transcriptional co-activator LEDGF/p75 
26 
surface that could potentially be blocked by a small-molecule inhibitor. For example, it has 
been shown that single D366A, I365A or F406A mutations in IBD completely knock out the 
interaction with IN (Cherepanov et al., 2005b). Importantly, since LEDGF/p75 is not 
subjected to the genetic variability of the virus, inhibitors can potentially be designed that are 
less jeopardized by resistance development. Drug design for the inhibition of this interaction 
is part of ongoing research. Finally, the chromatin binding of LEDGF/p75 and its possible 
role in tethering the pre-integration complex to chromatin has been put forward as an 
important function for HIV-1 replication (De Rijck et al., 2006). Inhibition of chromatin 
binding has been shown to have profound effects on HIV-1 replication and could possibly 
constitute another important step at which HIV replication could be targeted. 
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Chapter 2. Fluorescence correlation 
and cross-correlation spectroscopy 
2.1. Confocal microscopy 
Optical microscopy is used to produce a magnified image of a microscopic sample using 
light. In a conventional epi-fluorescence microscope the excitation light from a laser or lamp 
is focused at the back aperture of the objective. This excitation light enters the sample 
defocused, illuminating the complete field-of-view homogenously, hence the name ‘wide-
field’ illumination (Figure 2.1 left).  
 
 
Figure 2.1 The wide-field versus the confocal principle – In blue is the excitation light. 
The thin black or colored lines represent the optical path of a sample in (black), above (red) 
or below (orange) the focal point of the objective. Under confocal excitation, the objective 
and pinhole allow for optical confinement of the observation spot.. 
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Fluorescence light from the substrate passes through the objective again and is spectrally and 
spatially separated from the excitation light by a dichroic mirror placed in the optical path. An 
emission filter further selects the emission band of the fluorochrome, after which the 
emission is registered by a detector. This detector, which can be the human eye or a camera, 
registers an exact image of the substrate when it is positioned in an image plane that is 
conjugate to the objective front focal plane. Optical resolution in wide-field microscopy, 
defined as the smallest distance between two point sources in the sample that can still be 
distinguished, is equal to d=0.6λ/NA, with λ the wavelength and NA the numerical aperture 
of the objective lens. For a high-NA objective, the resolution of the registered image will thus 
roughly be half the wavelength used to observe the substrate.  
In a confocal fluorescence microscope, a laser source provides stable monochromatic 
excitation light (Figure 2.1 right). This collimated light beam completely fills the back 
aperture of an objective with high numerical aperture. This creates an excitation spot spatially 
limited only by the wavelength of the light, a so-called diffraction-limited spot. Owing to the 
higher contrast, the optical resolution achieved on a confocal microscope is slightly better 
than in a wide-field microscope (d=0.4λ/NA). Fluorescence seen by the objective is 
separated from the excitation by a dichroic mirror and directed to a detector with high 
quantum yield after passing through an emission filter. Optical sectioning in the axial 
direction is achieved by placing a pinhole in a conjugated image plane of the optical path. 
Under widefield illumination this pinhole would simply act as a field diaphragm, limiting the 
image of the sample in X-Y to a spot not much bigger than the optical resolution (Figure 2.2 
left). Under confocal excitation on the other hand only a diffraction-limited spot in the 
sample is illuminated (Figure 2.2 right). The pinhole will now act as a strong off-plane 
detection cut-off, since only light waves emanating from exactly the focal plane of the 
objective will be focused in the pinhole and thus pass through. The projection of the sample 
in confocal imaging mode is thus limited in both X and Y as in Z. 
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Figure 2.2 The function of the pinhole under confocal excitation – (left) All the tube 
lenses in the optical path determine the total magnification of the sample on the image 
screen. On the Zeiss ConfoCor2 FCS microscope, a 70-µm pinhole images a 1-Airy unit 
488-nm excitation spot created by the C-Apochromat 40x/1.2W objective optimally. This 
would roughly mean that, for a typical confocal volume diameter of ~500 nm, the total 
magnification is about 140×. (right) Under confocal excitation, the pinhole acts as an off-
plane detection cut-off. 
 
As such, fluorescence in a confocal microscope can be measured in a ‘confocal volume’ as 
small as a billionth-of-a-billionth cubic metre, even smaller than a bacterium, as illustrated in 
some quantitative imaging experiments we performed inside E. coli and on the P. aeruginosa 
cell membrane (Figure 2.3). When combined with sample scanning or laser scanning, 
confocal fluorescence microscopy can generate images of samples with a resolution at the 
border of what is theoretically possible with visible light, about 200 nm in the radial and 1 µm 
in the axial direction.  
 
Chapter 2. Fluorescence correlation and cross-correlation spectroscopy 
32 
 
Figure 2.3 Fluorescence recovery after photobleaching analysis of the peptidoglycan 
binding domain of Pseudomonas phage endolysin KZ144 (PDBKZ-GFP) (A) An 
immobilized E. coli cell expressing PBDKZ-GFP in its cytoplasm (upper) and an 
immobilized P. aeruginosa cell with bound PBDKZ-GFP molecules (lower) are imaged shortly 
before photobleaching (left). Subsequently, a pole of an immobilized cell (white circle) is 
irreversibly photobleached and a new image is collected immediately (middle). After 15 
minutes a final image of the cell is collected (right). The scale bar represents 1 µm. (B-C) A 
time profile of the fluorescence signal within the bleached region is shown. Whereas 
fluorescence is recovered quickly in the E. coli cytoplasm (B), PBDKZ-GFP mobility is low 
when bound on P. aeruginosa peptidoglycan (C). The profiles are average of five (B) or three 
(C) replicates (Briers et al., 2009). 
 
At nanomolar concentrations of fluorochromes, less than 10 molecules will be present in the 
confocal volume. With fluorescence correlation and cross-correlation spectroscopy, the 
fluorescence signal from such low molecule numbers is analysed quantitatively. 
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2.2. Fluorescence correlation spectroscopy 
2.2.1. Introduction  
Fluorescence correlation spectroscopy (FCS) is a quantitative fluorescence technique that can 
be used to determine the concentration and dynamic behaviour of molecules (Magde et al., 
1972; Elson and Magde, 1974; Rigler and Elson, 2001). FCS is performed on a confocal 
microscope where, at low concentrations of fluorochrome, the recorded fluorescence signal 
spontaneously fluctuates around a constant mean. These fluctuations arise from entry and 
exit of individual fluorochromes into and out of the confocal volume. Autocorrelation, a 
mathematical signal processing technique, of the fluctuating fluorescence signal allows to 
determine both concentration and rate of diffusion. Intuitively it can be understood that the 
concentration of the fluorochrome determines the amplitude of the fluorescence fluctuations; 
the higher the concentration, the smaller the amplitude of the fluorescence fluctuations 
relative to the mean signal. The rate of diffusion on the other hand determines the duration 
of the fluorescence fluctuations. 
2.2.2. The fluorescence autocorrelation function 
In signal processing, autocorrelation is used to reveal the similarity of a signal with a time-
delayed version of itself, in order to reveal repeating patterns in the signal. For a signal X(t) 
one can calculate an autocorrelation of time delay τ as follows: 
  =<  +  > Equation 2.1
Where < > denotes the ‘time average’, the sum over all products normalized for the elements 
in the sum. We can rewrite Equation 2.1 to give the normalized fluorescence intensity 
autocorrelation function I(τ): 
  = <  +  ><  > ²  Equation 2.2
Usually, fluorescence autocorrelation is defined in terms of the fluorescence fluctuations, 
δI(t), the deviation from the mean fluorescence intensity <I>: 
  =<  > + Equation 2.3
Now we can define the normalized fluorescence autocorrelation function G(τ) (ACF) (Magde 
et al., 1972; Elson and Magde, 1974; Rigler and Elson, 2001): 
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  =  − 1 =  <  +  ><  > ²  Equation 2.4
FCS microscopes generally come with a hard- or software correlator that calculates the ACF 
in real-time so the experiment can be analysed directly after the measurement. The shape of 
the ACF is determined by the molecule detection function (MDF) and by the translational 
and rotational diffusion coefficient and photophysical propeterties of the molecules under 
observation. The MDF quantifies the efficiency with which a photon is detected from a 
fluorescing molecule in solution. It depends on the intensity distribution of the focused laser 
light and on the efficiency of detecting a photon from its point of origin (Schwille et al., 1997; 
Enderlein et al., 2005). When the MDF is approximated by a Gaussian in axial and lateral 
directions, the autocorrelation function can be described by an analytical model. In the case 
of normal Brownian diffusion of fluorescent molecules having no dark states in a 
homogenous solution under normal excitation conditions, this analytical model takes the 
following form:  
  =  1<  > ,  
,  = 11 +  
11 + ² 
Equation 2.5
With 1/<N> the amplitude of the ACF, τdiff the average diffusion time of the particles and 
S=ω2/ω1 the structure parameter, which is obtained by calibration. Parameters ω1 and ω2 are 
respectively the radial and axial distances at 1/e² times the maximal emission. Because the 
latter parameters cannot be obtained independently from fitting an ACF with Equation 2.5, 
the structure parameter S is used as a fit parameter instead. The amplitude of the 
autocorrelation function is inversely related with <N>, the average number of molecules in 
the confocal volume (Figure 2.4). This inverse relationship is logical, the lower the 
concentration, the bigger the fluctuation relative to the mean signal, so the higher the 
normalized autocorrelation. The second part of the equation describes the decay of the 
autocorrelation function. The diffusion time τdiff, the average time a molecule spends in the 
confocal volume, is defined as the correlation time at which the autocorrelation amplitude 
has decayed to half its maximal value (Figure 2.4). In Chapter 3 we will investigate which 
other factors, besides the concentration and diffusion, can affect the shape of the ACF. 
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Figure 2.4 The normalized autocorrelation function – (left) the higher the concentration, 
the higher the average number of particles N in the confocal volume, so the lower the 
autocorrelation function amplitude. (right) the slower the dynamics of the molecule of 
interest, the smaller the diffusion coefficient of the molecule, the higher the average diffusion 
time τdiff, so the further the autocorrelation function is shifted to the right.  
Generally, the autocorrelation amplitude is a brightness-weighted sum of all the individual 
species present in the solution (Rigler and Elson, 2001): 
 0 = ∑ ²  ∑   Equation 2.6
Note that in the case of a homogenous solution containing only particles with brightness B, 
the amplitude indeed simplifies to 1/N. In autocorrelation analysis, the squared dependence 
on the brightness has important consequences for analysis of mixed species with unequal 
brightness, as we will discuss further on. 
2.2.3. The apparent brightness  
The normalized ACF in principle does no longer carry any information about the absolute 
brightness of molecules, only their brightness relative to each other. However, the ratio of the 
total average signal <I> with the average number of particles <N>, the counts-per-molecule 
(CPM), can be used as an ‘apparent brightness’: 
  !" # $%&'()%*+$. (+$- = <  ><  > Equation 2.7
The CPM depends on the ‘signal-to-background’ ratio of the experiment. More specifically, 
the ‘signal’ is determined by the photophysical properties of the fluorophore (extinction 
coefficient, quantum yield, photophysical states) and by the experimental conditions (laser 
power, microscope optics, detector quantum yield). The ‘background’ on the other hand 
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represents all phenomena that contribute photons to the signal that are not originating from 
the diffusing molecules present in the 3-dimensional Gaussian detection volume (cellular 
autofluorescence, out-of-focus emission detection, scatter, APD afterpulsing,...). Importantly, 
uncorrelated noise will not affect the amplitude of fluorescence fluctuations δI, but it will 
increase the total average signal <I>. Hence, following Equation 2.4, noise will decrease the 
normalized ACF amplitude, increase the apparent particle number <N> and consequently, 
decrease the CPM. For example, for <N> = 4, <Isignal>=4 kHz and <Inoise>=4 kHz, the 
CPM will be 1 kHz/molec in absence of noise, but it will be 0.5 kHz in the presence of noise 
and moreover, <Napparent> will be 16 instead of 4. The photon counting histogram (PCH) 
technique (Chen et al., 1999), fluorescence intensity distribution analysis (FIDA) (Kask et al., 
1999) or time-integrated fluorescence cumulant analysis (TIFCA) (Wu and Muller, 2005) are 
alternative techniques to determine the brightness (and stoichiometry) of molecules, although 
they in principle suffer from the same artefacts and challenges that compromise FCS analysis. 
2.2.4. Measuring molecular properties 
The motion of a single molecule by diffusion in solution is described by a ‘random walk’ 
(Tinoco et al., 2001). At any time t, the distance (d) of the molecule from its original location 
is the standard deviation σ (Figure 2.5). The variance, σ², also called the mean squared 
displacement (MSD) is given (in two dimensions) by: 
 .² = 40 Equation 2.8
 
Figure 2.5 Random walk – Brownian diffusion of a molecule (black spot) can be 
approximated by a random walk model, where the molecule takes steps in a random 
direction with a certain step length. At time t, the distance d from its point of origin is a 
measure for its dynamic properties    
with D the diffusion coefficient, which for a globular molecule is defined by the Stokes-
Einstein law: 
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 0 = 126456 Equation 2.9
with k = 1.38×10-23 J/K the Boltzmann constant, T the temperature, η (J.s/m³) the viscosity 
(pure water 1 cP – 0.001 J.s/m³) and rH the hydrodynamic radius of the molecule. The 
diffusion coefficient thus describes the displacement of a molecule in solution over time, 
given its molecular properties (shape, rH) and that of the environment (η,T). 
In terms of the FCS analysis, measuring diff in a focal volume of ‘standard deviation’ or 
radius ω1, allows to calculate an absolute, instrument independent property of the molecule, 
D: 
 0 μ) ⋅ (9: = ;:4 Equation 2.10
Typically, ω1 is obtained by measuring the diffusion time of a reference fluorochrome with a 
known D (Table 2.1). 
 
Table 2.1 Diffusion coefficient standards – List of commonly used fluorochromes for FCS calibration 
with their most accurately determined D. ME = mercaptoethanol derivative, CA = free carboxylic acid, 
SE = succinimidyl ester derivative. 
Fluorochrome 
D 
(µm²/s) 
T 
(°C) 
References 
rhodamine 6G 426 22.5 (Petrasek and Schwille, 2008) 
oregon green 411 25 (Muller et al., 2008) 
ATTO 655 ME 407 25 (Muller et al., 2008) 
ATTO 655 CA 426 25 (Muller et al., 2008) 
alexa fluor 488 SE 435 22.5 (Petrasek and Schwille, 2008) 
alexa fluor 546 SE 341 22.5 (Petrasek and Schwille, 2008) 
fluorescein 436 22.5 (Paul et al., 1998; Petrasek and Schwille, 2008) 
eGFP 95 22.5 (Schenk et al., 2004b; Petrasek and Schwille, 2008) 
 
As said above, D allows to calculate rH, which for a globular molecule allows to give an 
estimate about the relative molecular mass, Mr: 
 "<  = ⋅ )%*9: = 43 4?@6A Equation 2.11
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With ρ the density of the molecule (1.2 g/cm³ for proteins) and NA Avogadro’s number. One 
can thus see that D and Mr are related as follows: 
 D ~ ME9:/A Equation 2.12
Knowing D for a reference protein in a certain medium, allows to estimate the D for another 
protein in the same medium.   
The dimensions of the confocal volume can be determined by measuring τdiff and S for a 
probe with known D and calculating ω1 and ω2. From these parameters the volume can be 
calculated with: 
 G)A = 4A/;:; Equation 2.13
Alternatively, the volume can be approximated with a cylinder (applications handbook of the 
Zeiss ConfoCor2 microscope): 
 G)A = 2π;:; Equation 2.14
With the volume and the average number of particles known, one can also calculate the 
absolute concentration of the molecule: 
  " = <  >G@  Equation 2.15
If one assumes a confocal volume of 1 fL (1 µm³), at a concentration of 1 nM about 0.6 
particles are on average present in the confocal volume.  
2.2.5. Experimental models for FCS 
2.2.5.1. Fast fluorochrome intensity fluctuations 
When a fluorochrome is in the excited state, there can be a certain probability with which it 
can enter a short-lived dark state, such as the triplet state, a light-enhanced cis-trans 
isomerized state, a light induced protonated state, etc. At the excitation intensities used for 
FCS, fluorochromes frequently enter non-fluorescent states. Triplet conversion for example, 
renders a fluorochrome dark for a couple of microseconds, and typically appears in the 
experimental ACF at this time scale.  
To account for this in the fitting of the ACF we can expand Equation 2.5 (Widengren et al., 
1995; Schwille et al., 2000): 
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 =  1 I JK<L1 − JK<L exp #− K<L- + , ,PQ Equation 2.16
Mostly, τdark << τdiff, and Equation 2.16 is often rewritten as: 
 
 
 =  1 I JK<L1 − JK<L exp #− K<L- + 1Q , ,P Equation 2.17
In the presence of a fast dark state, the ACF amplitude is equal to N(1-Fdark) and thus 
represents the average number of molecules in the bright state. This model may easily be 
expanded to contain multiple dark states, as we will see in Chapter 7 when the photophysical 
properties of red fluorescent proteins are studied. 
2.2.5.2. Two diffusing species 
In the case a mixture of two different species (different size or brightness) the ACF looks as 
follows: 
  =  RS²TSRSTSURVTV² , ,: +  RV²TVRSTSURVTV² , ,  Equation 2.18 
with B1,2 the brightness of species 1,2 and N1,2 the number of particles of species 1,2. In the 
case that B1 = B2 this model simplifies to: 
 
  =  TSTSUTVV , ,: +  TVTSUTVV , , Equation 2.19 
 which in a simpler form looks like: 
 
 WX =  YZYUZ[ \]YW^X, X_`aa,Y + Y − ]YW^X, X_`aa,[b Equation 2.20
where total number of particles N = N1 + N2 defines the amplitude of the ACF, and F1,2 are 
the respective fractions of species 1 and 2. This is the standard model for 2-component 
diffusion. We can try to rewrite Equation 2.18 similarly: 
  = :TSUTV c RSVdSRSdSURV:9dS² , ,: + RVV:9dSRSdSURV:9dS² , ,e  Equation 2.21
Consequently, without preliminary knowledge of B1 and B2, fitting with Equation 2.20 works 
as well for species with unequal brightness, but the fraction components will be scaled by the 
square of their brightness and by their fraction. Not only that, as we can see from the 
amplitude of the ACF, the obtained particle number is not the real particle number: 
 0 = :: + ::+² = 1: +  :J:+1 − J:²:J: + 1 − J: =
1f Equation 2.22
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For example, if B2 = 10×B1 and N1=N2, then F2,app = 100×F1,app and the apparent particle 
number is 40% smaller than the real value. Knowledge of the brightness of the particles is 
thus absolutely necessary for correct concentration determination if particles tend to form 
oligomers. As we will see further on, Equation 2.22 can also be used to correct for or 
quantify FRET. 
2.2.5.3. Anomalous diffusion 
In the case of Brownian diffusion the mean squared displacement of a molecule increases 
linearly in time (Equation 2.8). Under circumstances of anomalous or obstructed diffusion, at 
short time scales diffusion still seems normal but as time increases the MSD seems to lag 
behind (Crank, 1975). Empirically, under these circumstances the MSD follows a power law 
of t: 
 "0 =  40g Equation 2.23
With α<1 the anomaly parameter describing the strength of obstruction (Figure 2.6 left). We 
can modify Equation 2.5 to take anomalous diffusion into account (Schwille et al., 1999; 
Wachsmuth et al., 2000): 
  =  1<  > 11 + # -g 
11 + 1² # -g Equation 2.24
Since the diffusion coefficient has units of µm²/sα, it can no longer be interpreted in terms of 
molecular size, even though the correlation time at half amplitude is unaffected by an 
anomalous trend of the ACF (Figure 2.6 right). Apparent anomalous diffusion can be a 
consequence of obstructed diffusion (Saxton, 1994; Weiss et al., 2004), or binding to 
immobile structure (Saxton, 1996), as has been simulated for chromatin binding (Wedemeier 
et al., 2008) or in some cases heterogeneous particle size distributions. Binding of proteins to 
chromatin will be discussed in detail in Chapter 4. 
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Figure 2.6 Anomalous diffusion – (top) Mean square displacement versus time for normal, anomalous 
and superdiffusion (Crank, 1975). (bottom) Simulated ACFs in a confocal volume with S=5, N=5 and a 
diffusion time of 500 µs. The relaxation time of the fast process is 5 µs. The anomaly parameter α is 1,0 
(── ); 0,8 (- - - ) en 0,6 (). 
2.2.5.4. Rotational diffusion 
Diffusing molecules move both by translational and rotational diffusion. Next to translational 
diffusion, rotational diffusion, in principle, is also observed in the ACF of a fluorochrome 
when using linearly polarized excitation light. In eGFP for example, the rigid fluorophore is 
part of the protein, so rotational diffusion of eGFP can be observed in the tens of 
nanoseconds time scale. Generally, when the excitation and emission polarization directions 
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are parallel, a high autocorrelation is observed at a time scale faster than the rotational 
correlation time. When excitation and emission polarization directions are perpendicular, an 
anti-correlation is seen at this time scale. Since the time scales of rotational and translational 
diffusion are usually well separated, the autocorrelation function can be expanded with an 
exponential to take the rotational diffusion into account (Ehrenberg and Rigler, 1974; Kask et 
al., 1987; Widengren et al., 1999a): 
  = 1 +  1<  > c1 + h exp− i e  Equation 2.25
With A, the amplitude of the exponential, that depends on the geometry of the experimental 
setup and θ the experimental rotational correlation time. Rotational diffusion is, due to its 
third-power dependence on the hydrodynamic radius of the molecule, much more sensitive 
to study the size of particles: 
 i = 60<9: = 4456A3j2  Equation 2.26
With Dr the rotational diffusion coefficient and R = 8.314 472 JK−1 mol−1 the gas constant.  
2.2.6. Quenching 
FCS is often used in ligand binding studies. It can happen that the brightness of the 
fluorochrome is altered upon binding. By introducing a parameter R, the relative brightness 
of the fluorochrome in the bound versus the free state (Foldes-Papp, 2005), this quenching 
can be taken into account: 
  = <kk + jlmnP<kk + jlmnP² Equation 2.27
Quenching will result in a lower apparent brightness. For fluorescent proteins, quenching is 
often not a problem since the fluorophore lies inside of the rigid beta-barrel structure and is 
rather insensitive to the environment. 
2.2.7. Advanced FCS 
In its original form, FCS is performed on a setup with a continuous-wave excitation laser and 
a single channel detection unit. Although in many cases this is adequate, continuing efforts 
are made to improve the performance of FCS. These efforts, illustrated in Figure 2.7 and 
discussed in the following sections, can be divided into 4 categories: increasing the range of 
concentrations, increasing the timescale of dynamics, increasing the statistical accuracy and 
precision and increasing the spatial information per measurement. 
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Figure 2.7 Time scale and dynamic range of different FCS based methods 
– For details on the techniques see sections 2.2.7.1-2.2.7.5. 
2.2.7.1. Low concentrations and fast dynamics 
The signal-to-noise ratio of an FCS experiment, as discussed in 2.2.3, sets the lower limit for 
accurate concentration measurements to about 1 nM. By using picosecond pulsed lasers 
instead of CW-lasers in combination with time-correlated single photon counting (TCSPC) 
instrumentation, this barrier can be overcome. With time-gated FCS, only photons arriving in 
a certain ‘time gate’ with respect to the excitation pulse are used for calculating the ACF 
(Lamb et al., 2000). Like this, the signal originating from background or scatter can be greatly 
suppressed. With time-resolved FCS, also known as fluorescence lifetime correlation 
spectroscopy (FLCS), the fluorescence decay curve of the fluorochrome is used to calculate a 
‘statistical filter’, that in term is used to eliminate all non-wanted photons from the signal 
prior to the calculation of the ACF, effectively eliminating the noise (Bohmer et al., 2002; 
Kapusta et al., 2007). Both with time-gated FCS as with FLCS, the accuracy of the ACF at 
extremely low concentrations is greatly improved and FCS measurements can be performed 
reliably down to the pM range. With time-gated FCS and FLCS the ACF can be measured 
from the picosecond time scale all the way to the standard FCS timescale, eliminating the 
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need for a dual detector cross-correlation setup to avoid detector artefacts (Widengren et al., 
1995; Enderlein and Gregor, 2005). In this way, ultrafast dynamics, unaccessible by standard 
FCS can now be studied, such as rotational diffusion, as discussed in section 2.2.5.4. Also, the 
antibunching properties of the fluorochrome can be measured, and stoichiometries can be 
determined (Sykora et al., 2007).  
2.2.7.2. High concentrations 
At high concentrations the low fluctuation amplitude decreases the precision of an FCS 
measurement. This sets an upper limit of about 1 µM to the concentrations that can be 
measured accurately with FCS. A straightforward solution to this problem would be to 
decrease the confocal volume in order to increase the fluctuation amplitudes. Some methods 
have been put forward to circumvent the diffraction-limitation of FCS measurements. The 
first method is based on total internal reflection and allows to measure the concentration of 
molecules close to or bound to the glass surface (Thompson et al., 1981). The second 
method is based on stimulated emission depletion of the fluorochromes everywhere but in 
the centroid of the focal spot, leading to an apparent smaller focal spot (STED-FCS) (Hell 
and Wichmann, 1994; Eggeling et al., 2009). The last method is based on the physical 
limitation of the focal spot in solution by measuring on a cover glass with a metal film 
containing nanoholes (Levene et al., 2003). 
2.2.7.3. Slow dynamics 
Fluorescence fluctuations arise from the diffusion of molecules. If a protein or protein 
complex is very slow or immobile, fluorescence will not fluctuate fast enough or not at all for 
FCS to accurately measure protein dynamics and interaction. In addition, because FCS is a 
point-measurement, the same fluorochromes will be illuminated the whole time. This will 
lead to photobleaching, the irreversible loss of fluorochrome fluorescence. If photobleaching 
is significant, the apparent diffusion time will decrease and the apparent particle number will 
continuously decrease. Photobleaching of slow molecules can be avoided by keeping the 
excitation stress low, while still allowing to acquire as many photons as needed for a 
statistically good measurement. Originally, this was done by physically moving the sample 
with respect to the laser (Petersen, 1986), but nowadays laser scanning has largely replaced 
sample scanning. In the line scanning FCS and circle scanning FCS method, the laser is 
moved in discrete patterns across the sample (Meyer and Schindler, 1988; Berland et al., 1996; 
Ruan et al., 2004; Petrasek and Schwille, 2008; Ries et al., 2009), allowing to study slow 
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dynamics more accurately. In the image correlation spectroscopy (ICS) method, the size and 
concentration of immobile clusters can be determined (Petersen et al., 1993). The raster 
image correlation spectroscopy (RICS) method allows to calculate both fast and slow 
dynamics by a spatio-temporal correlation of individual pixels in a LSM image (Digman et al., 
2005). What all the above cited methods have in common is that the exposure time of the 
molecules can be tuned to their mobility, thus avoiding photobleaching. Finally, a 
mathematical ‘trick’ also exists to correct for photobleaching by correcting the count rate 
trace prior to autocorrelation (Ries et al., 2009): 
 
 Jom<<kopk = J<kom<kqr/r0 + r01 − qr/r0 Equation 2.28
Where f(t) is a function used to fit the experimental count rate trace 
 r = s0 + t h exp −/u Equation 2.29
Correcting the ACF in this way does restore the amplitude and shape of the ACF when 
photobleaching occurs, but it does not correct or quantify the apparent faster diffusion time.  
2.2.7.4. Absolute diffusion coefficients 
Determining absolute diffusion coefficients with FCS can be challenging, since the exact 
shape of the confocal volume is hard to take into account when analysing the ACF. Several 
FCS methods that use an extrinsic ruler to determine absolute diffusion coefficients have 
recently been proposed. Enderlein reported two-focus or dual-focus FCS (Dertinger et al., 
2007b). In this method a Nomarski prism is placed in front of the back aperture of the 
objective. When two coinciding alternatively pulsing excitation (pulsed interleaved excitation, 
PIE) beams, each linearly polarized but orthogonal to each other, pass through this prism, a 
small ~200-nm shift occurs between them. These two beams are focussed by the objective 
and two focal spots are created next to each other. Emission from these spots is finally 
detected in cross-correlation mode. The diffusion time from the cross-correlation function of 
one spot with the other is a function of only the properties of the Nomarski prism. All 
optical artefacts (cover glass thickness, astigmatism, refractive index) are cancelled out by this 
way of measuring, providing a way to measure accurately the absolute diffusion coefficient 
(Table 2.1). In addition, 2-focus FCS seems to be more precise than standard FCS, allowing 
to measure differences as small as 3% in D (Dertinger et al., 2007a). Furthermore, since 2-
Chapter 2. Fluorescence correlation and cross-correlation spectroscopy 
46 
focus FCS is performed on a pulsed laser setup, there is an extra advantage of removing the 
noise. Another method for determining absolute diffusion coefficients is dual-line scanning 
FCS, because the distance between two arbitrary scan lines is known with very high accuracy 
(Ries and Schwille, 2006). Finally,  circle scanning FCS can  also be used for absolute 
concentration measurements if the circle diameter is calibrated well (Petrasek and Schwille, 
2008). 
2.2.7.5. Spatial information 
Standard FCS measurements are point measurements. Spatial information can logically be 
obtained by measuring consecutively at different spots. Recently however, a microscopy 
setup was proposed that uses two independent foci, allowing the simultaneous measurement 
of FCS (or FCCS) in two arbitrary points (Ferrand et al., 2009). Determining (slow) dynamics 
in whole images at once is possible with temporal image correlation spectroscopy (ICS) and 
variants thereof (spatiotemporal ICS, k-space ICS)(Hebert et al., 2005; Kolin et al., 2006). 
This holds great promise for the future of correlation analysis in biological samples. Very 
recently a method, based on second-order correlation functions of photoblinking 
fluorophores, has been put forward, super-resolution optical fluctuation imaging (SOFI), that 
can increase the resolution of wide-field imaging in three dimensions (Dertinger et al., 2009). 
2.3. Fluorescence cross-correlation spectroscopy 
2.3.1. Introduction  
Dual-color or two-color fluorescence cross-correlation spectroscopy (FCCS) is an extension 
of FCS that allows studying the interaction between molecules (Schwille et al., 1997). The 
principle of this technique, fluorescence fluctuation measurements, is similar to that of FCS, 
but in FCCS two spectrally separated excitation and detection paths allow independent 
studying of two fluorochromes. More specifically, autocorrelation of the two signals provides 
dynamic and concentration information about each of the molecules and cross-correlation of 
the two signals provides information on the interaction between the molecules. Intuitively 
this can be understood as follows: if a complex of both molecules crosses the confocal 
volume then two independent fluorescence peaks will be registered at the same time. 
However, if the molecules are not interacting the two fluorescence peaks will likely not 
coincide in time. 
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2.3.2. The fluorescence cross-correlation function 
In signal processing, cross-correlation is used to reveal the similarity of two signals as a 
function of the time delay between them. For two signal X(t) and Y(t), one can calculate the 
normalized cross-correlation as follows: 
  =< v +  > Equation 2.30
Similar as for FCS, we can write for the normalized fluorescence cross-correlation function 
GCC(t) (Schwille et al., 1997; Rigler et al., 1998): 
 ww =  < x< +  >< x >< < >  Equation 2.31
Where Ig and Ir represent the average fluorescence intensity in the green and red detection 
channel, respectively. Generally, as for autocorrelation analysis, the cross-correlation 
amplitude is a weighted sum of the individual species (Schwille, 2001): 
 ww0 = ∑ ,x,< ∑ ,x ∑ ,<  = 1< ww > Equation 2.32
Where Ni is a particle with brightness Bi,g in the green channel and Bi,r in the red channel. The 
mathematical model describing the whole CCF is similar as the one given in Equation 2.5, 
with  the amplitude ‘1/<N>’ from Equation 2.32. We can simplify Equation 2.32 for the 
simplest case of a mixture of monomeric and heterodimeric particles: 
 ww0 =  x<x<xx + x<<< + x< 
= x<x + x<< + x< = x<x,pmpKy<,pmpKy 
Equation 2.33
This is the well-known standard formula for FCCS analysis (Schwille et al., 1997; Rigler et al., 
1998; Schwille and Haustein, 2001; Schwille, 2001; Foldes-Papp, 2005). This amplitude is 
inversely proportional to the total concentration of both green and red particles, similarly to 
an FCS measurement, and directly proportional to the number of double-labeled particles. 
When proteins do not interact, Ngr is 0, so the cross-correlation will be 0, the higher Ngr, the 
higher the cross-correlation. When the solution contains only heterodimeric particles, or if 
Ngr >> Ng, Nr, i.e. almost all particles are double labelled, then the cross-correlation 
amplitude is inversely related to the Ngr (Rigler et al., 1998): 
 ww = 1x< Equation 2.34
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When the green (or red) protein is in excess, then Equation 2.33 simplifies to: 
 ww = 1x m< < Equation 2.35
When both proteins are in excess over their complex, Equation 2.33 simplifies to (Rigler et 
al., 1998): 
 ww = x<x< Equation 2.36
 
2.3.3. Measuring molecular properties 
Since the two optical paths of the two fluorochromes generally have different molecular 
detection functions, the confocal volumes Vgreen and Vred often are not the same. In fact 
(discussed further in section 2.3.4), the red volume is always slightly larger than the green 
volume. We can approximate the cross-correlation volume, where double labeled particles 
can be detected, with the root mean square of the axial and radial radii of the green and red 
confocal volume (Schwille et al., 1997): 
 ;:,ww = z;:,{ + ;:,|2  Equation 2.37
 ;,ww = z;,{ + ;,|2  Equation 2.38
 Gww = 42A/;:,x + ;:,< };,x + ;,<  Equation 2.39
This volume lies in between the green and red volumes. The diffusion coefficient of the 
double labelled particles, by analogy with Equation 2.10, is defined as (Schwille et al., 1997): 
 0 μ) ⋅ (9: = ;:,{ + ;:,|8  Equation 2.40
The concentration of double labelled particles can be calculated by analogy with Equation 
2.15:  
 [j]" = x<Gww@ Equation 2.41
Ngr can be obtained from Equation 2.33 simply by measuring the amplitudes of the ACFs 
and CCF and VCC can be obtained from Equation 2.39.  
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2.3.4. Non-idealities 
Under ideal experimental conditions for FCCS, the two fluorochromes used are each 
observed independent from each other in an identical confocal volume in solution. In 
practice however, there are some critical non-idealities that need careful consideration, if 
quantitative analysis of FCCS is needed. In Chapter 6, we will take these non-idealities into 
account when we analyse an FCCS experiment quantitatively. In the following sections, the 
common non-idealities volume overlap, crosstalk, FRET and dark states will be introduced. 
2.3.4.1. Volume overlap 
Ideally green and red molecules are ‘seen’ in the same confocal volume. In general terms, this 
means the two excitation and emission paths image the very same spot in solution. This has 
two requirements. First, excitation spots for different colors should overlap both in XY as in 
Z. Second, the two fluorochromes should have similar molecular detection efficiencies in 
their excitation spot. Although the second requirement depends on the choice of 
fluorochromes and on the calibration of the microscope, the first requirement is less trivial to 
fulfill. On a commercial multi-laser setup, lasers are coupled into a single optical fiber which 
is coupled into the microscope. This allows independent calibration of the laser coupling unit 
and the microscope and moreover, it makes different laser lines create a concentric 
multicolour beam in the microscope. However, because of the wavelength dependence of 
optical refraction, most objectives focus light of a different color in a different spot, a 
phenomenon called axial chromatic aberration (Figure 2.8).  
 
Figure 2.8 Axial chromatic aberration The more red the excitation 
wavelength is, the bigger the excitation spot will be and the farther it is located 
from the objective front aperture. 
Even objectives that are maximally corrected for optical aberrations, ‘Apochromats’, still 
exhibit axial chromatic aberration, which is especially noticeable when two wavelengths differ 
much, for example 488/633-nm excitation. In what follows, the parameters from an FCCS 
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measurement are first evaluated in the presence of incomplete overlap, after which some 
methods will be discussed that allow to minimize or avoid incomplete volume overlap. 
 
2.3.4.1.1. Evaluation 
If the sizes of the different volumes (green, red and cross-correlation volume) are known, 
then an incomplete volume overlap can be taken into account when analyzing the curves. We 
illustrated the effect of and incomplete overlap in Figure 2.9. The particle numbers in 
Equation 2.33 are each observed in their respective confocal volume (Schwille et al., 1997; 
Rigler et al., 1998; Bacia et al., 2002; Kohl et al., 2005; Oyama et al., 2006): 
              VCC 
                   ↑ 
 ww0 = x<x< + xx< + < Equation 2.42
                             ↓                ↓ 
                            VG                VR   
 
2.3.4.1.2. Optimizing the pinhole diameters 
In principle, by opening the green pinhole and closing the red pinhole a little, the effective 
size of the confocal volumes can be changed (Schwille et al., 1997). First, one calibrates the 
XYZ positions of the pinholes at the two respective excitation wavelengths (for example 488 
nm for the green detection path and 543 nm for the red detection path). The pinholes then 
image their conjugate excitation spots perfectly. In a next step, an FCCS measurement is 
performed with only one laser on a probe that emits in the two detection channels. If the two 
pinholes image exactly the same spot in solution, the three curves (one CCF and two ACFs) 
overlap completely. If not, the pinholes can be tuned such that the amplitudes of the three 
curves overlap. This step can be repeated with the other laser and should provide the same 
overlap. Importantly, the particle numbers obtained at both excitation wavelengths need not 
be the same, considering the wavelength-dependence of refraction and considering possible 
excitation intensity dependent photophysics such as optical saturation (section 3.3.5) and dark 
state formation (section 7.3.1.1). Finally, when two excitation wavelengths are used that give 
focal spots with a significant axial shift, such as 488 nm and 633 nm, pinhole optimization 
cannot completely correct for incomplete overlap. It is then better to optimize the beam 
diameter. 
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Figure 2.9 Incomplete overlap (top and middle) Simulated ACFs and CCF for the case of a 
solution containing only green-and-red particles and green:red volume ratio of 1:1 (top) or 
1:1.37 (middle) as is the case for the Zeiss ConfoCor2 microscope. The particle numbers 
obtained from each CF scale with the size of the respective volume. (bottom) Simulated 
ACFs and CCF for the case of a solution 100 nM green-and-red particles and 100 nM green-
only and red-only particles. Incomplete overlap decreases the CCF amplitude. 
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2.3.4.1.3. Optimizing the beam diameter 
By decreasing the diameter of the laser beam entering the back aperture of the objective, the 
effective numerical aperture of the objective at that wavelength is reduced, resulting in a 
slightly larger focal point. Like this, the overlap of the two focal excitation points can be 
optimized (Figure 2.10). On a commercial microscope, this is usually not possible since laser 
lines are combined in a single fiber before entering the microscope. 
 
Figure 2.10 Optimizing beam diameter – By decreasing the 
blue beam diameter, a bigger blue excitation spot is created that 
overlaps better with the red excitation spot. 
To calibrate such a setup, a fluorochrome is needed that is excitable by the two lasers and 
emits in the two detection channels. Absolute (optical saturation error free and dark state 
error free) particle numbers are obtained by extrapolation to zero excitation intensity. If the 
ACF amplitude is independent of the laser used to excite the probe, or the channel in which 
it is detected, then a perfect 3-dimensional volume overlap is achieved. 
 
2.3.4.1.4. Single wavelength or two-photon excitation 
When only a single wavelength is used to excite the two fluorochromes (SW-FCCS), all auto- 
and cross-correlation functions are measured in the same volume, provided that the pinholes 
are correctly aligned (see section 2.3.4.1.2). For example, it has been shown that by using only 
the 514-nm Ar-ion laser line both eGFP and mRFP can be excited at the cost of a lower 
CPM for both fluorochromes (Hwang and Wohland, 2004). Similarly, by employing cyanFP 
in combination with a fluorescent protein with an ultra-long stokes shift (mKeima), SW-
FCCS could successfully be performed at 458 nm excitation (Kogure et al., 2006). Finally, it 
has been shown that eGFP and Alexa633 can be both efficiently excited at 920-nm by two-
photon excitation (Kim et al., 2005), avoiding an incomplete volume overlap and more 
importantly, significantly reducing cross-talk (which will be discussed in the next section). 
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2.3.4.2. Cross-talk 
Ideally, the fluorescence of the green and red fluorochrome can be spectrally separated in the 
detection part of the microscope but in reality there is always some unwanted emission of the 
green fluorochrome into the red detection channel, called cross-talk. One can minimize 
cross-talk by choosing a fluorochrome pair with large spectral separation, but in cells one is 
very often obliged to using fluorescent proteins, which have a significant spectral overlap. 
 
2.3.4.2.1. Evaluation 
Because cross-talk cross-correlates with the signal in the green channel, it can pose a problem 
for quantitative FCCS measurements. Suppose one is working at equimolar concentrations of 
green and red protein and the emission of the green protein in the red channel is 10 times less 
than the red protein in the red channel. We can account for cross-talk of the green 
fluorochrome in the cross-correlation amplitude (Equation 2.32): 
 ww = xox + 0<< + x< + ox<xx + 0< + xx<ox + << + < + ox< Equation 2.43
With Bg the brightness of the green fluorochrome in the green channel,  Br the brightness of 
the red fluorochrome in the red channel and Bc the brightness of the green fluorochrome in 
the red channel. Dividing numerator and denominator with BgBr simplifies the expression 
(Rigler et al., 1998; Foldes-Papp, 2005): 
 ww = x< + x + x<x + x<\<+x< + x + x<b 
= x< + x,pmpKyx,pmpKy<,pmpKy + x,pmpKy 
Equation 2.44
with    
  = o< = ℎ+ + +)((%' %r ℎ+ =++' r*&%%$ℎ%)+ ℎ+ + +)((%' %r + r*&%%$ℎ%)+  Equation 2.45
To calculate Ngr, one has to know <Ncc>, Q, Ng,total, Nr,total.  Q can be measured in an in vitro 
experiment, <Ncc> is measured in the CCF and Ng,total is measured in the green ACF. Nr,total 
can only be known from a single color excitation red AC measurement, since in two color 
excitation Equation 2.21 would have to be used to fit the data, where Ntotal and F1 would be 
both unknown. (F1 = Nred/Ntotal). Importantly, when Ngr >> Ng  and Nr, then Equation 2.44 
simplifies to 1/Ngr, i.e. cross-talk can be ignored. Likewise, for a mixture of green and green-
and-red molecules, Nr = 0, and the CCF amplitude simplifies to 1/(Ng+Ngr). For fluorescent 
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proteins, Q can be measured in vitro in a viscous buffer, to separate photophysics and 
diffusion well. Equimolar concentrations of the proteins are mixed, as judged by the 
amplitude of the ACFs measured in single color excitation mode. The signal in the red 
channel upon 488 excitation relative to dual color excitation is equal to Q. When using 
mRFP1/mCherry and eGFP as fluorescent tags Q ≈ 0.2. We will discuss this further in 
Chapter 6 when we analyse FCCS of mRFP-eGFP and mCherry-eGFP in detail. Finally, as 
we have discussed in section 2.2.5.2 the dim green particles observed in the red channel will 
not contribute significantly to the decay of the red FCS curve (Fdimgreen=0.01Fred), but the red 
particle number will be underestimated by 40%, which has to be corrected for. 
 
2.3.4.2.2. FCCS without cross-talk 
A disadvantage of fluorescent proteins is their limited spectral range, which gives rise to both 
cross-talk (2.3.4.2.1) and FRET (as we will discuss in the next section), when performing 
FCCS as originally proposed (Schwille et al., 1997). Although in principle possible to correct 
for, they complicate FCCS analysis considerably. Over the last years, variations on the 
original FCCS method have emerged that rely on the temporal separation of fluorochrome 
excitation, avoiding cross-talk completely. Thews et al reported a method for the temporal 
separation of excitation of eCFP and eYFP with detection on one detector, by using acousto-
optical modulated CW-excitation at 425-nm and 515-nm (Thews et al., 2005). This method, 
also called alternating laser excitation (ALEX) in FRET studies, completely avoids emission 
cross-talk. Muller et al concurrently reported a method, pulsed interleaved excitation (PIE) 
FCCS, with both temporal excitation separation as spectral emission separation by using a 
dual detection setup and pulsed diode lasers (Muller et al., 2005). This setup has as additional 
advantage that APD afterpulsing and excitation cross-talk is also completely avoided. Finally, 
Takahashi et al. introduced a simple method to avoid cross-talk on a microscope with CW-
lasers by using an acousto-optical tunable filter in the excitation path (switching method) 
(Takahashi et al., 2008). The availability of a 531-nm pulsed diode has recently opened the 
way for exciting both GFPs and RFPs with picosecond pulsed diodes, allowing background 
and scatter light to be removed in addition to all previously mentioned advantages, which 
increases the S/N considerably. 
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2.3.4.3. FRET 
Förster resonance energy transfer (FRET) is the radiationless transfer of the excited state 
energy of a donor fluorochrome to an acceptor fluorochrome, provided that the donor 
emission spectrum overlaps with the acceptor excitation spectrum and provided that the 
distance between both fluorochromes is not too large (generally smaller than 10 nm). The 
efficiency of this process is expressed with the FRET efficiency E, which varies between 0 
(no energy transfer) and 1 (complete transfer). The intermolecular distance has a strong effect 
on the FRET efficiency, due to the dipole-dipole coupling mechanism in FRET. The 
intermolecular (interfluorochrome) distance r can be estimated from E with: 
  = ju z1 −   Equation 2.46
With R0 the Förster radius of the fluorochrome couple, the distance between the 
fluorochromes when the FRET efficiency has decreased by 50%. How E is measured will be 
discussed in Chapter 5. We compared the different fluorescent protein couples generally used 
for FCCS (Table 2.2). Since these fluorescent protein couples perform quite well in FRET, as 
indicated by the small R0 values, we evaluated the effect of FRET on the obtained parameters 
from FCCS.  
 
Table 2.2 Comparison of different fluorescent protein couples used for FCCS – R0 = Förster 
distance, ∆λem,max = wavelength difference in the fluorescence emission maxima of the two 
fluorochromes, a larger difference is beneficial for FCCS, since it lowers cross-talk, photostability 
and brightness are represented as + (good) or – (not good) both for the green as for the red partner. 
Finally, the performance of the couples in FRET and FCCS are given. 
couple R0 ∆λem,max Photostability Brightness Reference FRET FCCS  
eGFP/mRFP1 4.7 100 +/- +/+ (Campbell et al., 2002) ++ ++ 
eGFP/mCherry 5.1 103 +/+ +/+ (Shaner et al., 2004) ++ ++ 
eGFP/TagRFP-T ~5 77 +/++ +/++ (Shaner et al., 2008) ++? +++? 
eCFP/mKeima - 144 +/+ +/- (Kogure et al., 2006) - + 
 
In principle, a reduction of the green fluorochrome brightness and an increase of the red 
fluorochrome brightness is observed, when the photophysical properties of the 
fluorochromes and the interfluorochrome distance and orientation allow for FRET. The 
amplitude of the ACFs can be calculated with Equation 2.22: 
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Green ACF 
Ng,app = x + 1 − x<x + 1 − x<  
= x,<kKy Jx + 1 − Jx<²Jx + 1 − Jx<  
Equation 2.47
Red ACF 
Nr,app = < + 1 − x<< + 1 − x<  
= <,<kKy J< + 1 + Jx<²J< + 1 + Jx<  
Equation 2.48
Knowing the fractions of green-only, red-only and green-and-red molecules, these equations 
allow to directly calculate the real particle numbers from the ACF amplitude. The amplitude 
of the CCF in the case of FRET can be calculated with Equation 2.33: 
CCF ww,K = 1 − 1 + x<x + 1 − x<< + 1 + x< Equation 2.49
While the error on the total concentrations (as determined from the autocorrelation curve 
amplitudes) stays below 10% even for 50% FRET efficiency, the error on the concentration 
of complex [GR] can increase up to 50%, so a good knowledge of possible FRET is crucial 
for quantitative FCCS analysis. FRET can be quantified by an ensemble fluorescence lifetime 
measurement by monitoring the decrease of the lifetime of the donor in the presence of the 
acceptor. However, ensemble results may not be easily translatable to the single protein level 
as measured in FCCS. For example, RFPs are known to have transient but also long lived 
dark states, and have been reported to take longer to mature. Reversibly, the effect of FRET 
on the CCF amplitude can be exploited to quantify the transfer efficiency (Muller et al., 
2005). 
2.3.4.4. Fast dark states 
If one of the fluorochromes in a complex enters a short-lived non-fluorescent dark state, a 
single-colored particle is temporarily formed. However, this does not reduce the experimental 
cross-correlation amplitude, as long as the dark state is significantly faster than the diffusion 
time scale. This can be understood quite easily, if a cross-correlation calculation is made for a 
discrete dataset: 
  = 1 t <,,p ∙ x,,pU< < >< x >
T
:  Equation 2.50
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If signal Ig is constant in time and signal Ir has transient dark states, their normalized cross-
correlation function will not change due to the dark states, since dark states decrease the 
average <Ir> as much as they decrease the correlation term Ir,i,t·Ig,i,t+τ. In terms of the real 
cross-correlation amplitude (Equation 2.33), dark states have the same effect on Ngr as on 
Ng,total or Nr,total so disappear from the equation. 
2.3.5. Higher stoichiometries 
It is possible to determine the stoichiometry of the protein complex of interest, provided a 
well characterized FCCS method is used: 
- Fluorochromes with dark subpopulations (such as RFPs) should be avoided, because 
they will complicate the analysis too much 
- FRET and cross-talk are better avoided, so the combination of a far-red and a green 
fluorochrome is best 
- Incomplete volume overlap is also best avoided, so it’s better not to use lasers that are 
coupled into one fiber if one wants to use 2-color excitation. If the fluorochrome pair 
allows it, one can also use 2-photon excitation. 
A good (and only) example of stoichiometry determination with FCCS is the in vitro and 
intracellular study of the binding degree, binding affinity and concentrations of Alexa633-
labeled Calmodulin (CaM) and Ca2+/CaM-dependent protein kinase II labeled with eGFP 
under different experimental conditions (Kim et al., 2004; Kim et al., 2005). In general, when 
considering the following binding reaction: 
 ) + 'j ↔ jP Equation 2.51
we can adapt the amplitude of the ACFs (Equation 2.6) and CCF (Equation 2.32) in the 
presence a higher order stoichiometry, neglecting cross-talk and FRET for reasons of 
simplicity (Bacia et al., 2002; Kim et al., 2005; Foldes-Papp, 2005):  
Red ACF <k0 = 1 + << + '<x<<<+'<x<² = < + 'x<< + 'x<² Equation 2.53
Green ACF x<kkP0 = 1 + xx + )xx<xx+)xx<² = x + )x<x + )x<² Equation 2.52
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CCF 
ww0 = 1 + ')x<x<xx + 'xx<<< + )<x< 
=  1 + ')x<x + 'x<< + )x< 
Equation 2.54
In excess of red protein, we can calculate: 
  ww0<k0 =
)'x<0 + )x<< + 'x<< + 'x<< + 'x<
 
=  '< + '²x<< + 'x<      [T]≫\Tb  = ' 
Equation 2.55
Which means the amplitude of the CCF, relative to the red ACF, will give the binding 
stoichiometry. In other words, the amplitude of the CCF will be higher than the red ACF 
amplitude.  
 
On the other hand, in excess of green protein: 
 ww0x<kkP0 =
)'x<x + )x<0 + 'x<x + )x<x + )x<
 
=  )x + )²x<x + )x<      \Tb≫\Tb  = ) 
Equation 2.56
So, in principle one can determine the binding stoichiometries with FCCS. If the amplitude 
of the CCF rises above either of the ACFs at excess of one protein, the stoichiometry is 
always different from 1:1. If considerable cross-talk occurs, at high excess of green protein 
only the cross-talk will be measured. 
2.3.6. Advanced FCCS 
One of the primary reasons for performing intracellular FCCS is to determine a protein 
binding equilibrium constant, free of any artefacts. As discussed, several parameters have to 
be considered to analyse FCCS measurements correctly, such as the mobility and 
photobleaching, affinity, volume overlap,  cross-talk, quenching or FRET, stoichiometry and 
finally fluorochrome dark states. It is virtually impossible to control or manipulate all these 
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parameters. Yet still, great advances in the FCCS methodology have been made to make 
measurements more transparent.  
2.3.6.1. Mobility and stoichiometry 
Methods that extend the dynamic time scale of standard point FCCS measurements have 
been developed, in analogy to FCS (section 2.2.7.3). Not surprisingly thus, spatial image 
cross-correlation spectroscopy (ICCS) (Wiseman et al., 2000) and the raster image cross-
correlation spectroscopy (RICCS) (Digman et al., 2009b) methods were recently introduced 
to allow probing the interactions in slower complexes. Digman et al. introduced a new 
method, the Number&Brightness (N&B) analysis, by which both the concentration and 
stoichiometry of intracellular complexes, irrespective of their mobility, can be determined 
(Digman et al., 2008). The theory of this technique has also been extended to the two-color 
case (cross-N&B)(Digman et al., 2009a), to determine the stoichiometry of double labeled 
complexes. Stoichiometry can also be determined with dual-color PCH (Chen et al., 2005b).  
Importantly, non-idealities that complicate the analysis of standard FCS/FCCS measurements 
will however also have an influence on these novel methodologies, but they do present a 
powerful addition to the group of protein-protein interaction techniques. Finally, FCCS has 
also been extended beyond the two-color scheme. Hwang et al. reported a 3-way SW-FCCS 
method to investigate the interactions between 3 proteins at te same time and Burkhardt et al. 
even performed a 4-way FCCS experiment by using a grating based detection scheme 
(Burkhardt et al., 2005; Hwang et al., 2006). 
2.3.6.2. Affinity and cross-talk 
As for FCS, FCCS has a lower an upper limit to which interactions can be measured (see 
section 2.2.7). The same methods that can be used to improve the FCS concentration range 
can be applied for FCCS. Exchanging CW excitation with pulsed excitation and TCSPC 
based detection greatly increases the precision of FCCS measurements. Furthermore, as we 
discussed in section 2.3.4.2.2, TCSPC can completely avoid cross-talk by measuring in a PIE 
fashion. Like this, even weaker affinity binding reactions could be quantified with FCCS. 
2.3.6.3. Better fluorescent protein pairs 
All photophysical aspects that affect the fluorescence emission of fluorophores  will have an 
effect in an FCCS experiment, which makes FCCS experiment considerably more difficult to 
interpret than an FCS experiment. As we will discuss in 0, photobleaching, long-lived dark 
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states and maturation of fluorochromes can have an effect on the observed cross-correlation 
between two proteins. In general, for quantitative FCCS one best uses a fluorochrome pair 
with minimal dark state formation, minimal FRET, minimal quenching and minimal cross-
talk. The continued development of new fluorescent proteins will eventually lead to a genuine 
superior fluorescent pair for FCCS.   
  
2.3. Fluorescence cross-correlation spectroscopy 
61 
 
 
 
  
 62 
  
 63 
 
Part III – Results 
Chapter 3. Exploring fluorescence correlation spectroscopy in vitro 
The challenge of the project was to perform quantitative measurements on proteins inside 
living human cells. A first goal is to investigate the performance of the FCS technique, 
originally designed to measure protein concentrations and dynamics in aqueous environment, 
for quantitative measurements inside living cells. We will do this by exploring experimental 
conditions in a controlled in vitro environment. Possible methodological artefacts, that would 
be left unnoticed when measuring directly inside living cells, can in this way be identified, 
controlled for or even eliminated.   
 
Chapter 4. Ultrafast chromatin binding kinetics of LEDGF/p75 
In the fourth chapter we focus specifically on chromatin interactions of transcriptional co-
activator LEDGF/p75 in living cell nuclei The goal is to characterize the known chromatin 
binding properties of LEDGF/p75 for the first time in real-time inside living cells, with FCS. 
By labelling LEDGF/p75 with a green fluorescent protein, eGFP, we can monitor dynamics 
of the protein in the cell with FCS. The kinetics of chromatin binding will be characterized by 
customizing the experimental setup. Finally, the role of a major chromatin interacting domain 
for targeting HIV-1 integrase to chromatin will be investigated, both with FCS, as with a 
complementary technique for measuring protein dynamics in the slow time scale. 
 
Chapter 5. Measuring the interaction of HIV-1 integrase and LEDGF/p75 in living 
cells 
In the fifth chapter, the interaction of HIV-1 integrase with its co-factor LEDGF/p75 is 
studied. The goal is to apply the FCCS technique for probing this interaction for the first 
time in living cells. Since their intranuclear complex is strongly tethered to chromatin, 
different strategies are followed to probe the interaction with FCCS: the chromatin binding 
 64 
domains of LEDGF/p75 will be removed, LEDGF/p75 will be retargeted to the cytoplasm, 
or the major chromatin binding domain of LEDGF/p75 will be altered. Finally, the FCCS 
technique will be used in a quantitative manner to determine and compare protein-protein 
interaction affinities. We aim at providing insight into the higher order structure of the 
complex, the affinity the two protein have for each other and try to relate this to the function 
for HIV replication. 
 
Chapter 6. FCCS for measuring protein-protein interactions quantitatively in cells 
Next, we evaluate the FCCS technique for measuring protein-protein interactions 
quantitatively in living cells. By combining FCCS measurements on a control system, a 
genetic fusion construct of two fluorescent proteins, with complementary measurements 
performed by another technique for quantifying protein-protein interactions, we gain more 
insight in the biophysical fundamentals of FCCS. Finally, the experimental setup and the 
fluorochromes used for FCCS are critically evaluated and limitations and possible 
optimizations are discussed. 
 
Chapter 7. Dark states in monomeric red fluorescent proteins 
Finally, we characterize monomeric red fluorescent protein photophysics with FCS, in 
combination with other spectroscopical methods. We provide structural-functional insight in 
this matter by linking our observations with crystallographic information. 
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Chapter 3. Exploring fluorescence 
correlation spectroscopy in vitro 
3.1. Introduction 
In Chapter 2 we have given an overview of fluorescence correlation spectroscopy (FCS) and 
have outlined the general biophysical parameters and models that allow to describe and 
understand a biological system. However, to apply FCS without introducing systematic or 
random errors, one needs to verify if the autocorrelation function measured under the 
experimental conditions indeed provides correct and unbiased information. Investigations of 
the performance of the FCS technique for measuring concentration and diffusion are 
reported in literature (Hess and Webb, 2002; Enderlein et al., 2004; Enderlein et al., 2005), 
but it still remains important to test the performance of our specific microscopic setup. In 
this chapter we test the experimental outcome of an FCS experiment by varying all possible 
experimental parameters in a controlled in vitro environment. We discuss which factors can 
influence an ACF, independent of the fluorochrome dynamics and concentration. When 
quantitative intracellular FCS is performed, each of these factors need careful consideration. 
Successively we investigate the effect of the refractive index, cover glass thickness, 
temperature, pinhole, viscosity, detector afterpulsing and optical saturation on the ACF.  
3.2. Materials and Methods 
3.2.1. Buffers 
For the refractive index measurements, we made a dilution series of guanidine hydrochloride 
(GdHCl) in ultra-pure water and measured the refractive index by refractometry (Nozaki, 
1972)(Table 3.1). For the viscosity measurements, a dilution series of glycerol in ultrapure 
water or phosphate buffered saline was used (Table 3.2). Occasionally, phosphate buffered 
saline pH 7.4 (PBS) was also used. 
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Table 3.1 Refractive index of GdHCl  
Concentration (M) n (calculated) n (measured) 
0.575 1.34 1.340 
1.158 1.35 1.350 
1.747 1.36 1.360 
2.342 1.37 1.370 
2.943 1.38 1.380 
3.548 1.39 1.390 
4.158 1.40 1.401 
4.772 1.41 - 
5.390 1.42 - 
Table 3.2 Viscosity of glycerol 
Glycerol (w/w) 
η at 20 °C 
(cP-mPas) 
0 1.005 
40 3.72 
75 35.5 
93 367 
 
 
 
 
3.2.2. Fluorochromes 
Rhodamine 6G (Laser grade, Acros Organics BVBA, Geel, Belgium) and Alexa 488 
succinimidyl ester, named ‘Alexa 488’ from here on (N.V. Invitrogen, Merelbeke, Belgium) 
were dissolved in dry DMSO at 10 mg/mL and stored at -20 °C. For experiments, the 
fluorochromes were diluted to 1-50 nM in ultrapure water or buffer. His-tagged enhanced 
green fluorescent protein was obtained by bacterial expression from pEXP5-eGFP (kind gift 
from Dr. Rob Lavigne, Afdeling Gentechnologie, Katholieke Universiteit Leuven) and His-
tagged monomeric red fluorescent protein was obtained by bacterial expression from 
pRSET-mRFP1 (kind gift of Dr. Roger Y. Tsien (HHMI-UCSD, La Jolla, CA). After 
transformation of the plasmid in E. coli BL21 cells, the cells were grown at 37 °C to an 
optical density of 0.6 after which protein overexpression was induced during 3 h with 1 mM 
IPTG. After sonication of the culture, the proteins were purified using gravity flow Ni2+-
affinity chromatography (Protino Ni-TED, Macherey-Nagel GmbH & Co. KG,  Düren, 
Germany). The protein purity was checked with SDS-PAGE. Fluorescent proteins were 
dissolved in appropriate buffer. 
3.2.3. Cover glasses 
Lab-TekTM Chambered Cover glasses (#1 d=0.13-0.16 mm) with 8 chambers (VWR 
International, Leuven, Belgium) were used for the cover glass thickness measurements. For 
all other measurements we used normal #1 cover glasses (Waldemar Knittel 
Glasbearbeitungs GmbH, Bielefeld, Germany). 
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3.2.4. FCS measurements 
FCS measurements were performed on a commercial ConfoCor2 system (Carl Zeiss, Jena, 
Germany). The 488-nm line of an Ar-ion laser was used to excite Alexa 488, rhodamine 6G 
and eGFP. The 543-nm HeNe  laser was used to excite rhodamine 6G and mRFP1. 
Excitation light was reflected by a 488/543 dichroic mirror and focused in the sample 
through a C-Apochromat 40x-NA1.2-W objective (Carl Zeiss). Excitation intensity was 
regularly measured at the back aperture of the objective with a power meter (Orion PD-300, 
BFi OPTiLas, Alpen aan den Rijn, The Netherlands), to ensure proper laser alignment in the 
fiber coupling unit (Figure 3.1). Also, because experimental parameters of fluorochromes, 
especially fluorescent proteins (section 7.3.1.1), are dependent on the excitation intensity, this 
ensures reproducibility of the results.  
 
Figure 3.1 Laserpower versus AOTF (acousto-optical tunable filter) – 
Experimentally measured laser power of 488-nm Ar-ion and 543-nm HeNe at 
the back aperture of the objective. 
Laser intensity is controlled with an acousto-optical tunable filter (AOTF). Fluorescence in 
the green channel passed through a 505-530 bandpass filter and was focused on an avalanche 
photodiode (APD) through a 70-µm pinhole. Fluorescence in the red channel passed through 
a 600-650 bandpass filter and was focused on another APD through a 78-µm pinhole. For 
the different experimental conditions 10 measurements of 20 seconds were performed and 
the average autocorrelation curve was calculated. Measurements were performed at room 
temperature (21 °C) unless stated otherwise. Measurements were analysed in Igor Pro 5 
(Wavemetrics Inc., Lake Oswego, OR, USA). 
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3.3. Results 
3.3.1. Refractive index mismatch 
When focused excitation light from the objective traverses the cover glass it is refracted into 
the sample solution. Under normal circumstances, when the refractive index of the 
immersion solution is the same as that of the sample solution, the objective focuses the light 
optimally. For a water-immersion objective the refractive index should thus be n=1.33. 
Although the refractive index of most buffers does not differ much from that, the 
intracellular environment can have a n=1.35-1.40 (Brunsting and Mullaney, 1974; Bereiter-
Hahn et al., 1979; Lanni et al., 1985; Curl et al., 2005).  
Enderlein et al. reported alarming numerical quantifications of the effect such refractive index 
mismatches would have on the obtained parameters from FCS measurements (Enderlein et 
al., 2005). To test this experimentally, we performed an experiment where we incubate HeLa 
cells that had been cultured on a cover glass with PBS containing a nM-concentration of 
eGFP. We then measured the ACF in this medium, well above a cell and at certain positions 
with respect to the cell. Because the concentration of the probe logically is independent of 
the location, the effect of a cell in the optical path on the experimental parameters can be 
directly observed (Figure 3.2). 
  
Figure 3.2 FCS of extracellular eGFP in the presence of cellular refraction – (left) LSM 
image of a HeLa cell taken 15 µm above the cover glass, which makes the cell appear out-of-
focus. Crosses indicate the FCS measurement positions. (right) FCS measurement of a 50-
nM solution of eGFP in PBS at 15 µm above the cover glass. The underlying cell  had a 
maximum height of 11.5 µm.  
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The experimental count rate depended strongly on the position with respect to the cell, 
suggesting a defocussing of the excitation/emission light by the cell. The increasing particle 
number and diffusion time also confirmed an enlarging focal spot and the experimental CPM 
(Equation 2.7), which is an excellent sensor for the quality of the focal spot, decreased 
considerably. We thus concluded that the presence of the cell influences solution FCS 
measurements of eGFP considerably. Furthermore, because this effect was so strong, we 
suspected that also intracellular parameters such as the diffusion coefficient and the 
concentration were heavily biased by the differential refractive index.  
Next, to investigate this effect more quantitatively, we performed an FCS experiment on a 
20-nM solution of rhodamine 6G, in a series of buffers with different refractive indices and at 
different heights above the cover glass. It is immediately obvious that ACFs measured at 10 
µm above the cover glass suffered from a relatively small, yet significant effect of the 
refractive index, while the measurements at 100 µm were drastically influenced even upon a 
small refractive index mismatch (Figure 3.3 A and B). The experimental ACFs were fit with 
Equation 2.17, to check the effect of the refractive index on the individual parameters. As can 
be seen in Figure 3.3 C, the experimental count rate decreased, even at 5 µm from the cover 
glass. This is partially due to a quenching effect of the guanidine hydrochloride at high 
concentration. Figure 3.3 D and E show that at 5-10 µm distance from the cover glass, which 
is about the height at which a typical intracellular measurement is performed, the particle 
number and diffusion times are not influenced much by the refractive index. For example, at 
10 µm in a refractive index similar to the intracellular environment (n=1.38) the particle 
number was decreased about 13% from that at n=1.33, in accordance with reported 
suggested values (Enderlein et al., 2004). Further from the cover glass, at 100 µm, this 
amplitude was decreased by almost 83%. A larger n also had an effect on the viscosity of the 
solution (about a factor of 1.4 for n=1.42), explaining the increase of the diffusion time in 
water. To relate the observations with actual defocussing of the objective, we calculated the 
size of the confocal volume from the experimental  particle numbers (Figure 3.3 D inset). 
The confocal volume increased from 0.53 fL up to 6 fL, when measuring far from the cover 
glass in a buffer with a large refractive index mismatch. Because a more diffuse focal spot 
means a lower light/area, a decrease in counts-per-molecule (CPM) was also observed. Of 
importance, this decrease in CPM could not be related only to an effect of GdHCl on the 
optical properties of rhodamine 6G, since close to the cover glass the brightness was much 
less affected by GdHCl. In conclusion, for in vitro measurements it is always better to stay 
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close to the cover glass, because potential artefacts due to refractive index mismatches are 
almost completely avoided. Intracellular FCS measurements do provide an adequate (within 
10% error at 5 µm height) estimation of the concentration and dynamics given a particular in 
vitro calibration of the setup.  
 
 
Figure 3.3 Effect of refractive index on FCS of rhodamine 6G – ACFs were measured at 
different heights above the cover glass on a solution of 20 nM rhodamine 6G in water. 
Panels (A) and (B) exemplify the ACFs measured at resp. 10 µm and 100 µm in buffer with 
different refractive indices. The gray fit line is the concentration amplitude of the ACFs. 
Different parameters obtained after fitting: (C) average count rate, (D) particle number and 
(inset) confocal volume, (E) diffusion time and (F) counts-per-molecule.  
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3.3.2. Cover glass thickness 
An FCS objective has a correction collar to adjust the focussing of the objective to the actual 
thickness of the cover glass. We verified the objective collar-cover glass thickness mismatch 
experimentally by performing FCS measurements on Alexa 488 in water at various positions 
of the collar, each time at 10 µm from the cover glass. As a cover glass we used the cuvettes 
for intracellular measurements. In principle, these ‘#1’ 0.13-0.16 mm cover glasses should 
have an average thickness of 0.145 mm. 
   
Figure 3.4 Effect of objective collar setting on FCS of 
Alexa 488 – ACFs were measured at 10 µm above the #1 
cover glass on a 20-nM solution of Alexa 488 in water. 
CPM: counts-per-molecule. 
As can be seen in Figure 3.4, both the experimental CPM as the particle number clearly 
depends on the setting of the correction collar. An optimal focussing (lowest particle number 
and highest brightness-per-molecule) was found for a collar setting of 0.145 mm, which is 
exactly the average thickness. The particle number is quite constant in a range of +/- 5 µm of 
cover glass thickness.  
We thus conclude that an FCS setup is better calibrated with identical cover glasss to the ones 
used for intracellular measurements. Doing the calibration measurement in an empty 
chamber of the same cover glass containing the cells is even recommended, although a large 
variation on the actual thicknesses was not observed. 
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3.3.3. Temperature 
When FCS measurements are to be performed in living cells, it is sometimes necessary to 
work at 37 °C. The effect of the temperature on the experimental diffusion coefficient will 
first be briefly discussed, after which the practical implementation of 37 °C incubation and 
the effect on the microscope optics will be discussed.  
The diffusion coefficient is directly related to the temperature, but inversely related to the 
viscosity of the medium (Equation 2.9). For water, the dynamic viscosity is empirically 
approximated by (Vogel, 1921): 
 52 = h × 10 R9w Equation 3.1
where A=2.414×10−5 Pas, B = 247.8 K and C = 140 K. 
 
 
Figure 3.5 Temperature dependence of the 
viscosity of water (Vogel, 1921). 
If the temperature is increased from 21 °C to 37 °C, the diffusion coefficient of a 
fluorochrome in vitro will thus increase by 49.4%. In living cells however, the diffusion 
coefficient of a protein might not have the same temperature dependence as predicted by the 
Stokes-Einstein law, since some parts of the cellular metabolism might be more dependent 
on temperature than others. Also, at 37 °C living cells exhibit a higher mobility than at room 
temperature, which in some cases might even complicate FCS measurements.  
Next, for stable and uniform 37 °C incubation of the sample, both the cuvette containing the 
cells as well as the objective need to be warmed. High-NA objectives act as a strong heat-
sink, because they make physical contact with the sample through the immersion solution. 
Since some cellular reactions are strongly temperature dependent, an absolute, homogenous 
and reproducible temperature distribution needs to be assured in all positions of the cuvette, 
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which in our case were Lab-TekTM Chambered Cover Glasses. Because commercial cuvette 
heaters did not provide this, a custom heater that provided equal heating of each chamber 
was constructed. A commercial objective heater was also used (Bioptechs Inc., Butler, PA, 
USA). We measured the ACF of a 15-nM Alexa 488 solution with the 488-nm line of the Ar-
laser, or a 10-nM rhodamine 6G solution with the 543-nm HeNe laser at either room 
temperature (RT) or 37 °C, and varied the cover glass-thickness correction collar of the 
objective. When the temperature of the sample and objective was raised to 37 °C, a 30-
minute incubation period was applied after the set temperatures had been reached, to allow 
complete equilibration of the system. 
 
 
Figure 3.6 Effect of temperature on the objective optical properties – Apparent particle 
number and counts-per-molecule at different objective collar settings for a (left) 15-nm 
Alexa 488 or (right) 10-nM rhodamine 6G solution in water at room temperature or 37 °C. 
As can be seen in Figure 3.5, a rather large effect on the focussing of the excitation beam was 
observed for Alexa 488 at 37 °C, since the counts-per-molecule dropped by a factor of more 
than 3, for the standard setting of the collar (0.145 mm). For rhodamine 6G we observed a 
similar defocussing of the objective. By turning the correction collar to smaller values, we 
could partially recover the focussing, reaching up to 70% of apparent brightness for Alexa 
488 and 80% for rhodamine 6G. Taking the diffusion coefficients of Alexa 488 and 
rhodamine 6G (Table 2.1) and the temperature into account, we calculated the size of the 
confocal volume (Table 3.3). Both at 488-nm excitation as 543-nm excitation the correction 
collar could not achieve the optimal focussing achieved at room temperature, although at 
488-nm excitation the difference was only small. 
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Table 3.3 Size of the confocal volume at room 
temperature and 37 °C under optimal focussing 
conditions – τdiff = diffusion time,  ω1,2 = radial and axial 
radii of the focal volume, V = confocal volume. 
  τdiff (µs) ω1 (nm) ω2 (nm) V (fL) 
alexa fluor 488 RT 22.4 197 1160 0.29 
 37 °C 16.8 209 1170 0.32 
rhodamine 6G RT 32.8 236 1110 0.39 
 37 °C 26.7 260 1250 0.53 
 
Summarized, it is possible to measure at varying temperatures but the optical properties of 
the objective will be influenced. The objective need to be carefully characterized when 
working at 37 °C, especially if results at RT and 37 °C are to be compared. Also, the volume 
overlap for FCCS measurements needs careful characterization when working at 37 °C. 
3.3.4. APD afterpulsing 
In avalanche photodiodes (APD, SPAD), the detectors mostly used for FCS measurements, 
an emission photon is detected and converted into an electrical pulse. However, nanoseconds 
to microsecond after the initial pulse is generated, these detectors also generate a so-called 
‘after-pulse’. When the signal-to-noise ratio is low, i.e. the propability of detecting a ‘real’ 
photon is low due to a low concentration or brightness of the fluorochrome, this afterpulsing 
appears in the autocorrelation curve at a (sub-)microsecond time scale. We experimentally 
verified APD afterpulsing on the Zeiss ConfoCor2 microscope by measuring a low 
concentration of rhodamine 6G at increasing laser powers. As the concentration of the probe 
remains constant, the photophysical phenomena in the ACF can be verified. As can be seen 
in Figure 3.7, at low count rates the afterpulsing is clearly detectable as a sharp rise of the 
ACF in the submicrosecond time scale and obscures the contribution of µs-time scale triplet 
conversion to the ACF. At higher count rates (shown by the arrow), the ACF becomes 
gradually less and less distorted so that even submicrosecond ACF datapoints are unbiased by 
the afterpulsing phenomenon.  
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Figure 3.7 Influence of detector afterpulsing on the experimental ACF – A 
low-concentration rhodamine 6G solution was measured with FCS at rising 
543-nm HeNe laser powers, shown by the arrow.  
It is thus possible to minimize artefacts due to APD afterpulsing, by measuring at count rates 
where the afterpulsing does not contribute significantly to the signal. We have done this when 
studying the dark states of mRFPs (Chapter 7). Complete avoidance of afterpulsing from the 
ACF is possible by measuring in cross-correlation mode. Here, the emission of the 
fluorochrome is split 50/50, detected on two APDs and cross-correlated. At low count rates, 
that would give afterpulsing in autocorrelation mode (10 kHz), a photon is detected only 
once every 100 µs, so the chance that the two detectors in cross-correlation mode register a 
photon (and an afterpulse) at the same time is very low. In other words, afterpulsing does not 
cross-correlate between detectors and hence does not influence the ACF when measuring in 
cross-correlation mode. 
3.3.5. Optical saturation 
At low laser powers the emission intensity is linearly proportional to the excitation intensity. 
At higher laser powers on the other hand, the excited state population starts to saturate 
(Enderlein et al., 2005). We studied the excited state saturation of rhodamine 6G with FCS. 
In the previous section we measured a low concentration of rhodamine 6G at increasing laser 
powers. In Figure 3.8 the parameters obtained after fitting of these measurements are given. 
The counts-per-molecule levels off at high laser powers, clearly indicating optical saturation 
(Figure 3.8 A). Importantly, the diffusion time of rhodamine 6G steadily increased at 
increasing laser powers (Figure 3.8 B). Indeed, due to the Gaussian shape of the excitation 
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profile, an apparent increase of the confocal volume is observed under optical saturation 
conditions, explaining the increased diffusion time (Gregor et al., 2005). Since more 
molecules are observed in a larger volume, this also explains why the count rate seems to 
level off less than the CPM (Figure 3.8 C). Finally, as the excited state population increases 
with the laser power, so does the triplet state population (Figure 3.8 D). 
 
 
Figure 3.8 The effect of optical saturation on the experimental ACF of 
rhodamine 6G – A low-concentration of rhodamine 6G was measured with 
FCS at increasing 543-nM HeNe laser powers and the ACFs were analysed. 
In conclusion, optical saturation leads to an apparent increase in the laser focus. To avoid this 
it is better to measure ACFs always at low excitation intensity. Importantly, optical saturation 
depends not only on the laser intensity but also on the fluorochrome that is being used. 
Calibrating the microscope with one probe at a certain laser intensity might thus result in a 
different effective confocal volume for another probe, if it exhibits different optical 
saturation characteristics.  
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3.3.6. Volume overlap 
As we have discussed in section 2.3.4, different wavelengths of excitation are focused by the 
objective in diffraction limited excitation spots of unequal size. Since the coupling of the laser 
beams into the objective back aperture could not be modified, we wished to develop a 
simple, robust and reproducible procedure to calibrate the size of the confocal volumes. In 
each emission path there is a pinhole, to allow independent tuning of the size of the confocal 
volumes. We verified the effect of the pinhole diameter of the two detection channels on the 
experimental parameters from the ACF (Figure 3.9). 
  
 
Figure 3.9 The effect of the pinhole diameter on the experimental ACF – (left) A low 
concentration of Alexa 488 was measured with 488-nm excitation and (right) a low 
concentration of rhodamine 6G was measured at 543 nm excitation. The experimental 
counts-per-molecule, average particle number and diffusion time are depicted. 
As expected, when increasing the pinhole diameter a larger confocal volume is ‘seen’, 
translated in a larger diffusion time and particle number. The counts-per-molecule however, 
reaches a maximum at ~90 µm for 488-nm excitation of Alexa 488 and of about 80 µm for 
543-nm excitation of rhodamine 6G. Importantly, when the pinholes are set at their defaults 
values (as indicated in the manual of the microscope), 70 µm for cyan excitation and 78 µm 
for green excitation, and equilibrium between high CPM and small focus is guaranteed. Thus, 
by tuning the individual pinhole diameters one can have control over the effective size of the 
two confocal volumes. Incomplete volume overlap (section 2.3.4) can in this way be partially 
corrected for.  
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Next, we wanted to characterize the confocal volumes created by the 488-nm line of the Ar-
ion laser and by the 543-nm HeNe laser. First, we calibrated both pinholes in XYZ direction 
at the respective excitation wavelengths, 488 nm for the first pinhole, 543 nm for the second 
pinhole. Then we measured rhodamine 6G with 543-nm excitation and split the emission 
50/50 in the two channels (600-650 nm, 78-µm pinhole). The particle number from the ACF 
in the two channels was the same, which proves the 543-nm laser focuses at the same spot as 
does the 488-nm laser. This confirmed that both pinholes image the same spot in solution. 
Then we tested if rhodamine 6G could be used to calibrate the two confocal volumes. As can 
be seen in Figure 3.10, the 488-nm excitation intensity needed to obtain reliable parameters 
from the ACF measured in the green detection channel, about 7% of the maximal intensity, 
induces strong optical saturation, as judged from the CPM. In other words, it is not possible 
to obtain a reliable estimation of the absolute parameters (S, N, τdiff) at an excitation intensity 
that does not introduce optical artifacts. The 543-nm excitation intensity needed for reliable 
parameters estimation in the red detection channel on the other hand, which was about 15% 
of the maximal intensity, did not introduce any optical artefacts yet, since the extrapolated 
values are much alike the ones measured at 15%. In other words an optical artifact free 
particle number and diffusion time of rhodamine 6G can be measured in the red detection 
channel by doing a calibration measurement at 15% of the maximal 543-nm power. Only the 
size of the red confocal volume can thus be determined accurately with rhodamine 6G.   
 
 
Figure 3.10 Excitation power needed to obtain reliable parameter estimations from 
the rhodamine 6G ACF – (left) 488-nm excitation, a 505-530-nm bandpass emission filter 
and 70-µm pinhole. (right) 543-nm excitation, a 600/650-nm bandpass emission filter and 
78-µm pinhole. 
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For the green detection channel we then used Alexa 488 instead of rhodamine 6G. Already at  
1% of the maximal 488-nm intensity parameters could be estimated with an error of less than 
10% due to optical artifacts. At this laser intensity, optical saturation of Alexa 488 is thus still 
limited, as also judged from the CPM. 
 
 
Figure 3.11 Excitation power needed to obtain reliable parameter estimations from 
the Alexa 488 ACF – 488-nm excitation, a 505-530-nm bandpass emission filter and 70-µm 
pinhole.  
Importantly, if the 488-nm/green channel is characterized correctly with Alexa 488 and the 
543-nm/red channel with rhodamine 6G, then the ratio of calculated confocal volumes 
(Figure 3.10 right and Figure 3.11) should be equal to the ratio of particle numbers in each 
channel as measured for rhodamine 6G alone (Figure 3.10 left and right). Table 3.4 lists the 
parameters from the fitting. After linear extrapolation to 0 light intensity, we find that the 
ratio of volumes was 2.08, while that of the particle numbers was 2.10.  Importantly, at the 
laser powers used for calibrating the volumes, 1% of the 488-nm laser power and 15% of the 
543-nm laser power, this ratio only differed from 2.08 by 13%, which is within the error of 
cellular measurements.  
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Table 3.4 Comparison of the ratio of rhodamine 6G particle 
numbers, as measured with 488-nm and 543-nm excitation, 
with the ratio of calculated confocal volumes, as measured 
with Alexa 488 and rhodamine 6G – The values in bold are the 
values extrapolated to zero excitation intensity. 
rhodamine 6G  
excitation: 488 nm  
emission: 505-530 nm 
rhodamine 6G  
excitation: 543 nm  
emission: 600-650 nm 
Alexa 488 
excitation: 488 nm  
emission: 505-530 nm 
Iexc (%) N V (fL) Iexc (%) N V (fL) Iexc (%) N V (fL) 
0.70 2.47 
 
3.00 5.30 
 
0.20 3.39 0.20 
1.00 2.60 0.24 5.00 5.23 0.47 0.30 3.26 0.22 
2.00 2.64 0.25 7.00 5.46 0.46 0.50 3.59 0.22 
3.00 3.00 0.24 10.00 5.71 
 
0.70 3.53 0.28 
5.00 3.15 0.24 15.00 5.88 0.46 1.00 3.94 0.25 
7.00 3.45 0.21 20.00 6.05 0.45 1.60 4.38 0.31 
10.00 3.83 0.19 30.00 6.43 0.48 3.00 5.62 0.36 
15.00 4.46 0.18 
   
5.00 7.06 0.51 
20.00 5.23 0.17 
   
7.00 8.50 0.54 
      
10.00 10.37 0.63 
 
2.45 0.25 
 
5.16 0.46 
 
3.20 0.22 
 
In conclusion, the pinholes can be fine-tuned to image a smaller or bigger focal spot in 
solution. In a calibrated system, these pinholes image exactly the same spot in solution. The 
two confocal volumes created with 488-nm (AOTF 1%) and 543-nm (15%) excitation in a 
dual color FCCS setup can be determined accurately with Alexa 488 and rhodamine 6G. 
3.4. Discussion – Conclusion 
Ideally, the autocorrelation function of a certain protein in a cell as measured with FCS is 
determined only by the concentration and dynamics of the protein, as the biophysical theory 
we have outlined in Chapter 2 would lead us to assume. In practice, as we have seen in this 
chapter, a number of experimental parameters also critically determine the ACF. A good 
characterization of the microscopic setup was therefore important before experiments in cells 
could really be trusted. We showed that although the intracellular environment, in terms of 
optical density, is much different from an aqueous environment, the error introduced on 
experimental parameters is still acceptable.  
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Next, we showed that the cover glass thickness has a strong effect on the ACF and that the 
correction collar of the objective is best optimized for the cover glass to be used. Also, when 
experiments are performed at 37 °C, the performance of the system is still acceptable when 
the objective collar is re-optimized. In a two-pinhole system such as the Zeiss ConfoCor2 
FCS microscope, the individual pinholes can be adjusted to fine-tune the size of the confocal 
volume in a limited range, which can potentially increase the volume overlap when doing 2-
color FCCS measurements. We have shown that at low signal-to-noise detector afterpulsing 
can negatively influence the ACF at fast time scale and that measurements at high excitation 
intensities can suffer from optical saturation artefacts. FCS measurement are thus best 
performed at excitation intensities that are high enough to have a good CPM and low 
afterpulsing artefacts, but low enough to avoid optical saturation. Finally, we have provided 
an accurate method to characterize two confocal volume used for 488/543 dual color FCCS 
measurements. 
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Chapter 4. Ultrafast chromatin 
binding kinetics of LEDGF/p75 
Part of this chapter will be published in: 
Hendrix, J., De Rijck, J., Gijsbers, R., Voet, A., Hotta, J., McNeely, M., Vanstreels, E., 
Daelemans, D., Hofkens, J., Debyser, Z., and Engelborghs, Y. Dynamic chromatin scanning 
of transcriptional co-activator LEDGF/p75 is arrested by HIV-1 integrase (submitted for 
publication). 
4.1. Introduction 
Gene expression can be regulated by transcriptional cofactors, which fine-tune the interaction 
of the general transcription machinery with gene-specific transcription factors. Lens 
epithelium-derived growth factor/p75 (LEDGF/p75) was originally identified as a 
transcriptional co-activator protecting cells against apoptosis (Ge et al., 1998a). LEDGF/p75 
expression is upregulated under thermal or oxidative cellular stress (Sharma et al., 2000) and 
in turn, promotes transcription of stress-related genes by binding to promoters containing 
stress responsive (STRE) or heat shock elements (HSE) (Singh et al., 2001). The protein plays 
an important role in oncogenesis (Ahuja et al., 2000; Daugaard et al., 2007; Huang et al., 
2007; Yokoyama and Cleary, 2008), autoimmunity (Ganapathy and Casiano, 2004; Daniels et 
al., 2005) and integration and replication of the human immunodeficiency virus type 1 (HIV-
1) (Van Maele and Debyser, 2005; Engelman and Cherepanov, 2008). 
LEDGF/p75 belongs to the family of HDGF-related proteins characterized by a N-terminal 
PWWP-domain, a conserved DNA/chromatin-binding domain (Stec et al., 2000; Singh et al., 
2006). Indeed, eGFP-PWWP does interact with mitotic chromosomes and deletion of this 
domain from full-length LEDGF/p75 decreases its affinity for DNA/chromatin in vitro 
(Llano et al., 2006b) and in cell culture (Turlure et al., 2006; Llano et al., 2006b). A tripartite 
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element consisting of two AT-hooks and the nuclear localisation signal (NLS) cooperates 
with the PWWP-domain for DNA/chromatin interaction in vitro (Llano et al., 2006b) and in 
cell culture (Turlure et al., 2006). The integration of HIV in the genome of the infected host 
cell is catalyzed by integrase (IN) in close interaction with LEDGF/p75 (Cherepanov et al., 
2003). This interaction maps to the conserved integrase binding domain (IBD) at the C-
terminus of LEDGF/p75 (Cherepanov et al., 2004; Cherepanov et al., 2005a). Potent 
knockdown or knockout of LEDGF/p75 drastically hampers HIV replication (Llano et al., 
2004b; Vandekerckhove et al., 2006; Zielske and Stevenson, 2006; Marshall et al., 2007; Shun 
et al., 2007). Multiple roles in the HIV integration process have been attributed to 
LEDGF/p75: (i) protection of IN against cytoplasmic proteasomal degradation (Llano et al., 
2004a), (ii) promotion of the oligomerisation of IN to allow DNA strand transfer (Faure et 
al., 2005; McKee et al., 2008; Michel et al., 2009), (iii) tethering of the HIV-1 pre-integration 
complex to the chromatin (Turlure et al., 2006; Llano et al., 2006b) and (iv) targeting of 
integration into actively transcribed regions of the genome (Ciuffi et al., 2005; Marshall et al., 
2007; Shun et al., 2007).  
In vivo chromatin binding is classically studied with Fluorescence recovery after 
photobleaching (FRAP)(Sprague et al., 2004; Phair et al., 2004) and very recently, 
Fluorescence correlation spectroscopy (FCS) was also applied for this purpose (Michelman-
Ribeiro et al., 2009). Despite the fact that FCS analyzes diffusion on a much faster (µs-ms) 
timescale than FRAP (seconds) and might thus be a better method to study chromatin 
binding kinetics, it is still arguable that these kinetics might even be faster than quantifyable 
with standard FCS (Michelman-Ribeiro et al., 2009). In this chapter, we investigate chromatin 
binding kinetics of LEDGF/p75 with tunable focus FCS to show extraordinary fast 
chromatin binding kinetics.   
4.2. Materials and Methods 
4.2.1. Plasmids 
For the expression of eGFP in human cells we used a peGFP-C1 construct (Clontech 
Laboratories, Inc., Mountain View, CA), that allows for easy expression of eGFP labelled 
genetic fusion constructs downstream of a cytomegalovirus immediate early promoter. The 
molecular clonings of the constructs for the eukaryotic expression of eGFP-LEDGF/p75, 
eGFP-LEDGF/p75 K150A, eGFP-∆325, eGFP-∆325 D366A and eGFP-IN in HeLa cells 
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are described elsewhere (Maertens et al., 2003; Maertens et al., 2004; De Rijck et al., 2006). 
The PWWP mutants were constructed by site-directed mutagenesis of pCP-Nat75 (Maertens 
et al., 2003). Lysine56 was mutated to aspartic acid using the Kirsch-Joly method (Kirsch and 
Joly, 1998). First, two 483-bp primers were synthesized by PCR with two primers: 5’-GAGA 
CTGCTTTTTTAGGACCAGACGATATCTTTCCTTACTCAGAAAATAAGG (sense, 
mutated positions underlined) and 5´-GTCACTCTCTGAAGGAC (antisense). These 
primers were then used to synthesize the whole plasmid in an additional PCR reaction, after 
which template DNA was digested with DpnI.  Colonies were screened by restriction and 
sequence analysis.  Arginine74 was mutated to aspartic acid using the same protocol with 5´-
GGAAAAGTATGGCAAACCAAATAAAGACAAAGGTTTTAATGAAGGTTTATGG
G (sense) and the same antisense primer to form two 433-bp primers.  Colonies were 
screened by sequence analysis.  The pCP-Nat75 K56D-R74D construct was obtained by 
mutagenesis of the pCP-Nat75 R74D construct with the K56D primer set.  
Protein purification was performed as for wild-type LEDGF/p75 (Maertens et al., 2003). For 
imaging inside live cells, the mutant LEDGF/p75 genes were PCR amplified with 5’- 
CACGAGATCTGACTCGCGATTTCAAACCTGGAGACC (sense) and 5’- CCGCGAA 
TTCTAGTTATCTAGTGTAGAATCCTTC (antisense) and cloned into peGFP-C3 via BglII 
and EcoRI restriction sites. Clones were verified with restriction and sequence analysis. A 
construct for the eukaryotic expression of mRFP1 was obtained by exchanging the eGFP 
gene in a peGFP-C1 construct. Therefore the mRFP1-gene was PCR-amplified from pRSET-
B-mRFP1, a kind gift from Dr. Roger Y. Tsien (Howard Hughes Medical Institute, 
University of California at San Diego, La Jolla, CA),  with two primers: 5’-
GAATTCAGCGCTATGGCCTCCTCCGAGGACGTC (sense) and 5’- GAATTCAG 
ATCTGGCGCCGGTGGAGTGGCGG (antisense). The amplicon was subcloned in 
peGFP-C1 through the Eco47III and BglII restriction sites. The cloning of pmRFP-INs was 
similar; the mRFP1-gene was amplified with the same sense primer and with the 5’-
GAATTCAGATCTGGGCGCCGGTGGAGTGGCGG antisense primer. The amplicon 
was subcloned in peGFP-INs-C2 (Maertens et al., 2003) to yield pmRFP-INs-C2. The clones 
were verified with PCR, PstI-restriction and sequence analysis.  pH1-eGFP was constructed 
by PCR-amplifying histone-H1 from an in-house construct, restriction with SalI-BamHI and 
ligation into peGFP-N1 restricted with XhoI-BamHI. Clones were checked with PCR, 
restriction and sequencing analysis. The plasmid encoding eGFP-HP1β was a kind gift from 
Dr. Tom Misteli (National Cancer Institute, National Institutes of Health, Bethesda, MD, 
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USA). The cloning of the PWWP mutants of LEDGF/p75 was performed by Melissa 
McNeely in the Laboratory for Molecular Virology and Gene Therapy, under the supervision 
of Prof. Zeger Debyser. 
4.2.2. Cell lines 
HeLa cells were obtained from the NIH Reagent program and were grown in ‘Complete 
Medium’, high-glucose Dulbecco’s Modified Eagle Medium (Gibco BRL, Belgium), 
supplemented with 10% heat-inactivated fetal bovine serum (Sigma-Aldrich gmbh, 
Taufkirchen, Germany) and 50 µg/mL Gentamycin (Gibco BRL, Belgium), at 5% CO2 and 
37 °C in a humidified atmosphere. To generate cell lines stably suppressing LEDGF/p75 
mRNA, 20,000 HeLaP4-CCR5 cells were seeded in a 96-well plate and transduced with 
MLV-based   retroviral   vector  encoding  two  identical  miRNA-based  hairpin  sequences  
directed against the L3 sequence in the LEDGF/p75 mRNA (Maertens et al., 2003; 
Vandekerckhove et al., 2006) together with a Zeocin resistance cassette driven by a 
ubiquitous human immediate early CMV promoter. Cells were subsequently selected using 
Zeocin (Gibco BRL, Belgium) at 200 µg/ml. Selection resulted in a polyclonal cell line. A 
monoclonal cell line was generated by seeding at 0.2 cells per well and selection of a cell clone 
with strongest knockdown (HeLa-p75KD). The cell line stably suppressing LEDGF/p75 was 
made by Dr. Rik Gijsbers (Laboratory for Molecular Virology and Gene Therapy, 
K.U.Leuven). CHO cells stably expressing eGFP tagged hRPB1, the largest subunit of 
human RNA polymerase II, were a kind gift from Dr. Peter Cook (Sir William Dunn School 
of Pathology, University of Oxford, UK)(Sugaya et al., 2000).  
4.2.3. Transfections 
For the transient transfections 0.5-1×105 cells were seeded per well in a Lab-TekTM 
Chambered Cover glass (VWR International, Leuven, Belgium) to obtain 50-70% cell 
confluency after overnight incubation. Transfections were performed with a Mirus TransIT®-
HeLaMONSTER® transfection kit  (VWR International, Leuven, Belgium), with 1 µL 
TransIT reagent, a maximum of 0.5 µg plasmid DNA per well and 1 µL MONSTER reagent 
per µg of DNA. After the transfection mixture was prepared in 50 µL fresh OptiMEM per 
well (Gibco BRL, Belgium), 450 µL prewarmed Complete Medium was added and this 
mixture was slowly added to the cells and the cells were incubated for at least 12 hours. 
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4.2.4. Western blotting, cellular fractionation assays 
Western blotting was performed on whole cell lysates as described before (Vandekerckhove 
et al., 2006) with a specific anti-LEDGF/p75 antibody (A300-847A, Bethyl Laboratories, 
Montgomery, TX, USA). Cellular fractionation assays were performed as described before 
(Llano et al., 2006b), with the specific LEDGF/p75 antibody, an anti-RFP antibody for 
mRFP-IN (AB3216, Millipore N.V., Brussels, Belgium), an in-house polyclonal anti-GFP 
antibody and anti-α-tubulin (T5168, Sigma-Aldrich, Bornem, Belgium). Briefly, 24h post-
transfection cells were harvested and either lysed for checking overall expression (T) or 
extracted with Triton X-100 to separate the soluble (S1) and insoluble (P1) cellular proteins. 
DNaseI-treatment allowed subsequent separation into a soluble, chromatin binding fraction 
(S2) and an insoluble, non-chromatin binding fraction (P2).  
4.2.5. Cellular fluorescence correlation spectroscopy 
For normal FCS measurements a commercial FCS/FCCS microscope (LSM510/ConfoCor2, 
Carl Zeiss, Jena, Germany) was used. Practically, enhanced green fluorescent protein (eGFP) 
(Heim et al., 1995) and monomeric red fluorescent protein (mRFP1) (Campbell et al., 2002) 
were used as fluorescent tags. The 488-nm line of the Ar+-laser (acousto-optical tunable filter 
(AOTF) 0.1%, ~0.25 µW) was used to excite eGFP and the 543-nm line of the HeNe laser 
(AOTF 7%, ~8.6 µW) was used to excite mRFP1. The excitation light was reflected by a 
dichroic mirror (HFT 488/543) and focused through a C-Apochromat 40×/1.2 W 
Korr/0.13-0.17 objective. The fluorescence emission light was split by a second dichroic 
mirror (NFT 570) into two separate beam paths and passed through a 505-530 nm bandpass 
filter and 70-µm pinhole for eGFP fluorescence and a 600-650 nm bandpass filter and 78-µm 
pinhole for mRFP1 fluorescence. In each cell cytoplasm or nucleus, 10 consecutive 
fluorescence intensity (detected photons per second) and correlation measurements of 20 
seconds were performed. The first fluorescence intensity curve was used to determine the 
photobleaching and the following nine correlation curves were averaged after individual 
inspection. All FCS measurements were performed at room temperature. 
4.2.6. Cellular tunable focus FCS  
For the cellular tunable focus FCS we used a home built FCS setup (Wawrezinieck et al., 
2005)(Figure 4.1). The 30-mW 488-nm line of a Ar-Kr laser (Newport Spectra-Physics, 
Utrecht, The Netherlands) was split 50/50. One beam was maximally focused at the back-
aperture of the objective (Olympus UPlanSApo 100x/NA1.4/Oil, Olympus Belgium N.V., 
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Aartselaar, Belgium) to create wide-field excitation for observing the fluorescence of the cells 
through the eyepiece of the microscope (Olympus IX). The other beam was carefully 
expanded, collimated and directed centrically through an adjustable diaphragm, to allow for 
tunable focus FCS measurements. A fixed 50-µm pinhole was used for confocal detection on 
an avalanche photodiode (SPCM-AQR-15, Perkin-Elmer, Wiesbaden, Germany). The 
excitation power at each diaphragm setting was attenuated to give a constant power/area in 
the focal spot suitable for cellular FCS, avoiding potential intensity-dependent artefacts. 
Reproducible switching was achieved by measuring the residual power behind the diaphragm. 
These experiments were carried out at the Laboratory for Photochemistry and Spectroscopy, 
under the supervision of Prof. Johan Hofkens. 
 
 
Figure 4.1 Schematic representation of the tunable focus FCS setup – Shutters 
controlled which path the excitation light followed. From the combiner either defocused 
(wide-field) or focused (confocal) excitation light travels to the objective. The focussing lens 
was removed for confocal excitation. Dichroic: dichroic mirror reflecting light below 490 
nm. ND filter: attenuating neutral density filter. Emission filter : band pass 530/50. Pinhole: 
fixed at 50 µm. APD: avalanche photodiode.   
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4.2.7. FCS in the presence of binding to an immobile structure 
Consider a binding equilibrium of a protein L that can interact with an immobile binding site 
S on the chromatin: 
  +      ℎ K   = 1mP1m 
 ¡((%$¡%' ¡+ = 1mP[][] ¢£≫¤£ 1mPu[] = 1mP∗ [] 
 ((%$¡%' ¡+ = 1m[] 
 <kk = 1/1mP∗   ¡'  lmnP = 1/1m 
Equation 4.1
 
With [L] the free concentration of protein L, in this case, LEDGF/p75, [S] the free 
concentration of immobile binding sites, [LS] the concentration of protein L bound to a 
binding site, Kass the association binding constant, kon the rate constant for association and 
koff the rate constant for dissociation. When the concentration of binding sites is high, k*on = 
konS0 is the pseudo rate constant for association. If L has a strong affinity for S, L will   
immobilize for a considerable amount of time after binding, which in term will lead to 
photobleaching of L during an FCS experiment and hence, the binding event will not be 
observed in the autocorrelation function. In terms of FCS, four dynamic regimes can 
generally be thought of: 
4.2.7.1. Fast association (tfree << τdiff,free) and slow dissociation (tbound > τdiff,free) 
The protein binds to the immobile structure with very strong affinity. It will be 
photobleached in the laser focus when FCS is measured. FRAP is a better method to analyse 
these binding kinetics. FRAP will give a diffusion dependent slow to very slow recovery 
(Sprague and McNally, 2005). 
4.2.7.2. Slow association (tfree > τdiff,free) and very slow dissociation (tbound > 100 ms) 
The chance of binding is low but once bound the fluorochrome will be photobleached. The 
fraction of the signal that photobleaches is a measure for the affinity: 
 JlykKo¦kJnPlykKo¦k = [][] = 1mP∗1m = K  ∗  Equation 4.2
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K*ass (Kdiss) can be determined by non-linear least-squares fitting of the percentage 
photobleaching versus the total concentration of protein L0: 
 JlykKo¦k = []u = su + u + u +    − qu + u +    − 4uu2u    Equation 4.3
In terms of LEDGF/p75 chromatin binding, [LS]/L0 represents the fraction of eGFP-
LEDGF/p75 that photobleaches. The total concentration L0 is measured with FCS. The 
parameter y0 is a constant accounting for the constant fraction of photobleaching at high 
concentrations.  
4.2.7.3. Fast association (tfree < τdiff,free) and fast dissociation (tbound < τdiff,free) 
The binding reaction is observed as an additional slow component in the ACF, that is 
dependent on the size of the laser spot. The ‘effective’ diffusion coefficient defines the 
affinity: 
 0ml k<§k = 0<kk1 + 1mP∗1m Equation 4.4
4.2.7.4. Slow association (tfree>>τdiff), moderate dissociation (τdiff,free<tbound<100ms) 
The binding reaction is observed as an additional slow component in the ACF, that is not 
dependent on the size of the laser focus. The fraction of free and ‘apparent slow’ diffusion 
components from the ACF is a measure for the affinity: 
 J ym¨JK p = [][] = 1mP∗1m = K  ∗  Equation 4.5
While in the first two regimes, the binding event is not seen in the ACF, in the third regime a 
seemingly slow diffusion is observed. In the fourth regime, as Michelman-Ribeiro et al. have 
shown, an FCS fit model for binding can be used (Michelman-Ribeiro et al., 2009): 
  = 12/A \Jk© +  k©exp9Lª««pb Jk© = 1m1m + 1mP∗  ¡'  k© = 1mP∗1m + 1mP∗  
Equation 4.6
with GD(τ) the standard fit model (Equation 2.5) and Feq the fraction of free protein and Ceq 
the fraction of bound protein. From this fit, both the diffusion coefficient of the free species 
as the rate constants for association and dissociation can be determined. 
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4.2.8. Scanning confocal fluorescence recovery after photobleaching 
Fluorescence recovery after photobleaching (FRAP) is a quantitative fluorescence technique 
that is used to study protein dynamics (Axelrod et al., 1976). Scanning confocal FRAP is 
performed on a laser scanning microscope. By illuminating a defined region-of-interest in the 
sample with a brief high-intensity laser pulse, the fluorescence is rapidly photobleached. It 
will recover due to the exchange of bleached molecules inside with unbleached molecules 
outside this region. The fluorescence recovery is generally determined by the diffusion rate of 
the molecules under investigation, but can also be determined by binding reactions to slow or 
immobile structures. In this research, FRAP was used to investigate whether or not immobile 
cellular subpopulations existed and to investigate dynamics that were too slow to be studied 
with FCS. Cellular FRAP curves for eGFP-LEDGF/p75 were obtained on a LSM510 (Carl 
Zeiss). A circular bleach spot in the nucleus with a radius of 1 µm was briefly scanned once 
with a high laser intensity (AOTF 100%) and the average fluorescence intensity (in arbitrary 
units) was subsequently monitored at low laser intensity (AOTF 2%) as a function of time. 
Neglegible acquisitional photobleaching (as measured for eGFP) was observed and 
measurements were normalized before averaging different cells. The optical path was similar 
to that for FCS. Depending on the nature of the dynamic process, different fit models have 
to be used to analyze FRAP data. 
4.2.8.1. FRAP in the case of Brownian diffusion 
A relative simple closed form solution of the diffusion equation exists for FRAP when 
measurements are performed in a circular disk profile (Axelrod et al., 1976; Soumpasis, 1983; 
Sprague et al., 2004):  
 r*&% = exp ¬− 2 ­ cu ¬2 ­ + : ¬2 ­e 1 − J Equation 4.7
With τdiff the characteristic diffusion time of the probe through the bleach spot, Fimm the 
fraction of the fluorescence intensity that does not recover and Iα a modified Bessel function 
of the first kind and order α. This analysis model can be approximated by a Taylor expansion 
for fast recoveries (Figure 4.2): 
 u ¬2 ­ + : ¬2 ­ = 
1 + 12 ¬2 ­ + 14 ¬2 ­ + 116 ¬2 ­A + 164 ¬2 ­® + 1348 ¬2 ­¯ Equation 4.8
The diffusion coefficient from a FRAP measurement can be calculated as follows: 
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  = ;0  Equation 4.9
where ω² is the radius of the bleach spot. 
 
Figure 4.2 Simulated FRAP curve for a fast recovery (left) and a slow recovery (right) 
The respective approximations by a 4, 6 or 8 term Taylor expansion of the sum of Bessel 
functions. In the case of fast diffusion, practically the whole FRAP curve is described well 
with any Taylor expansion. However, in the case of slow diffusion, a significant part of the 
FRAP curve (left of the black vertical line) is not described well with the Taylor expansion.  
As a rule of thumb, the circular disk method generates accurate diffusion coefficients as long 
as the bleach pulse is not longer than one tenth of the diffusion time (Meyvis et al., 1999). 
More complex fit models for studying diffusion with FRAP exist that take the 3-dimensional 
shape of the bleach spot into account, but since FCS can be used for studying diffusion 
accurately we only mention this as a reference (Braeckmans et al., 2003). Equation 4.7 can be 
modified to account for anomalous diffusion (Feder et al., 1996). 
4.2.8.2. FRAP in the case of binding to an immobile structure 
4.2.8.2.1. Binding kinetics – diffusion uncoupled FRAP 
When a protein can bind strongly to an immobile structure, the FRAP recovery will be 
governed by the kinetics of this binding reaction and can be accurately described by an 
exponential function, or in the case of multiple binding sites, a sum of exponentials (Sprague 
et al., 2004): 
 r¡° = 1 − t 1mP,∗1m, + 1mP,∗ exp−1m,
P
:  Equation 4.10
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Where k*on is the pseudo rate constant for association, koff the rate constant for dissociation 
and n the total number of binding sites. In this case, k*on follows from the maximum possible 
bleach depth. If k*on >> koff, then the maximum bleach depth is zero. 
 
4.2.8.2.2. Binding kinetics – diffusion coupled FRAP 
When a diffusion model (Equation 4.7) gives a good fit, but a much lower D is obtained than 
expected (relative to a reference protein), binding kinetics are likely contributing to the 
recovery. When the relaxation time for the association process, 1/k*on, is smaller than the 
average diffusion time, diffusion will still contribute to the FRAP recovery, and Equation 
4.10 will not describe the dynamics correctly. In principle, even very slow (small koff) FRAP 
recoveries can still be governed by diffusion (large k*on). The observed diffusion coefficient 
can be used to calculate the ratio of rate constants, the pseudo equilibrium constant. The 
existence of different binding sites cannot be inferred from such a recovery, since only the 
sum of the ratios is obtained (Sprague et al., 2004): 
 0ml k<§k = 0<kk1 + ∑ 1mP,∗1m,P:  Equation 4.11
When 1/k*on and τdiff are in the same order of magnitude, a more complex FRAP model has 
to be used, that includes both rate constants and the diffusion coefficient as fit parameters 
(Sprague et al., 2004). 
 
4.2.8.2.3. Discerning diffusion coupled from uncoupled FRAP 
In general, the contribution of diffusion to the observed FRAP recovery can be checked by 
varying an experimental parameter that only influences the diffusion time scale. For example: 
- If the FRAP measurement is performed in a spot with variable size, the recovery 
should be slower for a bigger spot if diffusion contributes to the observed dynamics. 
If only koff determines the FRAP, the curves should be identical. 
- Similarly, if a half-nucleus bleaching is performed and the recovery is measured at 
different distances from the bleached region, the curves should be identical if only koff 
determines the recovery.  
- Finally, when a half-nucleus bleaching is performed and the recovery is measured on a 
line orthogonal to the bleach border, the line profile has a different evolution if 
diffusion or binding determines the dynamics (Figure 4.3) (Mueller et al., 2008). 
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Figure 4.3 Half nucleus bleaching to check diffusion dependence (top) Half of a 
nucleus is photobleached instantaneously and the recovery is measured on a line 
orthogonal to the bleach border. (middle-bottom) Evolution of the fluorescence along 
the arrow when diffusion describes the dynamics (middle) or when the binding kinetics 
are rate limiting (bottom). 
4.2.9. Structure based mutation of PWWP residues important for DNA binding 
To determine the residues important for the interaction of the PWWP domain of 
LEDGF/p75 with DNA we used biomolecular modelling. First, we modelled the structure 
of the PWWP domain of LEDGF/p75 using the latest available version of Modeller (Sali and 
Blundell, 1993), with the NMR structure (PDB 2B8A) of the HDGF-PWWP as a template 
(Lukasik et al., 2006). Secondly, we predicted putative DNA binding residues using the 
HotPatch algorithm (Pettit et al., 2007). Among these we chose the residues K56 and R74 
that were solvent exposed and not required to stabilize the tertiary structure of the protein. In 
this way, we avoided the generation of a mutant protein that would be unable to form the 
correct PWWP-fold. Of concern, these residues in the LEDGF/p75-PWWP were identical 
to the residues in the HDGF-PWWP sequence and had already been shown to be important 
for DNA binding of the HDGF-PWWP (Lukasik et al., 2006). The modelling part of this 
chapter was performed by Arnout Voet at the Laboratory for Biomolecular Modelling at 
K.U.Leuven. 
time = 0
time = 0
I
position
time = 0I
position
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4.3. Results 
4.3.1. Subpopulations of LEDGF/p75 in the living cell 
To image LEDGF/p75 in the living cell, we expressed a fusion protein of LEDGF/p75 and 
the enhanced green fluorescent protein (eGFP), eGFP-LEDGF/p75, displaying a 
heterogeneous nuclear distribution characteristic of endogenous LEDGF/p75 (Figure 4.4 A) 
(Cherepanov et al., 2003). Western blotting revealed no protein degradation of eGFP-
LEDGF/p75 (Figure 4.4 B). Chromatin binding properties of the fusion were similar to that 
of endogenous LEDGF/p75 as demonstrated by in vitro cell fractionation (Figure 4.4 C): 
following extraction of the cells with Triton X-100, eGFP-LEDGF/p75 was present in the 
insoluble pellet (P1), whereas a DNaseI treatment of the P1 pellet released the protein into 
the supernatant (S2), as demonstrated earlier for endogenous LEDGF/p75 (Llano et al., 
2006b). Thus, a N-terminal fluorescent tag does not affect the chromatin binding properties 
of LEDGF/p75. All further experiments were carried out in LEDGF/p75 knockdown HeLa 
cells (Figure 4.4 D) with transiently expressed eGFP-LEDGF/p75. In a spot in the 
nucleoplasm with bright and homogenous eGFP fluorescence we measured the fluorescence 
intensity Ifluo in function of time. While Ifluo instantaneously decreased (~40%) for eGFP-
LEDGF/p75 (Figure 4.4 E, red curve), it remained largely constant for our control protein 
eGFP (Figure 4.4 E, black curve). At steady state, Ifluo in the focal spot of the laser is a 
measure for the dynamic equilibrium between molecules in the spot that have a probability of 
being photobleached by the laser and unbleached molecules outside the spot. We 
hypothesized that eGFP-LEDGF/p75 binds to chromatin, which increases the residence 
time in the focal spot and hence the photobleaching probability. Photobleaching was 
concentration-dependent in the nM range (Figure 4.4 F), we determined a concentration of 
‘chromatin binding sites’ of 50 nM and a steady state dissociation constant of 100 nM 
(Equation 4.3). The residual constant fluorescence intensity after the initial photobleaching 
was used to calculate an autocorrelation function (ACF), using Fluorescence Correlation 
Spectroscopy (FCS). This allowed us to study the dynamics of the bleaching insensitive 
fraction of eGFP-LEDGF/p75. Our control, eGFP, exhibited free diffusion in the nucleus 
(Figure 4.4 G, red ACF) and a diffusion coefficient (D) of 21.8 µm²/s was calculated (Table 
4.1), which is in good agreement with previous findings (Chen et al., 2002).  
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Figure 4.4 Dynamic subpopulations of LEDGF/p75 revealed by photobleaching and FCS (A) 
Confocal fluorescence image of HeLa cells expressing eGFP-LEDGF/p75 with a transmission image 
overlay, obtained by DIC microscopy. Scale bar = 10 µm. (B) Western blot with an anti-p75 antibody of 
HeLa cells transiently expressing eGFP-fusions. eL = eGFP-LEDGF/p75, e∆ = eGFP-∆325, KR = 
K56D-R74D, L = endogenous LEDGF/p75. (C) Cellular fractionation assay of HeLa cells transiently 
expressing eGFP-fusions. Western blot of different fractions is shown using antibodies to indicated 
proteins. T = total cell lysate, S1 = Triton-soluble cellular fraction, P1 = Triton-insoluble cellular fraction, 
S2 = DNase/(NH4)2SO4-soluble cellular fraction, P2 = DNase/(NH4)2SO4-insoluble cellular fraction.  
(D) Western blot showing strong knockdown of endogenous LEDGF/p75 in HeLa-p75KD cells. MC = 
monoclonal HeLa-p75KD cells, Ctrl = control HeLa cell line, PC = polyclonal knockdown HeLa cell line. 
Equal loading was verified with an antibody against β-tubulin. L = endogenous LEDGF/p75. (E) 
Fluorescence intensity of eGFP and eGFP-LEDGF/p75 in living HeLa cells. (F) Concentration 
dependence of photobleaching of eGFP-LEDGF/p75 reveals stronger affinity sites. Solid line = fit with 
Equation 2.20. (G) Normalized ACFs of eGFP and eGFP-LEDGF/p75. The upper panel is a residual 
plot showing the best fit with a two-component diffusion model. Error bars = s.d. 
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The eGFP-LEDGF/p75 ACF on the other hand was strongly shifted to a slower time scale 
(Figure 4.4 G, green ACF), and could only be described using a 2-component model 
(compare δG(τ) in Figure 4.4 H): a minor component (35%) having an apparent D of 14.6 
µm²/s, in accordance with the value for free diffusion (14.7 µm²/s), and a major component 
(65%) having a very low mobility (D = 0.3 µm²/s) (Table 4.1). We hypothesized that even 
this slow component of the bleaching insensitive fraction of the LEDGF/p75 population 
involves interactions with chromatin. In the following two sections we will explain these 
observations further.  
 
Table 4.1 Subcellular protein dynamics of LEDGF/p75 and variants measured with FCS - 
Intracellular ACFs were fitted with a two-component or anomalous diffusion model (Equation 
2.20) and the fraction (F) and diffusion coefficients (D, in µm²/s) was calculated as described in 
the experimental procedures. The calculations of D were made assuming a diffusion coefficient of 
Rhodamine 6G equal to 280  µm²/s. The K150A mutant of LEDGF/p75 is explained in detail in 
Chapter 5. mNLS = mutated nuclear localisation signal, mPWWP = mutated PWWP domain, n = 
number of independent cellular measurements, s.d. = standard deviation, n.p. = fit not possible, * 
= fit not satisfying, a.u. = arbitrary units.  
Protein properties n Dfast ± s.d. Ffast ± s.d.(%) Dslow ± s.d. α ± s.d.(a.u.) 
   2-component fit anomalous fit 
Nucleus               
eGFP-LEDGF/p75 wild type 23 14.6 ± 2.6 35.9 ± 3.0 0.3 ± 0.1 n.p. 
eGFP-LEDGF/p75 K150A mNLS 13 13.4 ± 2.2 37.6 ± 4.5 0.3 ± 0.1 n.p. 
eGFP-LEDGF/p75 K56D mPWWP 22 10.8 ± 2.3 44.5 ± 9.3 0.7 ± 0.2 0.69 ± 0.05* 
eGFP-LEDGF/p75 R74D mPWWP 21 8.8 ± 1.6 58.5 ± 8.6 0.9 ± 0.4 0.78 ± 0.04 
eGFP-LEDGF/p75 K56D R74D mPWWP 28 9.9 ± 1.9 66.8 ± 9.6 1.0 ± 0.5 0.80 ± 0.05 
eGFP-∆325  9 14.0 ± 1.3 89.7 ± 2.8 0.6 ± 0.4 0.88 ± 0.03 
eGFP  19 21.8 ± 2.4 97.3 ± 0.7 0.5 ± 0.3 0.98 ± 0.02 
               
Cytoplasm               
eGFP-LEDGF/p75 K150A mNLS 18 11.9 ± 1.7 53.3 ± 9.4 1.0 ± 0.4 0.78 ± 0.03 
eGFP-∆325  10 16.9 ± 1.1 91.9 ± 4.3 1.0 ± 0.6 0.93 ± 0.05 
eGFP  17 23.8 ± 1.2 93.7 ± 2.8 0.6 ± 0.4 0.93 ± 0.05 
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4.3.2. Dynamic chromatin interaction of LEDGF/p75 
We constructed an eGFP fusion of the C-terminal ∆325-fragment of LEDGF/p75 that lacks 
the domains important for chromatin and DNA binding (Figure 1.8). The photobleachable 
fraction of this fragment in the nucleus decreased to that of freely diffusing eGFP (Figure 4.5 
A, red curve) and the ACF showed that the large majority (~90%) exhibited free intranuclear 
diffusion (Figure 4.5 B, red curve and Table 1). Chromatin binding of LEDGF/p75 was thus 
indeed responsible for the photobleaching and the slow component of the ACF. Next, we 
compared our measurements with those of well characterized chromatin interacting proteins: 
Heterochromatin Protein 1 (HP1), RNA polymerase II (RNAPII) and Linker Histone H1 
(H1). HP1 is a protein involved in heterochromatin formation through interaction with and 
oligomerization on nucleosomes (Eissenberg and Elgin, 2000). RNAPII is a multi-protein 
complex that synthesizes messenger RNA (Sugaya et al., 2000). H1 binds very strongly to the 
crossing-over of DNA twisted around an octamer of core-histone proteins stabilizing the 
nucleosome (Zlatanova et al., 2000).  
 
 
Figure 4.5 Dynamic chromatin interaction of LEDGF/p75 (A) Cellular point 
fluorescence intensity and (B) ACF of eGFP-∆325. Measurements on eGFP-LEDGF/p75 
and eGFP are also plotted in gray as a reference. (C) Cellular point fluorescence intensity and 
(D) ACF of eGFP-HP1β, RNA polymerase II (CHO cells stably expressing eGFP-hRPB1) 
and Histone H1-eGFP. Error bars = s.d.  
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All three proteins were expressed as a fusion with eGFP. For HP1 and RNAPII we observed 
markedly more photobleaching than for eGFP (Figure 4.5 C, resp. black and red curves), 
although their ACFs demonstrated that both proteins have a slightly higher mobility than 
LEDGF/p75 (Figure 4.5 D). For H1 we observed very strong photobleaching that increased 
throughout the measurements, distorting the ACF considerably (Figure 4.5 C and D, green 
curves). In conclusion, chromatin interacting proteins generally diffuse slowly, as measured 
with FCS and are hence more sensitive to photobleaching.  
4.3.3. Possible explanations for the observed dynamics 
Five mechanisms of chromatin binding of LEDGF/p75 can be thought of: (1) LEDGF/p75 
binds very strongly to chromatin and the observed diffusion coefficient (Dobs = 0.3 µm²/s, 
τdiff,obs = 25.9 ms) would reflect diffusion of chromatin (Figure 4.6 A). This is unlikely, since 
reported values for the diffusion coefficient of chromatin are 2-3 orders of magnitude lower 
than what we observed (Marshall et al., 1997).  
 
Figure 4.6 Five possible explanations for the slow dynamics of LEDGF/p75 (A) The 
observed diffusion time tdiff is that of the chromatin if LEDGF/p75 strongly associates with 
the chromatin. tbound is the bound time. (B) A multiprotein complex exhibits a very slow tdiff. 
(C) Diffusion-uncoupled FCS when tbound = tdiff. tunbound is the unbound time and is dictated 
by the fraction of the fast (Ffree) and slow (Fbound) components in the FCS curve. (D) 
Reaction-diffusion-coupled FCS when both tunbound and tbound are smaller than tdiff. The ratio 
of tdiff,obs and the tdiff for free diffusion dictates Ffree and Fbound. (E) One-dimensional diffusion 
on the chromatin. 
Chapter 4. Ultrafast chromatin binding kinetics of LEDGF/p75 
102 
(2) LEDGF/p75 is part of a multi-protein complex and the observed diffusion coefficient is 
a measure for the size of the complex (Figure 4.6 B). This is also unlikely, since a 
macromolecule (>MDa) would suffer from obstructed (anomalous) diffusion (Weiss et al., 
2004), which was not observed (Figure 4.4 H). Moreover chromatin binding is definitely 
contributing strongly to the observed dynamics (Figure 4.5 A-D). (3) LEDGF/p75 is 
immobilized during 25.9 ms (tdiff,obs= the bound time tbound) after associating with chromatin. 
In this case diffusion would not contribute to the observed dynamics (Figure 4.6 C). (4/5) 
LEDGF/p75 binds faster to the chromatin than the diffusion time, in a transient (Figure 4.6 
D) and/or continuous way (Figure 4.6 E). In this case the binding reaction but also diffusion 
would contribute to the observed dynamics.  
4.3.4. Dynamic chromatin scanning by LEDGF/p75 
We used an in-house developed tunable focus fluorescence correlation spectroscope (TF-
FCS) adapted for cellular measurements to determine whether the ACF was affected by the 
size of the confocal laser spot and thus by diffusion (see section 4.2.6 for an optical scheme 
of the setup). In vitro control measurements of a standard probe rhodamine 6G in MQ 
(Figure 4.7 A-C) showed that it was indeed possible to tune the time scale of diffusion in a 
broad range. Furthermore, measurements on eGFP in PBS (Figure 4.7 D) and of eGFP in a 
buffer with a refractive index matching that of the intracellular environment (PBS, 23.5% 
w/w sucrose, n=1.37) showed that the setup also performed well for measurements on eGFP 
under optical conditions similar to the intracellular environment.   
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Figure 4.7 Performance of the tunable focus FCS setup (A) When the focus is enlarged, 
the experimental ACF of rhodamine 6G shifts to a slower time scale. When the diaphragm is 
opened, more collimated light goes through, as measured with a power meter. Both the 
particle number (B) and the diffusion time (C) of rhodamine 6G decrease when the beam is 
enlarged, i.e. when the focus is smaller. (D) The in vitro ACFs of rhodamine 6G in MQ, 
eGFP in PBS and eGFP in PBS/sucrose all shift towards a slower time scale when the focus 
is enlarged. ω1 = radial radius of the focus. 
 
In cells, the ACF of intracellular eGFP was also clearly dependent on the size of the focal 
spot (Figure 4.8, black curves), consistent with the purely Brownian diffusion of the protein. 
The ACF of eGFP-LEDGF/p75 in the cell nucleus was also shifted in a larger focal spot 
(Figure 4.8, red curves), especially for the slower component of the curve. The slow 
component in the ACF is thus dependent on diffusion, and argues for an extraordinary 
dynamic interaction of LEDGF/p75 with chromatin (Figure 4.6 D and/or E). 
  
A B 
C D 
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Figure 4.8 Diffusion-controlled fast genome scanning by LEDGF/p75 – Cellular 
tunable focus fluorescence correlation spectroscopy measurements of eGFP and eGFP-
LEDGF/p75 in HeLa cells. ω1 is the radial radius of the excitation focus, experimentally 
determined from in vitro calibration measurements. Error bars = s.d.  
 
If a binding reaction to an immobile reactant such as the chromatin rapidly reaches an 
equilibrium, diffusion will appear to be slowed down. The ‘effective’ diffusion coefficient will 
be Dobs,eff = DfreeFfree with Dfree the expected diffusion coefficient for free nuclear diffusion 
(= 14.7 µm2/s for eGFP-LEDGF/p75) and Ffree the average fraction of molecules not bound 
to chromatin (Crank, 1975). Based on our measured Dobs,eff = 0.3 µm2/s LEDGF/p75 
remains 98% of the time bound to chromatin and during the remaining 2% of the time, 
LEDGF/p75 quickly moves to a new binding site. Next, it follows from a simple protein 
binding equilibrium that k*on/koff = (1-Ffree)/(Ffree). The pseudo rate constant for association 
k*on (= kon multiplied with the concentration of binding sites) for LEDGF/p75 is thus 49 
times larger than the rate constant for dissociation koff. Finally, since the binding times tunbound 
= 1/k*on and tbound = 1/koff would have to be faster than the expected diffusion time (tdiff = 
25.9 ms), the average koff (the rate constant for dissociation) would have to be larger than 
38.6 s-1 and k*on larger than 1.9x103 s-1. These estimations are in line with an effective 
diffusion regime, previously simulated for the analysis of FRAP and FCS measurements 
(Sprague et al., 2004; Michelman-Ribeiro et al., 2009). An association purely based on a 
collision of LEDGF/p75 and chromatin would result in a kon~109 M-1s-1. We estimated k*on 
larger than 1.9x103 s-1, so we estimate the concentration of binding sites of LEDGF/p75 on 
chromatin to be larger than 1.9 µM. If we assume a globular HeLa nucleus with a 10-µm 
diameter, 1.9 µM of binding sites roughly corresponds to 106 binding sites. This 
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concentration is consistent with our observation that the parameters from our FCS 
measurements were constant in the measured concentration range of LEDGF/p75 (< 3 µM). 
Importantly, at nM concentrations we observed stronger chromatin binding (Figure 4.4 E), 
suggesting the existence of a few (50 nM) strong-affinity binding sites. In summary, since the 
observed dynamics of chromatin binding scale with the confocal volume size, the association 
and dissociation time scales are smaller than the diffusion time scale, the apparent slow 
dynamics in our FCS measurements are thus due a high frequency of binding to chromatin, 
(high k*on, high koff). Strong-affinity chromatin binding (mechanism 3) thus does not 
determine the dynamics of LEDGF/p75 in the living cell nucleus. Rather, LEDGF/p75 
predominantly moves by dynamic ‘genome scanning’ (mechanism 4/5), a fast weak-affinity 
diffusion-collision driven chromatin interaction.  
4.3.5. Chromatin scanning of LEDGF/p75 is decelerated by HIV-1 integrase 
We checked the chromatin interaction of eGFP-LEDGF/p75 in absence or presence of IN. 
In absence of mRFP-tagged IN, about 40% of the fluorescence signal of eGFP-LEDGF/p75 
photobleached during the first seconds. Upon co-expression of mRFP-tagged IN, this 
photobleaching increased considerably (Figure 4.9 left). A larger fraction of the LEDGF/p75 
population photobleached (on average 75% instead of 40%), similar to the photobleaching 
observed for histone H1, a strong chromatin binding protein. These experiments imply an 
increased affinity of LEDGF/p75 for chromatin, upon co-expression of IN. Moreover, at 
increasing concentrations of eGFP-LEDGF/p75 a stronger interaction with chromatin was 
observed (Figure 4.9 right), resulting in up to 90% photobleaching during the first 20 
seconds. Importantly, in cells expressing only IN, this photobleaching was not present 
(Figure 5.3 and (Maertens et al., 2005)).  
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Figure 4.9 Dynamic chromatin scanning of LEDGF/p75 is decelerated by HIV-1 
integrase. (left) Point fluorescence measurement of eGFP-LEDGF/p75 in cells co-
expressing mRFP-IN. (right) Concentration-dependence of photobleaching of eGFP-
LEDGF/p75.  
In order to estimate the residence time of eGFP-LEDGF/p75 on chromatin in the presence 
of mRFP-IN, we used fluorescence recovery after photobleaching (FRAP). As expected, no 
permanent immobile fraction was observed in cells only expressing eGFP-LEDGF/p75, 
reaching 90% recovery in ~10 seconds (Figure 4.10 left, black curve), which is consistent 
with a protein that readily dissociates from the chromatin. Upon co-expression of mRFP-IN 
however, the fluorescence recovery was an order-of-magnitude slower and incomplete 
(Figure 4.10 left, red curve), reaching only about 60% after 100 seconds.  
 
 
Figure 4.10 Dynamic chromatin scanning of LEDGF/p75 is decelerated by HIV-1 
integrase. (left) Cellular FRAP measurement of eGFP-LEDGF/p75 in cells expressing 
mRFP-IN. Error bars = s.d. (right) Control photobleaching experiment to verify the 
contribution of diffusion to the observed photobleaching recovery (Mueller et al., 2008). 
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We also used a different FRAP method, to check the contribution of diffusion to the 
observed dynamics, analogously as we did for the fast dynamics of eGFP-LEDGF/p75 in 
absence of mRFP-IN. When photobleaching half of the nucleus, the fluorescence at a certain 
position either recovers with the same rate irrespective of the distance from the unbleached 
area (diffusion uncoupled mechanism) or exhibits a distance dependent recovery (diffusion 
coupled mechanism)(Mueller et al., 2008). This method is explained in more detail in the 
Materials and Methods section. Clearly, LEDGF/p75-IN still exhibited diffusion coupled 
recovery (Figure 4.10 right). Not surprisingly thus, a standard diffusion model (Axelrod et al., 
1976) described the FRAP data in Figure 4.10 nearly perfectly, even though the recovery of 
LEDGF/p75-IN is shifted by almost an order-of-magnitude to a slower time scale with 
respect to LEDGF/p75 alone.  
 
In conclusion, upon co-expression of IN, the dynamics of LEDGF/p75 shift towards a tight 
chromatin association. In absence of LEDGF/p75, IN behaves as a free protein (section 
5.3.1) and in absence of IN, LEDGF/p75 shows moderate affinity for chromatin (Figure 4.4 
H). Upon their co-expression, the protein population segregates into a concentration-
dependent immobile fraction and a mobile fraction with order-of-magnitude slower 
dynamics.   
4.3.6. The PWWP domain contributes to strong affinity chromatin binding of 
LEDGF/p75 
Finally, we set out to verify the previously documented contribution of the PWWP-domain 
to the overall chromatin binding of LEDGF/p75 (Turlure et al., 2006; Llano et al., 2006b). 
To affect the overall protein structure as little as possible, we sought to specifically alter the 
affinity of this domain for chromatin. Based on the molecular model of the PWWP-domain 
of HDGF in complex with DNA (Lukasik et al., 2006), we predicted that positively charged 
residues K56 and R74 are most likely interacting with the phosphates of the host DNA 
(Figure 1.8 and Materials and Methods). Next, we constructed and purified two single 
mutants of LEDGF/p75, K56D and R74D, and the double mutant K56D-R74D and 
corroborated the correct overall folding with circular dichroism spectroscopy (Table 4.2).  
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Table 4.2 Secondary structure of PWWP-mutants is not 
different from wild-type LEDGF/p75. Circular dichroism 
spectroscopy on purified wild-type and mutants of LEDGF/p75. 
Shown is the calculated secondary structure composition of the 
proteins. CD spectra were measured between 195 and 260 nm on 
a spectropolarimeter (Jasco Benelux bv, de Meern, The 
Netherlands). 
 WT K56D R74D K56D R74D 
Helix 12.80% 12.90% 12.00% 14.40% 
Antiparallel 20.80% 20.20% 22.00% 17.30% 
Parallel 4.40% 4.40% 4.40% 4.30% 
Beta-Turn 26.30% 26.30% 25.60% 27.60% 
Random Coil 36.30% 36.60% 36.60% 37.10% 
Total Sum 100.50% 100.40% 100.50% 100.70% 
 
Next, eGFP-fusions of these proteins were transiently expressed in HeLa cells. The proteins 
were characterized by a diffuse nuclear localisation instead of the typical heterogeneous 
nuclear distribution of the wild type protein (Figure 4.11 A-C), suggesting the chromatin 
binding properties were affected. Indeed, the photobleaching of the mutants decreased 
considerably (Figure 4.11 D, red curve) and the ACFs showed faster protein dynamics of 
eGFP-LEDGF/p75 carrying these mutations: the R74D mutation had a more pronounced 
effect than the K56D mutation (Figure 4.11 E, resp. red and black ACF) while the double 
mutant did not show an additive effect compared with the R74D single mutation (Figure 4.11 
E, green ACF). The PWWP-domain of LEDGF/p75 thus ensures strong affinity chromatin 
binding. Importantly, the difference in cellular dynamics between the K56D and R74D 
mutants could not be inferred from a differential distribution of the proteins. It was only 
evidenced by our FCS measurements, demonstrating the sensitivity of this technique. We 
next verified whether the mutations in the PWWP domain of LEDGF/p75 affected 
chromatin tethering of IN. In FRAP experiments mRFP-IN co-expression affected the 
dynamics of eGFP-LEDGF/p75 K56D-R74D much less than for wild-type eGFP-
LEDGF/p75 (Figure 4.11 F, red curve). In fact, the immobile fraction disappeared 
completely and the time scale of the mutant protein complex dynamics was much alike free 
eGFP-LEDGF/p75. To verify that eGFP-LEDGF K56D-R74D and mRFP-IN still interact, 
we used cellular fluorescence cross-correlation spectroscopy (FCCS). Indeed, marginal 
photobleaching and a strong interaction was observed (Figure 5.8 and Table 5.2).  
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Moreover, in comparison with wild-type LEDGF/p75, PWWP-mutations targeted the 
protein complex away from the chromatin (Figure 4.11 F). We thus conclude that the PWWP 
domain in LEDGF/p75 is crucial for tight chromatin tethering of IN but not for the 
interaction of IN with LEDGF/p75.  
 
 
Figure 4.11 The PWWP domain of LEDGF/p75 contributes to strong affinity chromatin binding 
and is crucial for chromatin tethering of HIV-1 integrase (A-C) Confocal fluorescence images of 
HeLa cells expressing (A) eGFP-LEDGF/p75 K56D, (B) R74D and (C) K56D-R74D. (D) Cellular point 
fluorescence intensity and (E) ACF of eGFP-LEDGF/p75 K56D-R74D. (F) Cellular FRAP measurement 
of eGFP-LEDGF/p75 K56D-R74D in HeLa cells (n = 20). The arrows represent the shift in protein 
dynamics upon mRFP-IN co-expression. FRAP curves for wild-type LEDGF/p75 are plotted in gray as a 
reference.  
Chapter 4. Ultrafast chromatin binding kinetics of LEDGF/p75 
110 
4.4. Discussion 
4.4.1. Fast genome scanning of LEDGF/p75 relates to its cellular function   
Both Sprague et al. and independently also Phair et al. published methods in 2004 to analyse 
Fluorescence Recovery After Photobleaching in the presence of chromatin binding (Sprague 
et al., 2004; Phair et al., 2004). Recently, Michelman-Ribeiro and co-workers extended this 
theory for the analysis of Fluorescence Correlation Spectroscopy in the presence of 
chromatin binding (Michelman-Ribeiro et al., 2009). Both techniques allow observing the 
mobility of proteins over a defined distance, and since FCS does this over a much smaller 
distance than FRAP, individual chromatin association events are likely observed rather than 
mere diffusion of the protein. Consequently however, if many chromatin 
association/dissociation events occur during an individual observation, the individual events 
will be obscured as seemingly slow diffusion. Our TFFCS method allowed us to show for the 
first time that transcription factor chromatin binding kinetics can indeed be even faster than 
the FCS diffusion time scale and are obscured in seemingly slow ‘effective’ diffusion. For 
LEDGF/p75, a k*on > 1.9x103 s-1 and koff > 38.6 s-1 was found, considerably faster than 
reported before for other transcription factors (Phair et al., 2004; Mueller et al., 2008; 
Michelman-Ribeiro et al., 2009). These fast kinetics, which could represent either 3D-
hopping (Figure 4.6 D), 1D-sliding (Figure 4.6 E) or a combination of both (Figure 5.10), 
imply that LEDGF/p75 is predominantly associating with chromatin in a collision controlled 
fashion and finding a specific binding site amenable to tight interaction with LEDGF/p75 is 
thus a matter of chance. This result provides a novel insight in the field of transcription and 
urge a re-evaluation of former data. To that extent, we could already show with FCS that 
RNA polymerase II and Heterochromatin Protein 1 show slow dynamics in FCS, which are 
most likely due to fast chromatin binding kinetics. Specifically for LEDGF/p75, both the 
documented specific activation of stress responsive genes by LEDGF/p75 (Singh et al., 2001; 
Singh et al., 2006) and the targeting of HIV-integration to actively transcribed, yet non-
specific genes (Ciuffi et al., 2005; Marshall et al., 2007; Shun et al., 2007), do fit well in the 
proposed model.  
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4.4.2. Important role of the PWWP-domain in chromatin binding of LEDGF/p75 
It remained crucial to verify whether the dynamic interactions of LEDGF/p75 with 
chromatin are based on direct binding with DNA, as suggested before (Singh et al., 2001), or 
on indirect interactions with other chromatin-bound proteins. The conserved PWWP-domain 
of LEDGF/p75 contains a recently described general protein fold. The PWWP domain is 
present in proteins that carry chromatin-binding motifs and has been proposed to bind to 
DNA in several independent structural biology studies (Qiu et al., 2002a; Lukasik et al., 
2006). Other studies however suggested, albeit without experimental evidence so far, that the 
PWWP-fold is implicated in non-DNA chromatin interactions (Stec et al., 2000; Maurer-
Stroh et al., 2003). Although eGFP-PWWP did not show any DNA binding in vitro, it was 
shown to be localised on mitotic chromosomes, much alike full length LEDGF/p75 (Turlure 
et al., 2006). We studied the role of the PWWP domain of LEDGF/p75 in the intranuclear 
dynamic behaviour of the protein by introducing the K56D and R74D mutations in PWWP. 
Both mutations were designed to impede DNA binding. We showed a 4-fold increase in the 
overall protein dynamics and hence reduced DNA binding, as judged from the experimental 
ACFs, as compared to wild-type LEDGF/p75 (Figure 4.11 E). Notably, the mutant protein 
exhibited diffusion-dependent anomalous diffusion. This could result from interactions with 
the chromatin, as has been simulated before (Wedemeier et al., 2008), but could also imply 
that interactions with other cellular cofactors determine the dynamics when LEDGF/p75 is 
targeted away from the chromatin, resulting in a macromolecule suffering from obstructed 
diffusion (Weiss et al., 2004). Further research will address this issue. Our findings implicate 
that the PWWP domain is involved in direct interaction with DNA and validate the 
important, but possibly not unique role for PWWP in chromatin binding.  Since the PWWP-
domain strongly contributes to the molecular arrest and interference with the PWWP domain 
drastically handicaps LEDGF/p75-mediated chromatin tethering of IN, this domain may be 
a promising novel target for blocking LEDGF/p75 malfunction in AIDS but also 
oncogenesis. 
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4.5. Conclusion 
In this chapter we have applied FCS to investigate the dynamics of LEDGF/p75 in real-time 
in living cells. After pinpointing the overall slow dynamics to chromatin binding, we proved 
that the underlying mechanism of the dynamics of LEDGF/p75 is an extraordinary fast 
interaction with chromatin, with multiple association-dissociation events taking place while 
the protein traverses the confocal measurement spot. LEDGF/p75 thus seems to mainly 
interact non-specifically with chromatin, although tight chromatin binding was occasionally 
observed. Association with HIV-1 integrase results in a segregation between an immobile and 
a significantly slower fraction. By decreasing the affinity of the PWWP domain of 
LEDGF/p75 for chromatin, we observed a moderate increase of the dynamics of 
LEDGF/p75 but a strong increase on the dynamics of LEDGF/p75-IN. Future work will 
focus on investigating the importance of this tight PWWP-domain-controlled chromatin 
interaction for HIV replication.  
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Chapter 5. Measuring the interaction 
of HIV-1 integrase and LEDGF/p75 
in living cells  
Parts of this chapter are published in: 
De Rijck J., Vandekerckhove,L., Gijsbers,R., Hombrouck,A., Hendrix,J., Vercammen,J., 
Engelborghs,Y., Christ,F., and Debyser,Z. (2006a). Overexpression of the lens epithelium-
derived growth factor/p75 integrase binding domain inhibits human immunodeficiency virus 
replication. J. Virol. 80, 11498-11509. 
 
Hombrouck,A., De Rijck,J., Hendrix,J., Vandekerckhove,L., Voet,A., De Maeyer,M., 
Witvrouw,M., Engelborghs,Y., Christ,F., Gijsbers,R., and Debyser,Z. (2007). Virus Evolution 
Reveals an Exclusive Role for LEDGF/p75 in Chromosomal Tethering of HIV. PLoS. 
Pathog. 3, e47. 
 
Hendrix, J., De Rijck, J., Gijsbers, R., Voet, A., Hotta, J., McNeely, M., Vanstreels, E., 
Daelemans, D., Hofkens, J., Debyser, Z., and Engelborghs, Y. Dynamic chromatin scanning 
of transcriptional co-activator LEDGF/p75 is arrested by HIV-1 integrase. (submitted for 
publication). 
5.1. Introduction 
After LEDGF/p75 was identified in a co-immunoprecipitation experiment together with 
HIV-1 integrase (IN), both proteins were shown to co-localize in interphase and mitotic cells 
(Cherepanov et al., 2003). The nuclear localisation of IN was shown to be dependent on the 
concentration of LEDGF/p75 (Maertens et al., 2003). In vitro pull-down experiments 
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confirmed that the two proteins indeed interacted specifically. Furthermore, in vitro 
LEDGF/p75 increased DNA binding of IN, and this effect was shown to be lentivirus 
specific (Busschots et al., 2005). Finally, it was demonstrated with fluorescence correlation 
spectroscopy, that the nuclear dynamics of eGFP-tagged IN were dependent on the presence 
of endogenous LEDGF/p75, which is an indirect proof for their interaction (Maertens et al., 
2005). An assay for quantifying the direct intracellular interaction of IN and LEDGF/p75 
did, however, not yet exist at the time. Fluorescence cross-correlation spectroscopy is a good 
candidate for such an assay, since it is one of the few techniques that can probe an interaction 
in a non-invasive manner in the natural environment of the cell. If such an assay could be set 
up, potential inhibitors of the interaction between IN and LEDGF/p75 could be validated 
for their activity on the IN:LEDGF/p75 interaction directly in living cell culture. In this 
chapter the efforts that were made to create such an assay are presented. Together with the 
results from 0, we finally build a first mechanistic model that unifies paradoxical notions of 
transcriptional co-activation and HIV-1 targeting by LEDGF/p75.   
5.2. Materials and Methods 
The protocols for plasmid cloning, cell culture and transfections are given in Chapter 4.    
5.2.1. Fluorescence cross-correlation spectroscopy 
For the FCCS measurements a commercial FCS/FCCS microscope (LSM510/ConfoCor2, 
Carl Zeiss, Jena, Germany) was used. Practically, enhanced green fluorescent protein (eGFP) 
(Heim et al., 1995) and monomeric red fluorescent protein (mRFP1) (Campbell et al., 2002) 
were used as fluorescent tags. The 488-nm line of the Ar+-laser (acousto-optical tunable filter 
(AOTF) 0.1%, ~0.25 µW) was used to excite eGFP and the 543-nm line of the HeNe laser 
(AOTF 7%, ~8.6 µW) was used to excite mRFP1. The excitation light was reflected by a 
dichroic mirror (HFT 488/543) and focused through a C-Apochromat 40×/1.2 W 
Korr/0.13-0.17 objective. The fluorescence emission light was split by a second dichroic 
mirror (NFT 570) into two separate beam paths and passed through a 505-530 nm bandpass 
filter and 70-µm pinhole for eGFP fluorescence and a 600-650 nm bandpass filter and 78-µm 
pinhole for mRFP1 fluorescence. In each cell cytoplasm or nucleus, 10 consecutive FCCS 
measurements of 20 seconds were performed.  
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5.2.2. Qualitative FCCS analysis 
For qualitative FCCS analysis, one can normalize the cross-correlation function (CCF) to the 
green autocorrelation function (ACF) (Saito et al., 2004; Kohl et al., 2005). 
 +*.   = ww0x,@wd0 ≈ r¡$%' ²%&' Equation 5.1
This so-called ‘relative cross-correlation’ parameter is 0 for no interaction and 1 for 100% 
interaction, when the green-to-red concentration (Ngreen,total/Nred,total) ratio is 1. Due to 
unavoidable spectral cross-talk and non-ideal volume overlap however, the actual CCrel varied 
between ~0.2 (very weak or no interaction) and ~0.7 (very strong interaction). Comparable 
protein concentrations and concentration ratios were used to be able to compare different 
cellular measurements and different proteins. In living cells the expression ratio of green-to-
red protein can be easily controlled by the ratio of green-to-red plasmid. This method of 
representing the data allows for an easy assessment of the affinity but is however not very 
quantitative.  
5.2.3. Quantitative FCCS analysis: ‘apparent’ equilibrium dissociation constant 
ACFs and CCFs were fitted with Equation 2.20. The amplitude of the correlation functions 
can be used to calculate the actual concentrations. First, the correlation functions are 
corrected for spectral cross-talk (section 2.3.4.2), to obtain the real observed particle 
numbers: 
 x,pmpKy = x,@wd = x + x< Equation 5.2 
 <,pmpKy = T,³´µ9¶T,·ª·¸U}¶T,·ª·¸9T,³´µV9®¶T,·ª·¸¶T,·ª·¸9T,³´µ   Equation 5.3 
 x< = x,pmpKy<,pmpKy + x,pmpKywwd − x,pmpKy Equation 5.4 
 
Where Ng,total, Ng, Nr,total, Nr and Ngr are resp. the green-total, green-only, red-total, red-only 
and green-and-red particle numbers, Ng,ACF, Nr,ACF and NCCF are the inverses the respective 
correlation functions, and Q is the brightness of eGFP relative to the brightness of mRFP in 
the red detection channel. For the eGFP-LEDGF/p75 (or mutants thereof) and mRFP-IN 
couple, Q≈0.1. With these particle numbers known, the actual concentrations can be 
calculated: 
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  [] = ¹G¹@ Equation 5.5
With Nx the particle number of species X measured in volume X and NA Avogadro’s 
number. If protein G, tagged with eGFP, binds to protein R, tagged with mRFP, to form 
GR, then the affinity of this interaction defines the dissociation constant Kdiss: 
  + j º» j  with     = [{][|][{|]  Equation 5.6
 and [] = []u − [j] 
       [j] = [j]u − [j] 
with [G]0 and [R]0 the total concentrations of protein G and protein R. Importantly, to be 
able to accurately quantify an equilibrium with FCCS, the CCF amplitude at a given ratio of [{|][{]£[|]£ should still be well measurable above background. As a rule of thumb, to assure a 
measurable fraction of bound species, protein concentrations in the range Kdiss are best used, 
making FCCS especially suitable for the quantification of rather strong affinity protein-
protein interactions (Bacia et al., 2006)(Figure 5.1).  
 
Figure 5.1 Simulation of the percentage of complex formation in function of the total 
protein concentration, for a given affinity of two proteins – Whereas at strong affinity 
(low Kdiss) FCCS can already measure the interaction at nM concentrations, a significant 
concentration of proteins is needed if the proteins interact with weaker affinity. 
5.2.4. FLIM-FRET 
The fluorescence lifetime of a fluorochrome, in this case eGFP, corresponds to the relaxation 
time of the excited state depopulation by fluorescence. If a second fluorescent molecule with 
proper photophysical properties (mRFP) is at a distance smaller than ~10 nm from the first 
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molecule, e.g. due to protein-protein interactions, the excitation can be transferred without 
radiation in a process called Förster resonance energy transfer (FRET). This transfer will 
lower the average fluorescence lifetime of the first molecule, since its excited state will be 
depopulated faster.  Cellular time-resolved fluorescence lifetime imaging based FRET (FLIM-
FRET) can be used to study protein-protein interactions inside living cells by careful 
monitoring of the fluorescence lifetime at each cellular position. Because a whole cell or cell 
compartment rather than a diffraction limited spot is probed during one measurement, this 
technique is less prone to photobleaching than cellular FCCS. A commercial confocal laser 
scanning microscope (Leica TCS SP5, Leica Microsystems CMS GmbH, Mannheim, 
Germany) equipped with a pulsed laser (MaiTai-HP Ti:Sapphire laser, Newport Spectra-
Physics) and time-tagged time-resolved (TTTR) time-correlated single-photon counting 
(TCSPC) hard/software (Picoquant GmbH, Berlin, Germany) was used for FLIM-FRET. 
The 880-nm laser light was focused through a HCX-PL-APO-63x/NA-1.2/water objective 
(Leica) and eGFP emission was captured through a 535/50 bandpass filter. Practically, the 
LSM was adjusted to detect very low concentrations of expressed protein by single-photon 
excitation. A cell with a suitable expression ratio of green-to-red protein (< 1:5) was 
magnified and two-photon excitation of eGFP at 1.5% of the 80-Mhz 880-nm pulsed laser 
output allowed performing TCSPC-based FLIM-FRET. The fluorescence decay curve was 
calculated for the whole cytoplasm or nucleus and fitting was performed by a mono- or 
biexponential reconvolution fitting procedure. The instrument response function was 
determined by TCSPC of a solution of malachite green under the same experimental 
conditions. All FLIM-FRET experiments were carried out at the K.U.Leuven Rega Institute 
for Medical Research.  
5.3. Results  
5.3.1. LEDGF/p75 and IN form an immobile intracellular complex 
As a fluorochrome couple for these experiments, we used the best fluorescent protein couple 
that was available at the time, enhanced green fluorescent protein eGFP (Heim et al., 1995) 
and the first true monomeric red fluorescent proteins, mRFP1 (Campbell et al., 2002), which 
have a good spectral emission separation (eGFP λem,max=507 nm, mRFP λem,max=607 nm) and 
have a brightness that is compatible with FCCS measurements. We generated two fusion 
constructs, eGFP-LEDGF/p75 and mRFP-IN, co-expressed these hybrids in HeLa cells and 
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performed an FCCS experiment at an homogenous region in the nucleoplasm (Figure 5.2 
top). During the first seconds of the measurements strong photobleaching occurred (Figure 
5.2 A). As a consequence of this, correct auto- and cross-correlation of the fluorescence 
signals was no longer possible (Figure 5.2 B).  
 
 
Figure 5.2 FCCS measurements of wild-type eGFP-LEDGF/p75 are prohibited due to 
photobleaching. (top) Confocal LSM image of HeLa cells expressing mRFP-IN (red) and 
eGFP-LEDGF/p75 (green) and the overlay of the two images (yellow). (bottom)(A-B) In 
cells co-expressing wild-type eGFP-LEDGF/p75 and mRFP-IN strong photobleaching 
occurred during the first 20 seconds of the measurement resulting in erroneous correlation 
curves. (C-D) After the signal reached a plateau, no significant cross-correlation was 
observed.   
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The complex of these proteins is likely immobile, resulting in the photobleaching. Once the 
signals had reached a plateau (Figure 5.2 C), correct auto- and cross-correlation curves could 
be calculated and analysed, but the lack of a significant cross-correlation curve amplitude, 
which is a signature an interaction of the two proteins, lead us to conclude that no significant 
interaction between LEDGF/p75 and IN could be observed in the nucleoplasm (Figure 5.2 
D).  
To pinpoint this immobilisation to an interaction of IN and LEDGF/p75, we measured the 
dynamics of eGFP-tagged IN under different experimental conditions. First, we expressed 
eGFP-IN in wild-type HeLa cells and measured the fluorescence intensity versus time at a 
certain region in the nucleoplasm. We observed variable photobleaching from cell to cell 
(Figure 5.3 top left).  
 
 
 
Figure 5.3 The dynamics of IN are dictated by LEDGF/p75 – Point fluorescence 
measurements of eGFP-IN in (top left) wild-type HeLa cells, (top right) HeLa-p75KD cells 
and (bottom) HeLa-p75KD cells back-complemented with 500 nM mRFP-LEDGF/p75. 
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Then, we performed the same experiment in HeLa cells with a stable knockdown of 
LEDGF/p75 (HeLa-p75KD). No significant photobleaching of eGFP-IN could be observed 
in HeLa-p75KD cells (Figure 5.3 top right). This implies that the differential photobleaching 
of IN in normal HeLa cells was due to an interaction with LEDGF/p75 and corroborates 
that IN behaves as a free protein in the absence of LEDGF/p75 (Maertens et al., 2005). In a 
third experiment, we back-complemented HeLa-p75KD with RNAi-resistant mRFP-
LEDGF/p75. When measuring eGFP-IN in cells expressing at least 500 nM of mRFP-
LEDGF/p75 (Figure 5.3 bottom), a large fraction of eGFP-IN was photobleached, proving 
that photobleaching of IN was indeed dependent on the concentration of LEDGF/p75. 
These result confirms the observations of Busschots et al., who showed in vitro that 
LEDGF/p75 increases the affinity of IN for DNA considerably (Busschots et al., 2005).   
In conclusion, FCCS experiments on cell co-expressing eGFP-LEDGF/p75 and mRFP-IN 
were not successful due to protein immobilization. We clearly showed that LEDGF/p75 is 
the determinant for immobilization. In light of the known chromatin binding properties of 
LEDGF/p75 (Chapter 4), this immobilization is most likely due to chromatin binding. In the 
following section, we will investigate whether oligomerization or aggregation of IN 
contributes to the immobilization. 
5.3.2. IN-IN interactions as probed with FLIM-FRET 
It is known that the IN binding domain (IBD) of LEDGF/p75 needs at least an IN catalytic 
core domain dimer to bind to (Figure 1.9)(Cherepanov et al., 2005a). For our intracellular 
assay to probe the interaction of IN and LEDGF/p75, it is thus crucial that IN can still 
oligomerize. So in a next step, we determined whether fluorescent protein tagged IN 
monomers could interact with each other in a cellular context to form a binding pocket for 
LEDGF/p75, in the absence of the latter. We did this by using fluorescence lifetime imaging 
based Förster resonance energy transfer (FLIM-FRET). We co-expressed mRFP- and eGFP-
tagged IN in a >5:1 ratio in HeLa-p75KD cells. At this concentration ratio, each eGFP-IN 
will associate with at least one mRFP-IN if IN oligomerizes. When eGFP and mRFP in such 
a complex are within Förster distance apart, measuring the fluorescence lifetime of eGFP 
allows to probe the interaction. Indeed, both in the cytoplasm and in the nucleus the 
fluorescence lifetime of eGFP-IN decreased in the presence of mRFP-IN (Table 5.1 part 1), 
indicating a close intracellular interaction, independent of LEDGF/p75 or chromatin. This 
decrease in fluorescence lifetime was not as pronounced as for our control protein mRFP-
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eGFP, with eGFP as a control (Table 5.1 part 1). Since FRET depends on the intermolecular 
distance, the distance between the fluorophores in eGFP-IN complexed with mRFP-IN is 
likely larger. Since the interaction was detected at low concentrations of IN, as judged from 
the confocal fluorescence image, it classifies as a strong affinity interaction (Kdiss ≤ 100 nM). 
Of concern, fluorescence correlation spectroscopy measurements on cellular eGFP-IN did 
not reveal any significant change in molecular brightness with respect to eGFP, making it 
impossible to quantify this IN-IN interaction with FCS (data not shown).  
 
Table 5.1 HIV-1 integrase and LEDGF/p75 interactions as quantified with FLIM-FRET – 
Subcellular fluorescence decays were fitted by a single exponential reconvolution procedure, as described 
in the experimental procedures. s.d. = standard deviation, n = number of independent cellular 
measurements. Overexpression of protein 1 and 2, as well as back-complemented LEDGF/p75 was 
achieved via transient transfection of plasmid DNA in the HeLa cell line specified. LEDGF↓: 
LEDGF/p75 stable knockdown cell line. LEDGF/BC↑ and LEDGF/BC K56D-R74D↑: in the 
LEDGF/p75 stable knockdown cell line back-complementation with respectively wild-type and K56D-
R74D mutant LEDGF/p75 was achieved after transfection with a plasmid carrying silent mutations in the 
LEDGF/p75 gene as not to be targeted by the miRNA.  
 protein 1 protein 2 Hela type Back-comp. location n lifetime (ns)  ± s.d. 
1 eGFP  HeLa  whole cell 11 2.43 ± 0.02 
 mRFP-eGFP  HeLa  whole cell 10 1.95 ± 0.05 
 eGFP-IN   LEDGF↓  nucleus 40 2.37 ± 0.05 
 eGFP-IN  LEDGF↓  cytoplasm 20 2.35 ± 0.04 
 eGFP-IN mRFP-IN LEDGF↓  nucleus 42 2.19 ± 0.02 
 eGFP-IN mRFP-IN LEDGF↓  cytoplasm 20 2.15 ± 0.04 
2 eGFP-LEDGF   LEDGF↓  nucleus 30 2.35 ± 0.03 
 eGFP-LEDGF mRFP LEDGF↓  nucleus 10 2.32 ± 0.03 
 eGFP-LEDGF mRFP-LEDGF LEDGF↓  nucleus 30 2.32 ± 0.05 
3 eGFP-IN mRFP-LEDGF LEDGF↓  nucleus 5 2.20 ± 0.02 
 eGFP-LEDGF mRFP-IN LEDGF↓  nucleus 10 2.23 ± 0.03 
4 eGFP-IN  LEDGF↓ LEDGF/BC↑ nucleus 10 2.24 ± 0.02 
 eGFP-IN mRFP LEDGF↓ LEDGF/BC↑ nucleus 10 2.24 ± 0.03 
 eGFP-IN mRFP-IN LEDGF↓ LEDGF/BC↑ nucleus 20 2.06 ± 0.04 
5 
eGFP-IN   LEDGF↓ 
LEDGF/BC  
K56D-R74D↑ nucleus 10 2.37 ± 0.02 
 
eGFP-IN mRFP-IN LEDGF↓  
LEDGF/BC  
K56D-R74D↑ nucleus 10 2.15 ± 0.02 
6 eGFP-IN mRFP-IN HeLa LEDGF K150A↑  cytoplasm 10 2.19 ± 0.01 
 
Likewise, we determined whether LEDGF/p75 monomers interact in the living cell (Table 
5.1 part 2). However, the fluorescence lifetime of eGFP-LEDGF/p75 was not altered upon 
mRFP-LEDGF/p75 co-expression, suggesting that dimerization is not occurring. This is in 
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accordance with in vitro dimerization studies of the PWWP-domain of human HDGF, that 
showed that, in absence of heparin, the dimerization affinity was very weak (Kdiss = 14.4 mM) 
(Sue et al., 2007). 
Next, we verified if the intracellular IN-IN interaction in absence of LEDGF/p75 could be 
an aggregation instead of an oligomerization. Aggregation is accompanied by the formation 
of large complexes containing multiple fluorochromes. In vitro purified mRFP-IN induces 
such aggregation of purified eGFP-LEDGF/p75, resulting in the appearance of bright 
fluorescence spikes in both red and green fluorescence traces (Figure 5.4). The method of 
Van Craenenbroeck et al. was used to analyse these burst-containing  fluorescence traces 
(Van Craenenbroek et al., 2001), but quantitative analysis was not possible due to problems 
with in vitro protein stability. Since we never observed momentary bursts of fluorescence in 
cells, a well known indication for aggregating protein complexes, we conclude that the IN:IN 
complex likely represents a dimer or tetramer, but not a higher oligomer. Next, we 
investigated whether the co-expression of LEDGF/p75 influenced IN:IN interaction. We 
compared the fluorescence lifetime of eGFP-IN in cells depleted for endogenous 
LEDGF/p75 with the same cells back-complemented with LEDGF/p75. Surprisingly, the 
fluorescence lifetime of eGFP-IN decreased from 2.37 ns to 2.24 ns in the presence of 
LEDGF/p75 (Table 5.1 part 3). Possibly, the immobilisation we described in the previous 
section alters the physicochemical environment of the eGFP tag affecting the fluorescence 
lifetime. Co-expression of mRFP-IN further decreased the lifetime, but not to a significantly 
higher extent than in cells without LEDGF/p75.  
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Figure 5.4 FCS and FCCS analysis of in vitro purified mRFP-IN and eGFP-LEDGF/p75 – (a-b) 
FCS measurement on a sample containing only mRFP-IN or only eGFP-LEDGF/p75 in a 20 mM Hepes 
pH 7.4 buffer with 150 mM NaCl. Both proteins show a stable fluorescence signal and artifact-free ACF. 
Results are plotted on the same graph. (c-d) FCCS measurement on a mixture of both proteins in the same 
buffer. Bright fluorescence spikes appear, with erronous FCCS curves as a result.   
 
In conclusion, individual IN monomers, tagged with a fluorescent protein, do interact in cells 
to form dimers or possibly tetramers, but not higher oligomers. LEDGF/p75 monomers do 
not interact in the living cell nucleus. Under conditions of LEDGF/p75 mediated 
immobilization of IN, we cannot detect an alteration of the IN:IN interaction using FLIM-
FRET.  
5.3.3. Strategies to cancel out the immobility of the complex 
FCCS is a fluorescence fluctuation technique. If a protein complex is immobile, fluorescence 
doesn’t fluctuate and no interaction is observed. To still be able to study the interaction 
between LEDGF/p75 and IN in the living cell with FCCS, we saught for methods to inhibit 
the immobilization. Different strategies were followed, based on the protein structure of 
LEDGF/p75 (Figure 1.8); Deletion of the complete N-terminal p52-domain of 
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LEDGF/p75, mutation of the nuclear localisation signal in LEDGF/p75 or mutation of the 
chromatin binding PWWP domain. 
5.3.3.1. Deletion of the complete N-terminal p52-domain of LEDGF/p75 
The N-terminal part of LEDGF/p75, that comprises the major part of its alternative splice 
variant p52 (Singh et al., 2000a), contains nearly all chromatin binding domains. Deletion of 
only this p52 part from LEDGF/p75 (∆325) should completely inhibit chromatin 
interactions of LEDGF/p75. We constructed and expressed eGFP-∆325 in HeLa cells, 
together with mRFP-IN. eGFP-∆325 still exhibited residual nuclear localization, likely due to 
two helix-turn-helix motifs in the ∆325-part of LEDGF/p75 (Shinohara et al., 2002) (Figure 
5.5). More importantly and quantitatively, FCS measurements showed that more than 89% of 
the protein population exhibited free diffusion, in comparison to only 35% for wild-type 
LEDGF/p75 (Table 4.1). Surprisingly, mRFP-IN does no longer localize in the nucleus in 
cells expressing eGFP-∆325 (Figure 5.5). This cytoplasmatic retention implies the formation 
of a protein complex that is too big to enter the nucleus by passive diffusion and imposes a 
strong block on HIV replication (De Rijck et al., 2006). When we performed FCCS 
measurements in the cytoplasm of such cells, no photobleaching occured and a high relative 
cross-correlation was observed (Equation 5.1), rel.CC = 0.62, pointing to a specific 
interaction of the two proteins (Figure 5.5 and Table 5.2). The measured relative cross-
correlation amplitude of 0.62 would imply that 62% of eGFP-∆325 is present in a complex 
with mRFP-IN. As a control we also performed an FCCS experiment with mRFP instead of 
mRFP-IN. Clearly, the cross-correlation was considerably lower, rel.CC = 0.15. 
We verified the specificity of the FCCS analysis by introducing the D366A point mutation in 
∆325. From in vitro binding studies it is known that the interaction with IN is decreased by 
this mutation and from crystallography it is known that the D366 residue lies exactly in the 
loop that extends from LEDGF/p75 into the cleft formed by the IN-CCD dimer (Figure 
1.11). The CCF amplitude is lowered to the background level, rel.CC = 0.15, by introducing 
this mutation in eGFP-∆325, validating that FCCS is sensitive to probe the interaction. 
Moreover, the diffusion time of eGFP-∆325 D366A in cells expressing mRFP-IN is 
significantly faster than that of eGFP-∆325 under the same conditions, which is also an 
indirect proof that the interaction is lower.   
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Figure 5.5 The eGFP-∆325/mRFP-IN cytoplasmic FCCS assay – (top panel) Confocal 
images of HeLa cells transiently expressing eGFP-∆325 and mRFP-IN. (bottom panel) 
FCCS measurements on mRFP-IN and eGFP-∆325. Colors are explained in the legend. 
In conclusion of these measurements, when the p52 chromatin binding part of LEDGF/p75 
is removed, a cytoplasmic complex with IN is formed. Importantly, this complex is no longer 
immobile and FCCS becomes a sensitive tool to probe the interaction. 
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Table 5.2 Interaction of mRFP-IN with LEDGF/p75 variants measured with FCCS – The 
relative cross-correlation was calculated with Equation 5.1. [G]0 = the total concentration of 
green protein, n = number of independent cellular measurements, s.d. = standard deviation, n.p. 
= fit not possible, a.u. = arbitrary units, * = negative control where mRFP1 instead of mRFP1-
IN was used. 
LEDGF variant properties n Gc(0)/Gg(0)±s.d. Ng,total/Nr,total±s.d. [G]0 ± s.d. (nM) 
Cytoplasm            
eGFP-∆325   22  0.62 ± 0.08 1.23 ± 0.27 647 ± 281 
eGFP-∆325 + mRFP1*  16 0.15 ± 0.08 1.04 ± 0.50 1025 ± 625 
eGFP-∆325 D366A mIBD 15 0.15 ± 0.08 0.69 ± 0.36 298 ± 259 
eGFP-LEDGF/p75 K150A mNLS 33 0.50 ± 0.11 0.98 ± 0.27 498 ± 243 
            
Nucleus  
          
eGFP-LEDGF/p75 wild type n.p.          
eGFP-LEDGF/p75 R74D mPWWP 10 0.48 ± 0.08 1.19 ± 0.26 1701 ± 777 
eGFP-p75 K56D-R74D mPWWP 19 0.50 ± 0.06 1.02 ± 0.20 1516 ± 512 
 
5.3.3.2. Mutation of the NLS of LEDGF/p75 
It has been shown that LEDGF/p75 carries a canonical nuclear localization signal, 
148GRKRKAEKG156 and that a single amino acid mutation, K150A, is sufficient to disrupt 
the natural localization of LEDGF/p75 (Maertens et al., 2004; Vanegas et al., 2005). We 
constructed eGFP-LEDGF/p75 K150A to probe the interaction of full-length LEDGF/p75 
with mRFP-IN in the cytoplasm. First, we verified the cellular localization of the protein. 
Within 24 hours after transfection, the localization of both proteins is cytoplasmic (Figure 5.6 
top left). After mitosis however, LEDGF/p75 K150A is retargeted back to the nucleus 
because of chromatin binding (Vanegas et al., 2005) (Figure 5.6 top right). Next, with 
fluorescence correlation spectroscopy we checked if the mutated protein, in spite of the 
amino acid mutation, retained nuclear dynamics similar to LEDGF/p75 (Figure 5.6 bottom). 
Indeed, in the nucleus the dynamics of eGFP-LEDGF/p75 K150A was identical to wild-type 
LEDGF/p75. In the cytoplasm faster dynamics were logically observed. Moreover, the ACF 
could only be described well with a model for anomalous diffusion. This suggests 
LEDGF/p75 interacts with other cellular components in the cytoplasm, resulting in a protein 
complex that experiences obstructed diffusion.      
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Figure 5.6 LEDGF/p75 K150A and IN interact in the cytoplasm - (top panels) Cellular 
distribution of eGFP-LEDGF/p75 K150A (top left) before and (top right) after mitosis. 
(bottom panel) Normalized cellular autocorrelation function of eGFP-LEDGF/p75 
K150A in the cytoplasm and nucleus of HeLa cells. Fitted curves and residuals are color 
coded in the figure legend. ACFs for eGFP and eGFP-LEDGF/p75 are shown for 
reference.  
Then, we co-expressed mRFP-IN. As for eGFP-∆325, mRFP-IN was retained in the 
cytoplasm by eGFP-LEDGF/p75 K150A (Figure 5.7 top). FCCS showed again a strong 
interaction could again be observed (Figure 5.7 bottom) which was within experimental error, 
the same as for mRFP-IN + eGFP- ∆325. The dynamics of this complex were significantly 
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slower than for the eGFP-∆325/mRFP-IN complex, as judged by the diffusion part of the 
CCF, suggesting a bigger protein complex is formed. 
 
    
 
 
Figure 5.7 The eGFP-LEDGF/p75/K150A-mRFP-IN FCCS assay – (top panel) 
Intracellular localisation of eGFP-LEDGF/p75 K150A (green) and mRFP-IN (red) in HeLa 
cells. (bottom panel) Normalized cellular cross-correlation function of eGFP-LEDGF/p75 
K150A and mRFP-IN in the cytoplasm. Solid line: fit with 2-component model. CCFs for 
eGFP-∆325 and mRFP-IN or mRFP are shown as a reference (De Rijck et al., 2006). 
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5.3.3.3. Mutation of the chromatin binding PWWP domain of LEDGF/p75 
Endogenous LEDGF/p75 is a nuclear protein, it thus would be useful if we could also 
measure the interaction with IN in the nucleus. As we have discussed in detail in Chapter 4, 
the N-terminal chromatin binding PWWP domain in LEDGF/p75 can be mutated at 
residues K56 and R74, to generate a LEDGF/p75 variant that retains nuclear localization, 
but does no longer form a tightly chromatin bound complex upon co-expression of IN. We 
generated eGFP-fusions of the LEDGF/p75 K56D-R74D mutant and expressed this protein 
together with IN and performed FCCS measurements. Nuclear localization was observed  
(Figure 5.8 top) and again a high relative cross-correlation was observed (Figure 5.8 bottom 
and Table 5.2). In summary, by using the PWWP-mutant of LEDGF/p75, FCCS can be used 
to probe the interaction with IN also in the nucleus. 
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Figure 5.8 The nuclear eGFP-LEDGF/p75 K56DR74D-mRFP-IN FCCS assay – (top 
panel) Intracellular localisation of eGFP-LEDGF/p75 K56DR74D (green), mRFP-IN (red) 
and overlay, together with a transmission image overlay. (bottom panel) FCCS 
measurements in cells expressing eGFP-LEDGF/p75 K56D-R74D and mRFP-IN (n = 20). 
The high amplitude of the black CCF means a strong protein-protein interaction. Error bars 
= s.d.  
We also tested both the NLS-mutant and PWWP-mutant LEDGF/p75 with FLIM-FRET, to 
see if the IN-IN interaction was affected by the presence of full-length LEDGF/p75, but in 
absence of chromatin binding. First we co-expressed in our LEDGF/p75 knockdown cell 
line eGFP-IN/mRFP-IN (<1:5 plasmid ratio) and untagged LEDGF/p75 K56D-R74D 
(IN:LEDGF plasmid ratio 1:1) for which we know that chromatin tethering is impaired but 
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not the interaction with IN. This resulted in high expression of mutant LEDGF/p75 in 
nearly all cells that expressed the fluorescent IN, as confirmed with immunocytochemistry. 
Additionally fluorescent IN, randomly distributed under LEDGF/p75 knockdown 
conditions, was retargeted to the nucleus upon LEDGF/p75 K56D-R74D co-expression. 
The fluorescence lifetime decrease of eGFP-IN in cells co-expressing mRFP-IN but no 
LEDGF/p75 equalled the decrease in cells co-expressing LEDGF/p75 K56D-R74D (Table 
5.1 part 5), suggesting that no alteration of the IN-IN interaction occurs in cells expressing 
full-length chromatin-binding-deficient LEDGF/p75. Secondly we co-expressed untagged 
LEDGF/p75 K150A, with a dysfunctional NLS in HeLa cells. Again no significant change in 
FRET was detected (Table 5.1 part 6), suggesting that also in the cytoplasm, LEDGF/p75 
has no detectable effect on the IN-IN interaction. In summary, in the absence of chromatin 
tethering we find no evidence that LEDGF/p75 affects the IN-IN interaction in cells. 
5.3.4. Quantitative FCCS analysis 
As we have shown in the previous sections, the FCCS technique can be used to provide 
conclusive information on the presence or absence of an intracellular protein-protein 
interaction, provided that the dynamics of the protein complex are not too slow. With respect 
to LEDGF/p75 and IN, in section 5.3.3 we measured the interaction of mRFP-IN with 
different LEDGF/p75 variants in cells. From Figure 5.7 and Figure 5.8, it might seem that 
the affinity of eGFP-LEDGF/p75-K150A and eGFP-LEDGF/p75-K56DR74D for mRFP-
IN is lower than that of eGFP-∆325. The ultimate quantification of affinity would be, 
however, an intracellular binding constant. As stated in the Materials and Methods section, by 
correcting the correlation functions for cross-talk, this becomes possible. Importantly, FRET 
can have a large influence on the correlation functions too (as we will see in Chapter 6), so we 
verified the FRET contribution. As can be seen in Table 5.1, the minor decrease of the 
fluorescence lifetime of eGFP-IN from 2.24 ns in cells expressing untagged LEDGF/p75 to 
2.20 ns in cells expressing mRFP-LEDGF/p75, suggests a neglegible contribution of FRET. 
We re-analysed the FCCS measurements and calculated the equilibrium binding constant Kdiss  
(Figure 5.9 and Table 5.3). As expected, the affinity of ∆325 and LEDGF/p75-K150A for 
IN in the cytoplasm is similar. We calculate a binding constant for dissociation of around 400 
nM, suggesting a fairly strong affinity.  
For the PWWP-mutant LEDGF/p75 K56D-R74D we observed a weaker apparent affinity 
for IN (Kdiss ~900 nM). This result is logical since these experiments were not performed in 
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cells with a stable knockdown of LEDGF/p75 (the knockdown cell line was not available at 
the time). Thus, in the nucleus there will be a vast concentration of endogenous 
LEDGF/p75 present which competes with the fluorescent LEDGF/p75 for binding to 
mRFP-IN. Secondly, it is known that other co-factors can bind to LEDGF/p75, at the 
integrase binding domain (IBD) (see section 1.6.3), and these co-factors also localize only in 
the nucleus. In other words, there will be either off-titration of fluorescent LEDGF/p75 by 
endogenous LEDGF/p75, or off-titration of fluorescent IN by cellular co-factors in the 
nucleus. In both cases, the apparent Kdiss for LEDGF/p75-IN in the nucleus will be lower 
than the ‘real’ Kdiss, which is what we observed. Next, for our negative control, eGFP-
∆325/mRFP, the binding constant was artificially high (Kdiss = ~49 µM), which is logical 
since these proteins cannot bind to each other. Finally, for the D366A mutant of ∆325, we 
could still calculate a binding constant (Kdiss = ~3400 nM), suggesting that at least some 
interaction with IN is maintained.   
 
 
Figure 5.9 Box-plot representation of the calculated Kdiss from the FCCS 
measurements of IN with different LEDGF/p75 variants – The box limits represent the 
25% and 75% percentile, the whiskers represent the 5% and 95% percentile, stars represent 
outliers, the line in the box is the median and the square in the box is the mean. 
In conclusion, when FCCS measurement are corrected for cross-talk, we can calculate 
intracellular binding constants of IN with LEDGF/p75 (and variants thereof). Quantitative 
analysis of this interaction is useful, because in vitro identified inhibitors of this interaction can 
now be quantitatively tested inside cells. 
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Table 5.3 Quantification of the interaction between mRFP-IN 
and eGFP-LEDGF/p75 variants – The Kdiss calculation is 
explained in de materials and methods section, For the calculation 
of Kdiss, the outliers were not included. n = number of independent 
measurements, s.e.m. = standard error of mean, * = negative 
control where mRFP1 instead of mRFP1-IN was used. 
LEDGF variant properties n Kdiss ± s.e.m.  
Cytoplasm       
eGFP-∆325   29 350 ± 31 nM 
eGFP-∆325 + mRFP1*  14 49 ± 12 µM 
eGFP-∆325 D366A mIBD 17 3380 ± 690 nM 
eGFP-LEDGF/p75 K150A mNLS 28 429 ± 38 nM 
       
Nucleus  
 
   
 
eGFP-p75 K56D-R74D mPWWP 16 890 ± 65 nM 
5.4. Discussion 
5.4.1. Fluorescent protein tagging does not affect chromatin tethering of IN 
We wanted to verify if the observed chromatin tethering is a consequence of the tag on IN. 
After transient expression, eGFP-IN displayed a diffuse nuclear localisation, with residual 
fluorescence in the cytoplasm ((De Rijck et al., 2006) and data not shown) as has been 
reported before for eGFP-IN (Maertens et al., 2005), GST-IN (Gallay et al., 1997) and IN 
(Cherepanov et al., 2000). When transiently co-expressing mRFP-LEDGF/p75, eGFP-IN 
localized exclusively in the nucleus with a much more heterogenous distribution pattern 
overlapping with that of mRFP-LEDGF/p75 (data not shown). This pattern has been 
reported before for unlabelled IN/LEDGF/p75 (Cherepanov et al., 2003) and HcRed1-
IN/eGFP-LEDGF/p75 (Maertens et al., 2003) and is consistent with both proteins 
interacting with each other.  
It should be noted that the same pattern was observed for cells co-expressing IN-3xFLAG, 
IN tagged with a triple FLAG tag for immunocytochemistry, and eGFP-LEDGF/p75 (data 
not shown). Furthermore, our measurements clearly showed that eGFP-IN nor mRFP-IN 
associate with chromatin in the absence of LEDGF/p75 (resp. Figure 5.3 and data not 
shown), as had been suggested before for untagged IN (Maertens et al., 2003). Of concern, 
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untagged IN has been suggested to form tetramers in the cell (Cherepanov et al., 2003). 
According to our FLIM-FRET measurements (Table 5.1) tagged IN monomers do interact 
so that oligomerization still can occur. Furthermore, the marked decrease in the dynamics of 
eGFP-LEDGF/p75 (Figure 4.9) is observed after co-expression of both mRFP-IN and IN-
3xFLAG (data not shown). In conclusion, although it is not known whether the 
stoichiometry of IN is affected by the fluorescent tag, tight chromatin association appears to 
be independent of its presence. 
5.4.2. Higher order complex formation causes deceleration of LEDGF/p75-IN 
It has been shown that LEDGF/p75 can act as a molecular tether coupling IN to the 
chromatin (Maertens et al., 2003; Cherepanov et al., 2003; De Rijck et al., 2006; Llano et al., 
2006b; Hombrouck et al., 2007; Shun et al., 2008). Much research effort has also gone into 
identifying the chromatin binding domains of LEDGF/p75 (Turlure et al., 2006; Llano et al., 
2006b; Shun et al., 2008) and to investigating the complex formed with IN in vitro 
(Cherepanov et al., 2003; Faure et al., 2005; Cherepanov et al., 2005b; Busschots et al., 2007; 
McKee et al., 2008; Michel et al., 2009). However, only few attempts have been made to 
define the actual intracellular complex between LEDGF/p75, IN and chromatin 
(Cherepanov et al., 2003; Maertens et al., 2005). The mere interaction of LEDGF/p75 and 
IN would logically not lead to the strong chromatin interaction we observed. Possible 
explanations are:  
(1) An allosteric effect. Binding of LEDGF/p75 to IN could influence the conformation of IN 
in an allosteric way, increasing the affinity of the latter for chromatin. If this would be true, 
then only the IBD portion of LEDGF/p75 (Figure 1.8) should have the same effect. 
Disproving evidence is the fact that eGFP-∆325:IN is not tightly associated to chromatin (De 
Rijck et al., 2006). Secondly, binding of IN to LEDGF/p75 could allosterically influence 
LEDGF/p75. However, since the IBD and chromatin binding sites are located in well 
separated domains in LEDGF/p75 (Figure 1.8), we assume this option is unlikely. Thirdly, 
LEDGF/p75 could change the conformation of the chromatin when binding to it. As we 
have clearly shown, the known chromatin binding motif PWWP in LEDGF/p75 grants tight 
chromatin association to the IN complex, which might be interpreted as increasing the 
accessibility of chromatin for IN. Further research will have to demonstrate this. 
(2) A cooperative effect. Binding of LEDGF/p75 to IN might shift the stoichiometry of IN. 
Indeed, it has been shown in vitro that LEDGF/p75 can promote IN tetramerisation (McKee 
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et al., 2008; Michel et al., 2009), but it remains to be proven if this occurs as well in the living 
cell. With FLIM-FRET, we could clearly observe a defined oligomerisation of IN (Table 5.1), 
but we did not observe an effect of LEDGF/p75 on the fluorescence lifetime of eGFP-
IN/mRFP-IN in the living cell, in the presence or absence of chromatin binding. Most likely, 
the mobile albeit slow fraction (66%) in our FRAP measurements (Figure 4.10) represents a 
defined stoichiometry, presumably IN4LEDGF/p752, as has been suggested from in vitro 
work (Cherepanov et al., 2003; Faure et al., 2005; McKee et al., 2008; Michel et al., 2009). The 
34% immobile fraction we observed with FRAP likely represents a higher order 
IN:LEDGF/p75 complex. It has been shown that recombinant IN can undergo a DNA 
induced polymerization in vitro (Vercammen et al., 2002), forming large complexes of DNA 
and IN. In addition, it has recently been suggested that IN in the viral particle could be 
present as a hetero-multimeric paracrystalline complex with multiple LEDGF/p75 proteins 
bound (Hare et al., 2009b). In summary, IN can oligomerize inside the cell to form a complex 
of defined or higher order stoichiometry and since more than one LEDGF/p75 binds to one 
IN complex, the dynamics shift to a much slower time scale.  
(3) A competitive effect. Finally, cellular cofactors that reduce the chromatin binding of 
LEDGF/p75, could be competing with IN that by itself promotes chromatin binding of 
LEDGF/p75. Recently, it has been shown that JPO2, a myc-interacting protein, and PogZ, a 
domesticated transposase, interact specifically with LEDGF/p75 and can compete with IN 
for binding to LEDGF/p75 (Maertens et al., 2006; Bartholomeeusen et al., 2007; 
Bartholomeeusen et al., 2009). Our observation that diffusion of ∆325 in the nucleus is 
slower than in the cytoplasm (Table 4.1) might indeed be related to these interactions. Insight 
in the contribution of these and other binding partners to the dynamics of LEDGF/p75 will 
certainly be of value to completely understand the cellular function of LEDGF/p75.  
5.4.2.1. The affinity between IN and LEDGF/p75 
For LEDGF/p75 to bind to IN, IN has to be present as a dimer, as crystallographic studies 
has shown (Cherepanov et al., 2005a). In fact, we were able to show with FLIM-FRET that 
IN was always present in at least a dimeric form, irrespective of LEDGF/p75. Recently, the 
affinity of IN-CCD and LEDGF/p75-IBD was determined in vitro with Surface Plasmon 
Resonance to be Kdiss = 10.9 nM. Our calculated cellular Kdiss values of full-length mRFP-IN 
and eGFP-∆325 or LEDGF/p75-K150A are around 400 nM, which would mean the affinity 
is weaker in cells. Considering the possibility of specific or aspecific competition in cells, this 
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results might not come as a surprise. Finally, it must be stressed that the technique of dual-
color FCCS with fluorescent proteins, only allows to measure apparent dissociation 
constants, as long as a positive control did not validate the technique yet. In other words, 
protein binding affinities of different protein couples relative to each other are possible, but 
are not to be interpreted as an absolute affinity.    
5.5. Conclusion 
We have set up a set of intracellular assays to probe for the presence or absence of the 
LEDGF/p75-IN interaction, based on fluorescence cross-correlation spectroscopy. Due to a 
higher order stoichiometry, the interacting complex likely contain multiple LEDGF/p75 and 
IN partners, and we had to target the protein complex away from chromatin in order to 
quantify the interaction with FCCS. The biological significance of the slow dynamics of the 
LEDGF/p75-IN complex may be advantageous for the viral integration complex, because it 
confers more time to IN to perform proper integration in the host cell genome. We speculate 
that the mechanism of the transcriptional coactivator, i.e. aspecific genome scanning followed 
by arrest at defined sites of gene activation, probably through association with the 
transcription machinery, has been hijacked by the lentiviral integration machinery to 
guarantee both high frequency of integration sites and proviral gene activation after 
integration. In Figure 5.10, we have summarized our results on the dynamic chromatin 
scanning of LEDGF/p75, and how IN likely manipulates these interactions.  
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Figure 5.10 Unifying model of the dynamic interactions of LEDGF/p75 with 
chromatin and of LEDGF/p75-mediated chromatin tethering of HIV-1 integrase – 
LEDGF/p75 is present in an equilibrium between free nucleoplasmic diffusion and dynamic 
chromatin scanning. The majority of time, LEDGF/p75 is dynamically scanning the 
chromatin and occasionally, is halted on the chromatin by strong-affinity binding. This might 
explain the paradoxical fact that LEDGF/p75 has been shown to both bind DNA 
specifically at HSE and STRE promoters and aspecifically in transcriptionally active regions. 
HIV-1 integrase forms oligomers in cells and upon association with LEDGF/p75 is tethered 
strongly to chromatin. The PWWP domain of LEDGF/p75 has a crucial role in strong 
chromatin tethering, but is not required to form the LEDGF/p75-IN complex.  
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Chapter 6. FCCS for measuring 
protein-protein interactions 
quantitatively in cells 
6.1. Introduction 
Fluorescence cross-correlation spectroscopy holds great promise for becoming the 
biophysical tool of choice for quantifying protein-protein interactions in cells, because in one 
single measurement, both the absolute concentrations of the two interacting partners as the 
concentration of their complex can directly be measured. This makes it possible to quantify 
the absolute affinity of two proteins inside living cells, something no single other technique 
can do. Fluorescent proteins are favorable for the application of FCCS in cells for several 
reasons. Genetic fusion of a protein-of-interest with a fluorescent protein is straightforward 
and fusion constructs can be expressed simply by transfection methods or by generating a cell 
line with stable expression. The fluorescent protein can be placed at either the N- or C-
terminus of the protein and if monomeric fluorescent proteins are used, the stoichiometry of 
labelling is always known beforehand. Additionally, fluorescent protein fusions can be 
expressed in the natural environment of the cell with all the benefits of eukaryotic expression, 
such as post-translational modifications and heat shock protein assisted folding. Finally, their 
photophysical properties can compete with those of fluorescent dyes. On the other hand, 
chemical in vitro labelling of proteins with fluorescent dyes requires in vitro expression, 
purification, labelling and introduction in cells, and one usually has little control over the 
labelling position or stoichiometry. In the worst case, in vitro purification of the protein is not 
possible because of protein stability issues.  
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Since the first reports of FCCS with fluorescent proteins (Saito et al., 2004; Baudendistel et 
al., 2005; Kohl et al., 2005), there have been many applications of the technique to study a 
variety of biological systems (for a recent review, see(Hwang and Wohland, 2007)). An 
important step in the development of the technique is the calculation of absolute intracellular 
parameters such as equilibrium binding constants, and first attempts in this direction have 
been made (Oyama et al., 2006; Shi et al., 2009). However, due to the complexity of the 
experimental setup and the often limited understanding of fluorescent protein photophysics, 
quantitative interpretation of experimental FCCS data can be challenging. In this chapter, we 
perform quantitative FCCS in living cells on a genetic fusion of the enhanced green 
fluorescent protein eGFP (Heim et al., 1995) with either one of two red fluorescent proteins, 
mRFP1, the first true monomeric RFP (Campbell et al., 2002) or mCherry, an improved 
point mutant of the latter (Shaner et al., 2004). We wish to investigate in detail the effects of 
FRET and cross-talk on the experimental ACFs and CCF. Finally, we discuss on future 
methods to improve intracellular FCCS.   
6.2. Materials and Methods 
The protocols for plasmids cloning, cell lines and transfections are given in Chapter 4. The 
details of the FCCS and FLIM-FRET setups are explained in detail in Chapter 5. All FLIM-
FRET experiments were carried out at the K.U.Leuven Rega Institute for Medical Research 
under the supervision of Dr. Dirk Daelemans. 
6.3. Results 
6.3.1. Low cross-correlation for fluorescent fusion proteins  
The fusion constructs mRFP-eGFP and mCherry-eGFP were expressed in HeLa cells and 
FCCS measurements were performed. Under ideal conditions, i.e. 100% confocal volume 
overlap and ideal fluorochrome optical properties, the eGFP and RFP autocorrelation 
functions (ACFs) and the cross-correlation function (CCF) should overlap completely. 
However, since the focal volume created by the 543-nm HeNe laser used to excite RFP is 
slightly bigger (factor 1.37) than the one created by the 488-nm Ar-ion laser used to excite 
eGFP, we expect the green ACF amplitude to be slightly higher, and the red ACF amplitude 
to be slightly lower than the CCF amplitude, as we have simulated in section 2.3.4. 
Experimentally, both for mRFP-eGFP as for mCherry-eGFP the red ACF amplitude is 
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highest (Figure 6.1 left panels) and moreover, the CCF amplitude is much lower than would 
be expected from a fusion protein. More specifically, the sharp rise of the eGFP and RFP 
ACFs at a sub-µs time scale is APD afterpulsing, which was discussed in detail in Chapter 3 
and can be omitted from the fitting (see fit borders in Figure 6.1 right panels). It must be 
stated however, that at low count rates, afterpulsing can contribute to the ACF even in the 
10s of microseconds time scale. Secondly, although it is not trivial to separate diffusion and 
photophysics from the RFP ACFs, a significant (50%) fraction of the RFP ACF represents a 
~50-µs dark state. In Chapter 7 these dark states have been characterized in detail. Finally, 
during the first 20 seconds of the measurement, on average 20% of the RFP signal 
photobleached, both for mRFP1 and mCherry. At the end of the 10×20 seconds 
measurement sequence, up to 60% of the RFP signal had photobleached. On the other hand, 
for eGFP only 10% of the signal had photobleached when the measurement was finished. It 
is known that both mRFP1 and mCherry are much less photostable than eGFP (Shaner et al., 
2008), and the laser power we used was the lowest power possible to get adequate 
signal/background. After fitting with the proper models, the concentration amplitudes of the 
correlation functions were plotted (Figure 6.1 right panels). Clearly, the RFPs have a much 
bigger fraction of dark states populations and the particle number seems a factor of 1.15 
(mCherry) and 1.3 (mRFP) lower than the particle number for eGFP.  
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Figure 6.1 FCCS experiment on fluorescent protein fusions – mRFP-eGFP (top), and 
mCherry-eGFP (bottom). The curves represent an average of ten individual measurements in 
different cells. In each cell 10 successive FCCS measurements were performed and averaged. 
This set of 2 ACFs and 1 CCF was finally normalized by multiplying with the green particle 
number. Error bar = s.d.. (right) Non-linear least squares fitting with Equation 2.17. For 
clarity, with the obtained parameters, we plotted the ACFs with or without the photophysics, 
to reveal the diffusion component amplitude on the graph. Different fit lines are explained in 
the legend. In Chapter 7 the RFP dark states are characterized in detail. 
6.3.2. ‘Apparent’ particle numbers 
With the concentration amplitude of the ACFs we can calculate an ‘apparent’ particle number 
of green and red molecules. These are not the absolute, concentration related particle 
numbers, but are biased by non-idealities in the experimental setup, as we discussed in the 
introduction (sections 2.3.4-2.3.5). First, due to the non-ideal volume overlap, particle 
numbers observed in different channels correspond to different concentrations, which is 
straightforward to correct for if the microscope is calibrated properly. Volume overlap has 
been discussed in the introduction (section 2.3.4) and a proper microscope calibration 
method will be discussed in section 3.3.6. Secondly, green molecules contribute to the 
autocorrelation function in the red detection channel due to emission cross-talk, which has to 
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be corrected for (section 2.3.4.2). Thirdly, although RFPs and eGFP have a large spectral 
separation (the emission maxima are separated by 100 nm) the emission spectrum of eGFP 
overlaps well with excitation spectrum of the RFPs, making them good FRET partners as 
well, which also has to be corrected for (section 2.3.4.3). Stoichiometry does not pose an 
extra complexity, since the fusion proteins have a 1-1 stoichiometry.   
6.3.3. Quantifying FRET with FLIM-FRET 
We performed whole-cell FLIM-FRET measurements to quantify FRET in mRFP-eGFP and 
mCherry-eGFP. Therefore, we measured the fluorescence decay of eGFP in cells expressing 
these constructs, with the fluorescence decay of eGFP in cells only expressing eGFP as a 
control. As illustrated in Figure 6.2 for mRFP-eGFP, the fluorescence decay of eGFP in 
mRFP-eGFP is shifter to a faster time scale, indicative of FRET. While for eGFP-only a 
mono-exponential fit model described the data well (Figure 6.2, green fit line), for the fusion 
protein a mono-exponential model did not describe the decay well (Figure 6.2, blue fit line), 
suggesting the existence of multiple species in the fusion protein. When using a bi-
exponential model the fit quality was much better (Figure 6.2, red fit line) and a significant 
fraction existed with a lifetime close to the donor-only lifetime. This fraction could be fitted 
as well with the slow lifetime fixed to the donor-only lifetime (2.43 ns), strongly suggesting it 
represents the donor without the presence of a FRET acceptor.  
The results of the fitting are summarized in Table 6.1. For mCherry-eGFP 61% and for 
mRFP-eGFP 63% of the eGFP-moieties in the fusion protein still have a fluorescence 
lifetime corresponding to donor-only (resp. Fg=0.61 and Fg=0.63). In other words, a large 
fraction of the fusion proteins can be considered to contain a permanent or transient dark 
acceptor. As we have observed during the FCCS experiments,  due to the limited 
photostability of the RFP fluorochromes, up to 60% of the fluorescence photobleached 
during the experiment, but these results could as well suggest that a vast percentage of the 
RFP fluorochromes have not fully matured.  
Next, from the fluorescence lifetime of eGFP in the presence or absence of the RFP FRET 
acceptor, the FRET efficiency E can be calculated: 
  = 1 − @  Equation 6.1
with τDA the fluorescence lifetime of the donor in the presence of acceptor and τD the lifetime 
in absence of acceptor. Like this, we calculated the FRET efficiency in a functional fusion 
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protein to be around 75% (Table 6.1). This is not unexpected, since the distance between the 
fluorochromes in such a fusion protein is expected to be around 40 Å, which is what we 
calculated. 
 
 
Figure 6.2 Fluorescence decay histograms of eGFP (green dots) and eGFP in the 
mRFP-eGFP construct (red dots) – Whole cell-decay of single representative cells. The 
instrument response function (as measured with malachite green is presented in gray. Fits 
and residuals are explained in the legend.   
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Table 6.1 Analysis of FLIM-FRET experiments in living HeLa cells – Reconvolution fitting 
was used to fit the fluorescence decays. The eGFP decay could be fitted well already with a one-
compenent model, whereas the fusion proteins had to be fitted with a two-component model. E = 
FRET efficiency. Intermolecular distances (r) were calculated with Equation 2.46. Chi² expresses 
the goodness-of-fit. Parameters are given ± s.d.  
protein n lifetime 1 (ns) Fg lifetime 2 (ns) Fgr E r (Å) chi² 
eGFP 11 2.43 ± 0.02 
               
1.02 
 
0.05 
  
2.66 ± 0.09 0.82 ± 0.04 0.83 ± 0.31 0.18 ± 0.04 
      
0.97 ± 0.03 
mRFP-eGFP 10 1.95 
 
0.05 
                  
  
2.34 ± 0.07 0.63 ± 0.02 0.59 ± 0.06 0.37 ± 0.02 0.76 ± 0.08 38.9 0.96 ± 0.03 
mCherry-eGFP 10 2.30 ± 0.1 0.61 ± 0.04 0.58 ± 0.04 0.39 ± 0.04 0.76 ± 0.06 38.8 0.95 ± 0.05 
6.3.4. Correcting the eGFP autocorrelation function 
With these parameters, we can now correct the eGFP ACF. The green ACF only has to be 
corrected for FRET with Equation 2.46: 
 x,K = x,pmpKy,<kKy Jx + 1 − Jx<Jx + 1 − Jx<  Equation 6.2
where the FRET efficiency E, the fraction green-only Fg and the fraction of green-and-red Fgr 
have to be measured with another technique. In Figure 6.3, we have plotted some simulated 
corrections of the eGFP ACF and the corrected ACF with the experimentally determined 
FRET efficiency. 
 
Figure 6.3 The effect of the FRET correction on the eGFP ACF –The simulated eGFP 
ACFs are calculated with Equation 6.2, with Fg and Fgr from the FLIM-FRET experiments. 
Arrow points from ‘no correction’ to ‘experimentally determined correction’. 
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In summary, by quantifying the FRET between mCherry and eGFP in the fusion construct, 
we could correct the eGFP ACF to obtain an unbiased particle number. Since FRET lowers 
the brightness of the eGFP in a functional fusion protein, it lowers the observed particle 
number. The unbiased particle number is, due to the high FRET, 28% higher than the 
apparent particle number. 
6.3.5. Correcting the mCherry autocorrelation function 
From the corrected number of green particles, Ng,total,real, and from the fractions we can now 
calculate the number of ‘only-green’ particles, Ng, and the ‘green-and-red’ particles, Ngr. The 
red ACF has to be corrected for both cross-talk and FRET. If we assume that there are no 
‘only-red’ particles, which is justified since eGFP did not show much photobleaching, it can 
be shown that the apparent red particle number is equal to: 
 <,K = x + 1 − x< + 1 + <,pmpKy,<kKyx + 1 − x< + 1 + <,pmpKy,<kKy Equation 6.3
Where Ng and Ngr are obtained from the green ACF and 
  = o< = ℎ+ + +)((%' %r ℎ+ =++' r*&%%$ℎ%)+ ℎ+ + +)((%' %r + r*&%%$ℎ%)+  Equation 6.4
Since we assume no ‘red-only’ particles are present in our system, Nr,total,real was approximated 
with Ngr, rescaled in the red confocal volume. Q was calculated by measuring the brightness 
of eGFP and mCherry in the red detection channel. First the ACF of eGFP was measured in 
the red detection channel upon single color 488-nm excitation and the apparent brightness 
was calculated (Equation 2.7). Subsequently, the ACF of mCherry was measured in the red 
detection channel upon single color 543-nm excitation and its apparent brightness was 
calculated. Q, the ratio of these apparent brightnesses, was then calculated to be ~0.2.  
In Figure 6.4 we have simulated the effects of the cross-talk and FRET corrections on the 
ACF of mCherry for different values of Q and FRET. As can be seen in the top panel, cross-
talk will lower the apparent mCherry ACF amplitude, since more particles are ‘seen’ in this 
channel when there is crosstalk. In absence of cross-talk, FRET would have no influence on 
the mCherry ACF, since only particles of brightness (1+E) are ‘seen’ in the red channel. 
However, as can be seen in the lower panel of Figure 6.4, in presence of cross-talk FRET will 
increase the apparent mCherry ACF amplitude. Importantly, under the experimental 
conditions of crosstalk (Q=0.2) and FRET (E=0.76), the calculated mCherry ACF coincides 
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perfectly with the experimentally measured mCherry ACF, justifying our assumption of no 
‘only-red’ particles, i.e. Nr,total,real=Ngr, rescaled in the red volume.  
 
 
Figure 6.4 The effects of cross-talk and FRET corrections on the mCherry ACF – (top 
panel) The simulated mCherry ACFs are calculated with Equation 6.3 and with E=0.76, as 
experimentally determined. (bottom panel). The simulated mCherry ACFs are calculated with 
Equation 6.3 and with Q=0.2, as experimentally determined. The arrows point from ‘no 
correction’ to ‘experimentally determined correction’. 
In summary, by using the unbiased eGFP particle number and the fractions of green-only 
and green-and-red particles from the FLIM-FRET experiment, we could calculate an ACF 
for mCherry that was exactly the same as the measured ACF. Of concern, a ‘red-only’ 
population did not need to be included.  
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We thus have strong suggestions that the population indeed consist of a mixture of green-
only and green-and-red particles, which can be explained through photobleaching part of the 
RFP population during the experiment. These simulations were also done for the mRFP-
eGFP fusion, and gave comparable results.      
6.3.6. Correcting the cross-correlation function 
From the known ‘green-only’ and ‘green-and-red’ particle numbers, and with the proper 
crosstalk and FRET correction, we should be able to predict the amplitude of the cross-
correlation function. We worked out Equation 2.32 to include both the contribution of 
FRET and crosstalk: 
 ww = 1 − x< + 1 − 1 + x< + xx + 1 − x< ¬1 + x< + 1 − x< + x­  Equation 6.5
Again, no ‘red-only’ particles are assumed, so that this equation simplifies to GCC(τ)=1/Ng,total 
in the absence of FRET. In Figure 6.5, we simulated the effects of FRET and crosstalk for 
different values of E and Q, including our experimentally determined values. As can be seen 
in the top panel of Figure 6.5, in the presence of FRET (E=0.76) but no crosstalk, the 
observed mCherry-eGFP CCF under the experimental conditions (Fg = 0.61 and Fgr = 0.39) 
would have an amplitude of only 0.27. Including cross-talk in the calculation of the CCF will 
increase this amplitude to 0.39, which is very close to the measured 0.44. Likewise, as 
illustrated in the bottom panel of Figure 6.5, in absence of FRET, the observed CCF is not 
biased by crosstalk (Equation 6.5) and its amplitude is equal to that of the green ACF. FRET 
clearly has a profound effect on the CCF amplitude and lowers it to a value that is very close 
to the experimentally observed value.  
In summary, it was possible to predict the amplitude of the CCF of mCherry-eGFP with 
reasonable accuracy if we used our determined Q and E parameters and if the fractions of 
green-only and green-and-red particles are known. As expected, cross-talk increases the 
apparent CCF amplitude, and more importantly, FRET lowers the CCF amplitude 
considerably. 
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Figure 6.5 The calculated and experimental CCF of mCherry-eGFP – The simulated 
CCFs are calculated with Equation 6.5 and with either (top panel) E=0.76 or (bottom panel) 
Q=0.2. The arrows point from ‘no correction’ to ‘experimentally determined correction’.  
6.4. Discussion 
In this chapter we wanted to verify if FCCS can be used to study the co-diffusion of a green 
(eGFP) and a red (mRFP1 or mCherry) fluorescent protein inside living cells in a very simple 
model system consisting of a genetic fusion of the two proteins. The principle for measuring 
and quantifing protein-protein interactions with FCCS on the Zeiss ConfoCor2 microscope 
is based on the independent excitation and detection of the two fluorochromes that are used 
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to label the proteins. Non-idealities of our experimental setup and principle do exist and can 
be divided into fluorochrome and instrument related non-idealities.  
6.4.1. Fluorochrome non-idealities 
With respect to the fluorochromes, we chose the superior fluorescent protein couples that 
were available at the time, eGFP and either one of two monomeric RFPs (mRFP1 or 
mCherry). It could be argued that eGFP and mRFP are, from a spectral point of view, not 
the right choice for performing two-color FCCS, because their small Förster distance (~5 
nm) renders them good FRET partners. However, the emission spectra of cyan or even blue 
fluorescent proteins still show considerable overlap with the emission spectrum of common 
mRFPs. Furthermore, no far-red fluorescent proteins exist that are compatible with FCCS. 
Enhanced green fluorescent protein, already engineered in 1995 (Heim et al., 1995), to date 
still has excellent properties for quantitative measurements of protein dynamics; high 
brightness and photostability and a monomeric stoichiometry. However, it must be stated 
that eGFP has been shown in vitro to be able to enter short-lived transient dark states such as 
the triplet process and pH-dependent and –independent protonation  (Haupts et al., 1998; 
Widengren et al., 1999a), rendering the protein non-fluorescent for periods up to 300 µs, 
which is in the time range of the diffusion dynamics and could potentially compromise 
quantitative measurements. In 2004, engineering of monomeric red fluorescent proteins with 
a good brightness opened the way for quantitative two-color measurements of dynamics. 
However, some properties of RFPs limit their use in quantitative spectroscopy. First, up to 
date, all red fluorescent proteins have been shown to enter microsecond-to-second time scale 
light enhanced dark states (Heikal et al., 2000; Malvezzi-Campeggi et al., 2001; Schenk et al., 
2004b; Hendrix et al., 2008). In 0, the photophysics of mRFPs will be investigated in more 
detail. Secondly, slow chromophore maturation has been reported in some mRFPs. DsRed 
for example, the parent protein from which mRFP1 and mCherry were constructed, has a 
maturation time of almost a day (Shaner et al., 2004). Although mCherry has been shown to 
have quite a fast (20 min.) maturation time, we do not rule out this possibility. Thirdly, it 
could be argued that an error in transcription or translation for the fusion constructs exists.  
However, when the position of eGFP and the RFP are switched, or when a modified amino 
acid linker was inserted between the two proteins, similar results were obtained. Finally, 
mCherry and even more its predecessor mRFP1, are quite sensitive to photobleaching. 
Photobleaching irreversibly removes red molecules and partially explains the lower average 
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particle number of red molecules. Improvements in RFP fluorophore photostability have 
recently been achieved with a new RFP, TagRFP-T, that has an estimated 40-fold improved 
photostability and 3-fold higher brightness compared to mRFP1 (Shaner et al., 2008).  
6.4.2. Instrumental non-idealities 
With respect to the instrumental non-idealities, two-color excitation was used for these 
experiments. We are confident that the confocal volumes are concentric in the XY direction 
since the two excitation beams, 488 nm and 543 nm originate from the same optical fiber in 
the fiber coupling unit (FCU) of the Zeiss ConfoCor2 microscope, and follow the same 
optical path. On the other hand, the wavelength dependence of the light refraction in the 
objective could cause the confocal volumes created by the 488-nm and 543-nm lasers to be 
non-concentric in the Z-direction, resulting in a smaller cross-correlation volume than 
expected (Figure 6.6). Since the CCF amplitude is directly proportional to the cross-
correlation volume (Equation 6.5), a lower CCF amplitude is obtained than expected. 
Although incomplete volume overlap does put a limit on the maximum CCF amplitude 
possible, in our case the effect was rather small and correcting for this in the analysis of 
FCCS is possible when performing a detailed characterization of the microscopic setup (see 
section 3.3.6). Furthermore, the observation of low CCF amplitude for a fusion protein has 
been observed even for single-wavelength (514 nm) excitation FCCS on fluorescent proteins 
(Liu et al., 2007). 
 
Figure 6.6 Axial chromatic aberration effect on FCCS – From left to right: 
the less the two excitation spots, shown in red and green, overlap in Z-
direction, the smaller the effective cross-correlation volume is, shown by the 
gray ellipsoid. 
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Secondly, since the microscope is equipped with ‘continuous wave’ (CW) lasers, we 
simultaneously excited the green and red fluorescent proteins. As seen earlier (sections 2.3.4.2 
and 2.3.4.3), this measurement principle has two main consequences when using fluorescent 
proteins: cross-talk of the green fluorochrome into the red channel and the possibility of 
Förster resonance energy transfer between the fluorochromes. In the experiments performed 
here all the parameters (crosstalk parameter Q, protein fractions Fg and Fgr and FRET 
efficiency E) needed to correct for these non-idealities could be extracted from control 
experiments. It has been shown that cross-talk can be eliminated by using temporal 
separation of the excitation, either by using acousto-optical tunable filters or modulators, or 
by using picoseconds pulsed lasers instead of CW lasers. Furthermore, since green and red 
fluorochromes are not excited simultaneously with these techniques, the red ACF and CCF 
are not influenced by FRET in the red detection channel. This would simplify the analysis of 
FCCS considerably and would likely make the technique more robust for quantitative analysis 
of protein-protein interactions.   
6.5. Conclusion 
Fluorescent protein cross-correlation spectroscopy has the potential of becoming the 
biophysical tool of choice for quantifying protein-protein interactions in cells, because the 
absolute concentrations of both partners and their complex can directly be measured. We 
have shown for a model system that FCCS measurements can be analysed quantitatively in 
the presence of dark states, cross-talk and FRET and have discussed the different 
fluorochrome and experimental setup related issues that can be optimized to render the 
technique more robust. Especially FRET proved to profoundly influence the correlation 
functions and should better be avoided. Future work will consist in searching for a better 
methodology for FCCS, both by applying pulsed-interleaved excitation or temporal laser 
switching FCCS, to avoid crosstalk and acceptor FRET artefacts, and by using new 
fluorescent proteins with a larger spectral separation, such as BFP or CFP in combination 
with RFP. 
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Chapter 7. Dark states in monomeric 
red fluorescent proteins 
A fluctuating fluorescence signal usually means molecules are diffusing into and out of the 
confocal volume… or doesn’t it? We have already seen that fluctuations due to noise, 
although not correlated in time, have a negative effect on FCS, and that fluctuations due to 
the triplet conversion, that do correlate in time, contribute to the autocorrelation function in 
the fast time scale. If one wants to study diffusion and concentrations, then a detailed 
understanding of the autcorrelation behavior of fluorochromes is necessary. In this chapter 
we will focus specifically on a certain category of fluorochromes, the monomeric red 
fluorescent proteins. Being an ideal partner of green fluorescent proteins for FCCS 
measurements, we have to characterize in detail how these proteins behave in a fluorescence 
fluctuation experiment. We discuss experiments performed in a controlled in vitro 
environment and provide detailed and useful information about the photophysics of these 
proteins.   
 
Part of this chapter has been published in the following article: 
Hendrix,J., Flors,C., Dedecker,P., Hofkens,J., and Engelborghs,Y. (2008). Dark states in 
monomeric red fluorescent proteins studied by fluorescence correlation and single molecule 
spectroscopy. Biophys. J. 94, 4103-4113. 
7.1. Introduction 
The green fluorescent protein was discovered in 1961 in the hydrozoan Aequorea victoria 
(Shimomura, 2005). Fluorescence microscopy in live cells has been revolutionized since the 
advent of GFP as a genetically encoded marker in 1992 (Prasher et al., 1992). In the following 
years, variants of the GFP with different absorption/emission maxima and higher brightness 
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and stability have created a fluorescence palette ranging from blue (eBFP) to yellow (eYFP, 
Citrine). In 1999 this palette was extended to the red by the discovery of red fluorescent 
proteins (RFPs) in anthozoans like Discosoma sp. (DsRed) and in 2002 also in Entacmaea 
quadricolor (eqFP611) (Matz et al., 1999; Wiedenmann et al., 2002). Irrespective of their color, 
all fluorescent proteins have a β-barrel tertiary structure, protruded by an internal α-helix. 
After folding of the protein, the light absorbing and emitting fluorophore spontaneously 
forms by chemical reactions of amino acids in this internal α-helix, as illustrated for DsRed in 
Figure 7.1. Importantly, the physicochemical properties of the reacting amino acids, together 
with the surrounding amino acids forming the fluorophore pocket, are the basis for both the 
color and photophysical properties of the fluorescent protein.  
 
Figure 7.1 Formation of the DsRed fluorophore – (A) the DsRed 
polypeptide in the right orientation. (B) the immature green fluorophore. (C) 
The mature red fluorophore. (D) Resonant form of (C) (Campbell et al., 2002).  
Being an obligate tetramer, DsRed was engineered in 2002 by Campbell et al. into mRFP1, 
the first true monomeric red fluorescent protein (Campbell et al., 2002). mRFP1 contains a 
total of 33 amino-acid mutations, but is structurally still very stable (Stepanenko et al., 2004). 
The chromophore in mRFP1 matures much faster than in DsRed, is less bright and its 
photostability is lower than DsRed, but still comparable to eGFP (Campbell et al., 2002).  
In 2004, further engineering of mRFP1 led to the mFruits family that covers the yellow 
(mHoneydew) to dark-red part (mPlum) of the visible spectrum (Shaner et al., 2004; Wang et 
al., 2004). Of the mFruits, mCherry is considered to be the superior monomeric RFP (Shaner 
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et al., 2005). It has a good photostability and even faster maturation but still is only 
moderately brighter than mRFP1. A brighter version of mRFP1 exists (Q66T), but at the cost 
of a 34-nm blue shift of the emission spectrum (Jach et al., 2006). Recently, a new mRFP 
(TagRFP) has been created from eqFP578, but the emission spectrum still is 24-nm blue-
shifted with respect to mRFP1 (Merzlyak et al., 2007). mRFP1 has also been converted into a 
photoactivatable protein (Verkhusha and Sorkin, 2005b). 
mRFPs are in great demand for experiments in live cells because of their interesting 
properties. First, their red emission leads to less scattering and less background fluorescence 
detection. Second, their emission spectrum can be well separated from eGFP, which makes 
them interesting for dual colour applications. Moreover, when fused to a certain protein, their 
monomeric structure preserves the natural function and allows for FRET measurements. 
However, previous photophysical studies of some RFPs have shown the presence of light-
induced dark states that can complicate the interpretation of the results of the cellular 
measurements (Heikal et al., 2000; Malvezzi-Campeggi et al., 2001; Schenk et al., 2004a). 
In 2000, Heikal et al. observed with FCS that DsRed in solution shows a large contribution 
of an excitation intensity-dependent (but not pH-dependent) flickering in the sub-ms 
timescale (Heikal et al., 2000). Subsequently, Malvezzi-Campeggi et al. proved that this 
flickering represents the transition between three interconvertible states (a red, a far-red and a 
dark state) (Malvezzi-Campeggi et al., 2001). Schenk et al. confirmed the observations for 
DsRed and observed a similar process in a different RFP, eqFP611 (Schenk et al., 2004a). 
The flickering was suggested to be a consequence of conformational rearrangements around 
the chromophore, such as photoisomerization and/or changes in the hydrogen-bonding 
network. Both for DsRed and eqFP611, Raman spectroscopy later showed that 
photoisomerization is indeed involved in the photodynamics of these RFPs (Habuchi et al., 
2005; Loos et al., 2006). In some green fluorescent protein mutants such as eYFP and Citrine 
(Heikal et al., 2000; Schwille et al., 2000), a pH- and intensity-dependent flickering was also 
found and assigned to fast protonation-deprotonation.   
In this chapter, we focus on the monomeric red fluorescent proteins mRFP1, mStrawberry 
and mCherry and on the presence of light-induced flickering. We have characterized this 
process with fluorescence correlation and single-molecule spectroscopy, and we have 
explored the effects of viscosity, excitation intensity and pH on this process. We have 
combined our experimental results with information based on known X-ray structures of 
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some RFPs, and we provide insight into the consequences that the chromophore 
environment has on the observed fluorescence properties. Also, we draw the attention to the 
implications of the fast flickering of RFPs when performing quantitative FCS measurements 
in live cells. 
7.2. Materials and Methods 
7.2.1. Proteins and buffers 
The pRSET plasmids coding for His-tagged mRFP1, mCherry and mStrawberry were a kind 
gift of Dr. Roger Y. Tsien (HHMI-UCSD, La Jolla, CA). After transformation of the plasmid 
in E. coli BL21 cells, the cells were grown at 37 °C to an optical density of 0.6 after which  
protein overexpression was induced during 3 h with 1 mM IPTG. After sonication of the 
culture, the proteins were purified using gravity flow Ni2+-affinity chromatography (Protino 
Ni-TED, Macherey-Nagel GmbH & Co. KG, Düren, Germany).  
The protein purity was checked with SDS-PAGE. On this gel, three bands could be 
observed, corresponding to native and cleaved protein. The cleavage occurs in the 
chromophore and is caused by a partial hydrolysis of the main chain acylimine linkage 
((Gross et al., 2000; Campbell et al., 2002; Verkhusha and Sorkin, 2005b) and data not 
shown). The extent of the cleavage does not increase over time, suggesting that the cleavage 
occurs only in a subpopulation which may represent poorly folded protein. This suggestion is 
underpinned by the fact that in the photoactivatible PA-mRFP1-1 a larger extent of cleavage 
occurs than in mRFP1 (Verkhusha and Sorkin, 2005a), which might be due to the mutations 
in the chromophore environment. The cleavage irreversibly changes the spectral properties of 
the RFP, converting it from a red to a green-like protein. The residual fluorescence of the 
green-like protein, if any, will not influence our measurements, since we are using a red 
emission filter. Most of the experiments were performed in phosphate buffered saline (PBS, 
pH 7.4). The pH buffer consisted of 50 mM of phosphate, citrate and glycine adjusted from 
pH 3-12 (with 0.5 increments) with 3 N of NaOH. If a higher viscosity was needed, glycerol 
was added to the buffer, and the pH was adjusted with NaOH containing the same 
concentration of glycerol. Samples for single-molecule measurements were prepared by spin-
coating the proteins (∼10-11 M) in PBS containing 1% (wt) polyvinyl alcohol (PVA) on a clean 
cover glass at 3000 rpm. 
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7.2.2. Absorption and emission spectra 
Absorption spectra were measured with a Shimadzu UV-1601PC spectrophotometer 
(Shimadzu GmbH, Duisburg, Germany). Excitation and emission spectra were taken with a 
PTI QuantaMaster fluorometer (Photon Technologies International, West Sussex, UK). For 
the excitation spectra, the excitation monochromator bandwidth was 2 nm and the emission 
monochromator to 650±10 nm. For the emission spectra, the excitation monochromator was 
set to 540±10 nm and the emission monochromator bandwidth was set to 2 nm. 
7.2.3. FCS in solution 
For FCS measurements in solution the concentrated protein was diluted to 1 nM in the 
appropriate buffer. The measurements were performed on a commercial ConfoCor2 system 
(Carl Zeiss, Jena, Germany).  
A 543-nm HeNe laser was used to excite mRFP1, with the acousto-optical tunable filter set 
to 3-100%, corresponding to an intensity of 2-122 kW/cm2 in the confocal spot (as measured 
with a light power meter). The excitation light was reflected by a HFT543 dichroic mirror and 
focused in the sample through a C-Apochromat 40×/1.2NA water immersion objective. The 
fluorescence light was filtered by a LP560 longpass filter and was detected on an avalanche 
photodiode through a 78 µm pinhole. For the different experimental conditions (intensity, 
pH,...) 10 measurements of 20 seconds were performed and the average autocorrelation curve 
was calculated. The measurements were analyzed in Igor Pro 5 (Wavemetrics, Inc., Oregon, 
USA) by means of global analysis with Equation 2.17, including 1 or 2 dark states.  
7.2.4. Single-molecule fluorescence spectroscopy 
For single-molecule experiments, excitation at 543 nm (8 MHz, 1.2 ps FWHM) from the 
frequency doubled output of an optical parametric oscillator (GWU Lasertechnik, Erftstadt-
Friesheim, Germany) pumped by a Ti:Sapphire laser (Tsunami, Spectra Physics) was directed 
into an inverted microscope (Olympus IX 70, Tokyo, Japan) and focused onto the sample 
through an oil immersion objective (60×/1.4NA, Olympus). Fluorescence was collected 
through the same objective and sent to an avalanche photodiode (SPCM-AQR-15, 
PerkinElmer, Whaltham, MA). For the single molecule experiments, the excitation intensity 
was 120 nW, which corresponds to ~ 261 W/cm². Time-resolved data were collected with a 
time-correlated single photon counting (TCSPC) card (SPC 630, Becker & Hickl, Berlin, 
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Germany) operated in first-in-first-out mode. The detailed description of the setup and the 
data acquisition process have been published previously (Vosch et al., 2003). 
7.2.5. Ensemble time-resolved fluorescence 
Ensemble time-resolved fluorescence measurements were performed using the TCSPC 
technique (Maus et al., 2001), with excitation at 543 nm using the same source as above, in a 
cuvette with a path length of 1 cm and an optical density of 0.1 at the absorption maximum.  
Fluorescence was detected under magic angle geometry, by means of a cooled microchannel 
plate photomultiplier (Hamamatsu R3809U). Fluorescence histograms of the sample and of 
the instrument response function were collected in 4096 channels, until they typically reached 
104 counts in the peak channel. The total width at half-maximum of the instrument response 
function was ~ 40 ps. Single-molecule and ensemble time-resolved fluorescence spectroscopy 
measurements were performed by Dr. Cristina Flors at the Laboratory for Photochemistry 
and Spectroscopy, under the supervision of Prof. Johan Hofkens.  
7.3. Results 
7.3.1. Fluorescence correlation spectroscopy of mRFP1 and mFruits 
We applied FCS to discover if dark-state formation also occurs in mRFP1, mCherry and 
mStrawberry, as found for the other RFPs described in the introduction. Since the viscosity 
of the medium only affects the translational diffusion, we can exploit it for the identification 
of non-diffusion-related processes. Whereas at 24 kW/cm² in aqueous buffer there are no 
distinct components visible in the autocorrelation curve (Figure 7.2, left curve), in 50% (v/v) 
glycerol two different components are clearly visible (Figure 7.2, right curve). The fastest 
component can be adequately described by an exponential blinking term in the fitting 
function and the slowest is best described by a translational diffusion term. The relaxation 
time of the fast component is much faster than the expected time necessary for a typical 
monomeric GFP to diffuse through the confocal volume, confirming its identity as a non-
diffusion related process. The fraction of flickering for mRFP1 and for mCherry molecules at 
24 kW/cm² is similar, 46±1% and 43±2% respectively. At the same Iexc mStrawberry showed 
a markedly increased fraction, 56±1%. Furthermore, the flickering also experienced a small 
viscosity effect. It should be noted, however, that glycerol changes the refractive index of the 
solution, which also has an effect on the autocorrelation curve (Enderlein et al., 2005). 
7.3. Results 
163 
Nevertheless, this experiment proves that also in these mRFPs dark-state formation occurs in 
a timescale of tens of µs.  
 
 
Figure 7.2 Experimental FCS curves of the mRFPs at Iexc = 24 kW/cm² normalized to 
the diffusion component – In each group of 3 curves the concentration of glycerol was 0, 
25, 50% (v/v). From left to right: mRFP1, mCherry, mStrawberry. The solid lines are global 
fits with Equation 2.17, where the fraction of the flickering was linked within one set. 
7.3.1.1. Intensity dependence 
To determine if dark-state formation is light-induced, we performed FCS measurements at 
different excitation intensities, ranging from 2 to 122 kW/cm2 (Figure 7.3 A). First, we 
determined the diffusion coefficient of mRFP1 in aqueous solution. The brightness of 
mRFP1 was not linearly dependent on Iexc at high excitation intensity (data not shown), 
which can be attributed to optical saturation of the fluorescent protein (Enderlein et al., 
2005). This optical saturation in combination with a larger contribution of flickering 
processes at higher Iexc caused the apparent D to vary with Iexc. By measuring at different Iexc 
and extrapolating to Iexc = 0 (Figure 7.3 B), we obtained a value of D = ~56 µm²/s, which is 
in good agreement with the value found for eGFP. Two-focus FCS might provide a 
confirmation for the value we obtained, since in this technique D is measured relative from 
one focus to another, and is less prone to optical artifacts (Dertinger et al., 2007b).  
Figure 7.3 C and D show respectively the relaxation time and the fraction of the non-
diffusion-related process(es). In the low Iexc-regime, the fraction and relaxation time of the 
flickering are clearly light-dependent (squares in Figure 7.3 C and D), meaning that the path 
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towards the dark state is favored, i.e., the dark state formation is indeed light-induced. In the 
higher Iexc-regime the fraction of the flickering appears to become constant.  
In addition, a second exponential term had to be included in the fitting. As an illustration, a 
fit of the FCS curve at the highest Iexc with one exponential function is also shown in Figure 
7.3 A. The relaxation time of the second exponential term could be kept constant and the 
fraction showed a linear increase (circles in Figure 7.3 C and D), even in the region where the 
other process appeared to have become saturated. This second process might represent 
another light-induced state, e.g. triplet conversion (Widengren et al., 1999b; Jung et al., 2005). 
Triplet lifetimes of red fluorescent proteins such as HcRed have been estimated at a few 
microseconds (Cotlet et al., 2006), similarly to our observations. Due to the low triplet 
quantum yield in GFPs (Jimenez-Banzo et al., 2008) the exponential term that accounts for 
its formation only becomes apparent at higher Iexc, as has already been observed for other 
GFPs (Haupts et al., 1998; Widengren et al., 1999b). These measurements thus suggest that 
there are (at least) two different dark-states for mRFP1  When mCherry and mStrawberry 
were measured, a similar trend was observed (Figure 7.4 and Figure 7.5). 
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Figure 7.3 Intensity dependence of the ACF of mRFP1 (A) Experimental autocorrelation 
curves of mRFP1 in aqueous buffer at excitation intensities ranging from (right to left) 2-122 
kW/cm². The curves were normalized to G(0) = [N.(1-F1).(1-F2)]-1 to emphasize the effect 
of Iexc on the fast component of the curve. It is worth to note that normalization in this 
manner causes the GD(0) (Equation 2.17) to decrease at increasing Iexc, even though the 
concentration stays constant. For the highest Iexc, both a one- (continuous line) and two- 
(dashed line) exponential fit are shown. (B) Apparent diffusion coefficient after fitting with 
Equation 2.17. (C) Relaxation times of the flickering (squares) and triplet (circles) processes. 
(D) Fraction of the fast processes when G(0) is normalized to 1.   
 
Moreover, for all three mRFPs we find that for the slower flickering process the associated 
dark fraction does not tend to zero in the limit of zero excitation intensity (Figure 7.3 D, 
Figure 7.4 D and Figure 7.5 D).  
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Figure 7.4 Intensity dependence of the ACF of mCherry (A) Experimental autocorrelation 
curves of mCherry in aqueous buffer at excitation intensities ranging from (right to left) 2-122 
kW/cm². The curves were normalized to G(0) = [N.(1-F1).(1-F2)]-1 to emphasize the effect of Iexc 
on the fast component of the curve. The measurements on mCherry did not show a clear trend in 
F1. When the latter parameter was kept constant, this resulted in a intensity dependence of both 
relaxation times. Due to the relatively small difference in both relaxation times and diffusion time, 
especially at high Iexc, it is difficult to say which fitting method yields the more realistic parameters. 
(B) Apparent diffusion coefficient after fitting with Equation 2.17. (C) Relaxation times of the 
flickering (squares) and triplet (circles) processes. (D) Fraction of the fast processes when G(0) is 
normalized to 1.  Because there was no clear trend in F1, it was globally linked.   
 
Therefore we conclude that one of the two dark states observed with ensemble FCS is 
populated even in the absence of excitation light, but that its formation is accelerated through 
irradiation, while the other dark state is only occupied when excitation light is present.  
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Figure 7.5 Intensity dependence of the ACF of mStrawberry (A) Experimental 
autocorrelation curves of mStrawberry in aqueous buffer at excitation intensities ranging from 
(right to left) 2-122 kW/cm². The curves were normalized to G(0) = [N.(1-F1).(1-F2)]-1 to 
emphasize the effect of Iexc on the fast component of the curve. (B) Apparent diffusion 
coefficient after fitting with Equation 2.17. (C) Relaxation times of the flickering (squares) and 
triplet (circles) processes. (D) Fraction of the fast processes when G(0) is normalized to 1.   
7.3.1.2. pH-dependence  
We explored the effect of varying pH on the dark-state formation in mRFP1 and mFruits, 
since it was shown for other fluorescent proteins that the pH can play a role in this process. 
FCS measurements of mRFP1 were performed at different pH values in 50% (v/v) glycerol 
(see Materials and Methods), to allow for an easy visual inspection of the autocorrelation 
curves (Figure 7.6 A).  
To emphasize the effect of pH on the flickering dynamics, the autocorrelation curves were 
normalized with respect to the translational diffusion part. The fraction of mRFP1 molecules 
that is, on average, in a dark state shifted from 50±1% to 64±1% when increasing pH from 7 
to 12 and the associated relaxation time shifted from 98.6±3.0 µs to 112.3±4.2 µs, indicating 
that mRFP1 is more often and longer in a dark state (since 1/τrelaxation = krelaxation = kbright→dark 
+ kdark→bright). In mCherry and Strawberry, a similar increase in the fraction and relaxation 
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times were observed (Figure 7.6 C). In an acidic environment (pH ≤ 5) a different fast 
process appears in the autocorrelation curve (data not shown). 
 
     
 
Figure 7.6 pH dependence of the ACF of mRFP1 (A) Experimental autocorrelation curves of 
mRFP1 at Iexc = 61 kW/cm² in pH buffer supplemented with 50% (v/v) glycerol. The 
autocorrelation curves were normalized to the diffusion part of the curve. Normalization in this 
manner emphasizes the effect of pH on the flickering. The red arrow indicates the increase of 
the fraction of the flickering upon increasing pH from 7 to 11.5. (B) Absorption and emission 
spectra of mRFP1 at varying pH. The red arrow indicates the hypsochromic shift of the spectra 
and the increase of the quantum yield of mRFP1. (C) Comparison of the pH-dependence of the 
mRFP1- (squares), mCherry- (circles) and mStrawberry-autocorrelation curves  (triangles) at Iexc 
= 61 kW/cm² in pH buffer supplemented with 50% (v/v) glycerol. The autocorrelation curves 
were normalized to the diffusion part of the curve. Normalization in this manner emphasizes the 
effect of pH on the flickering. (D) pH-titration of the emission intensity of mRFP1 at λmax. I = 
fluorescence intensity of the sample, I1 = fluorescence intensity when Glu-215 is 100% 
protonated and ∆I = I2-I1 the difference in fluorescence intensity when Glu-215 is deprotonated 
or protonated. 
C 
D 
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This process has already been described for eGFP and likely represents the protonation 
equilibrium of the hydroxyl moiety of the modified Tyr66 residue in the chromophore 
(Haupts et al., 1998). Since the chromophore is only fluorescent in the anionic state, 
protonation of Tyr66 at low pH quenches the fluorescence, giving rise to a dark state in the 
autocorrelation curve. Interestingly, although DsRed shares the same chromophore as 
mRFP1, the dark states of DsRed are not pH-dependent (Heikal et al., 2000). To investigate 
if the effects observed in FCS are related to changes in the steady-state absorption and 
emission properties, the pH-dependence of mRFP1 absorption, emission and excitation 
spectra were measured from pH 3 to 12 (Figure 7.6 B). The absorption maximum of mRFP1 
shifted from 584 to 567 nm when changing pH from 7 to 11, which is in good agreement 
with measurements on mCherry (Shu et al., 2006). Below pH 7 the absorption spectrum did 
not change significantly. In the emission spectra, a similar blue shift from 605 to 595 nm was 
observed when increasing from pH 7 to 11 (Figure 7.6 B). More interestingly, when raising 
the pH from 7 to 11 the intensity of fluorescence drastically increased (Iλ,max increased by a 
factor ~ 2.4). The shift of the emission intensity with pH fitted well with a model for a 
monoprotic acid/base sytem (Figure 7.6 D) and a pKa of 9.9 ± 0.1 was obtained for the 
process, which is in close accordance with values reported on mCherry and mStrawberry. The 
apparent fluorescence quantum yield of the chromophore thus rises as a result of a different 
protonation state of the chromophore environment. This brightness increase cannot be due 
to a decrease in the fraction or relaxation time of the dark state, since our FCS data show that 
at high pH the dark state lives longer and occurs more frequently. On the other hand, these 
observations can be explained based on the crystallographic information about mRFPs at 
different pH values.  
E.g. for mStrawberry, a significant drop of the twist and tilt angles of the chromophore was 
observed when the pH was increased from 9.5 to 10.5 (Shu et al., 2006), in very good 
agreement with our observations on mRFP1. Chromophore co-planarity is a very important 
factor in the fluorescence efficiency of GFPs (as is discussed further on in this paper). Similar 
effects were seen in the excitation spectrum of mRFP1 (data not shown).  
At pH 3 and 12 all fluorescence disappeared, indicating the denaturation of the protein. At 
these extreme values of pH the chromophore still showed a wide absorption peak in the blue 
(Figure 7.6 B), as has been reported for other fluorescent proteins (Gross et al., 2000).  
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7.3.2. Single-molecule spectroscopy of immobilized mRFP1 
We used single-molecule spectroscopy of immobilized mRFP1 in order to study the fast on-
off dynamics without the contribution of diffusion. A typical single-molecule intensity trace 
of mRFP1 in a PVA matrix is shown in Figure 7.7 A and B. Frequent on-off blinking is 
clearly observed in several timescales, even up to seconds, revealing a reversible transition 
from a bright to a dark state, similar to our observations in the FCS experiments. The 
flickering was found for the large majority of the molecules measured (>90%). In general, the 
emission intensity level is not stable due to this blinking, but there are no evident sequential 
photobleaching steps, which is consistent with the monomeric form of the protein. For 
comparison, immobilized DsRed showed several intensity levels as expected from its 
oligomeric form. In addition, on-off blinking was also present as reported before (Garcia-
Parajo et al., 2001; Cotlet et al., 2001a; Cotlet et al., 2001b), especially at the lower intensity 
levels after several units had photobleached. 
  
Figure 7.7 A single molecule trajectory of mRFP1 (A) A single-molecule fluorescence 
trajectory of mRFP1 immobilized in PVA matrix. (B) Zoom in A) from 40-70 s. (C) Typical 
autocorrelation curve of an immobilized single-molecule and fit with a 3-exponential 
function (540 µs, 1.8 ms, 250 ms).    
Autocorrelation curves of the fluorescence intensity of an immobilized molecule of mRFP1 
could be typically fitted with 3 exponentials of timescales of hundreds of µs, a few ms, and 
hundreds of ms. Figure 7.7 C shows an example with autocorrelation times of 540 µs, 1.8 ms 
and 250 ms. The fastest of these processes might represent the flickering observed in the 
ensemble FCS measurements. The relaxation time found in the ensemble FCS measurements 
typically was <100 µs, but the difference might be attributed to the higher excitation intensity 
used in the ensemble FCS experiments. The slower processes might reflect protein 
conformational changes in a slower timescale (see Discussion). The distribution of 
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fluorescence lifetimes, analyzed in bins of 2000 photons, is quite broad, but peaks at about 
the main value found in bulk experiments (1.8 ns, see next section). 
7.3.3. Time-resolved fluorescence spectroscopy of mRFP1 and mFruits 
We performed time-resolved fluorescence measurements on bulk solutions of mRFPs to gain 
more insight in their excited-state dynamics. mRFP1 has main fluorescence decay of 1.8 ns 
(96%) and a small component of ∼0.4 ns (4%) when excited at 543 nm and monitored at 610 
nm (Figure 7.8 left). A non-pure monoexponential decay for mRFP1 has been already 
reported in literature (Stepanenko et al., 2004). mStrawberry (Figure 7.8 middle) and mCherry 
(Figure 7.8 right) also decayed biexponentially, the former with components of 2.1 ns (85%) 
and ∼1 ns (15%) and the latter with 1.6 ns (90%) and ∼0.7 ns (10%). The presence of 
multiexponential decays in GFPs could be associated with conformational changes (see 
Discussion). In contrast, DsRed decayed monoexponentially when excited at 543 nm (Heikal 
et al., 2000; Cotlet et al., 2001a). A multiexponential decay was found when excited at 470 nm 
due to energy transfer processes from the immature subunits of the tetramer, but this process 
cannot occur in the case of the monomer. 
  
 
Figure 7.8 Fluorescence decays of the mRFPs – Fluorescence decay of (left) mRFP1, 
(middle) mStrawberry and (right) mCherry (λdet = 610 nm, solid line) and instrument 
response function (dotted line). Instrument response function (dotted line). Fit and residuals 
of a 1-exponential function (blue) and a 2-exponential function (red). 
7.3.4. Structural basis for the pH-dependence of the mRFPs 
It has been recently pointed out that Glu-215 is the key residue responsible for the pH-
induced spectral shift of mCherry and mStrawberry, as it is the only residue in the vicinity of 
the chromophore that markedly changes its conformation upon an increase of the pH from 
9.5 to 10.5 (Figure 7.9 top) (Shu et al., 2006). Although such a pKa is very high for a Glu 
(pKa for the γ-carboxyl group of Glu in solution is ~4.3), there are reports in the literature 
mCherry 
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for such high pKa values in some proteins (Forsyth et al., 2002) when the acid form is 
strongly stabilized. It is very intriguing that only the mRFPs show a pH-dependent red-shift 
and flickering, whereas all RFPs contain the same  Glu-215 residue.  
Figure 7.9 A and B show a stereo image of a 5 Å sphere around Glu-215 in mStrawberry and 
DsRed, respectively. Table 7.1 shows the residues surrounding Glu-215 that differ between 
DsRed and the mRFPs. The side chain of residue 41 is probably too distant from the side 
chain of Glu-215 to have an effect. Residues 42 and 44 are very similar among all RFPs. 
Residues 197 and 217 on the other hand differ strongly. While these residues are 
hydrophobic in the mRFPs, they are polar and involved in H-bond formation in DsRed. 
From the crystal structure of DsRed it is clear that Glu-215 forms a salt bridge with Lys-70, 
that is further stabilized by H-bridges with  Ser-197 and Thr-217 (Yarbrough et al., 2001). 
The deprotonated form of Glu-215 is thus strongly stabilized through the salt bridge, causing 
a very low pKa of the carboxylic acid and providing an explanation for the lack of a pH-
dependence of the fluorescence in DsRed.  
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Figure 7.9 Ball and stick stereo representations of the 5 Å-radius environment of Glu-215 in 
(A) mStrawberry and (B) DsRed – Residues that differ between mStrawberry and DsRed or have 
a markedly different conformation in acid or base are explicitly depicted as sticks. In mStrawberry 
Lys-70, Glu-148 and Glu-215 are depicted pink in acid and blue in conjugated base conformation. 
H-bonds are depicted in gray with the distance in Å. The figures were made with the PyMOL 
Molecular Graphics System (2002, DeLano Scientific, Palo Alto, CA, USA). 
 
 
 
 
A 
B 
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Table 7.1 Residues surround-
ding Glu-215 in RFPs that 
differ between DsRed and the 
mRFPs 
Position DsRed mRFPs 
41 His Thr 
42 Asn Gln 
44 Val Ala 
197 Ser Ile 
217 Thr Ala 
 
In mStrawberry, however, the distance between the positively charged Lys-70 and the 
carboxylic acid oxygen of Glu-215 is increased to 5.72 Å  and the local environment becomes 
more hydrophobic due to the presence of  the two hydrophobic residues Ile-197 and Ala-217.  
Lys-70 thus forms a salt bridge with Glu-148 and moreover a H-bond is formed between the 
protonated Glu-217 and  the imidazolinone nitrogen of the chromophore. This explains the 
high pKa of Glu-215. By way of comparison, in eqFP611, residue 197 is a His and 217 is an 
Ala. From the crystal structure, it is apparent that there is a H-bond between His-197 and 
Glu-215, stabilizing the carboxylate form and explaining  the lack of pH-dependence 
(Malvezzi-Campeggi et al., 2001; Wiedenmann et al., 2002). Our observed pH-dependence 
can now be explained in terms of this structural information. At neutral pH, a H-bond 
between the chromophore and Glu-215 exists, which pulls the chromophore  out of its 
planar conformation (Shu et al., 2006) causing a red shift of the spectrum and a decreased 
brightness. At a pH above the (high) pKa of Glu-215, the H-bond between the latter and the 
chromophore is broken, and as a result the chromophore will become more planar and thus 
brighter. Due to the breakage of the H-bond, conformational rearrangements will be favored, 
and a more frequent dark state formation occurs. A similar pH-dependence has been recently 
observed in a related chromoprotein (Battad et al., 2007).  
The transition-pH for the mRFPs is also around the pKa of an ε-amino group of  a Lys (10.5 
in solution). However, in the acid and basic structures of the mRFPs Lys-70 is forming a salt 
bridge with Glu-148, such that its deprotonation as a cause of the transition can be excluded.  
This interpretation is confirmed by the fact that Lys-70 in mStrawberry has only a slightly 
different conformation at pH 10.5 as compared to pH 9.5.  
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7.4. Discussion 
7.4.1. Dark states of mRFPs 
mRFP1, mCherry and mStrawberry all reveal a pH- and Iexc-dependent flickering, as shown in 
this work by means of FCS. As mentioned in the introduction, light-induced flickering has 
already been observed before with FCS and single-molecule spectroscopy in RFPs such as 
DsRed and eqFP611 (Malvezzi-Campeggi et al., 2001; Wiedenmann et al., 2002; Schenk et al., 
2004a). The conformation of the chromophore can have a large influence on the 
spectroscopic properties of a protein. Both cis- (DsRed and variants hereof) and trans- 
(eqFP611) conformations around the methylene bridge between the two cyclic parts can be 
fluorescent. In addition, coplanarity of the hydroxyphenyl and the imidazolinone moieties of 
the chromophore seems to be indispensable for fluorescence (Prescott et al., 2003; 
Henderson and Remington, 2006). It was suggested that conformational rearrangements of 
the chromophore might be responsible for flickering in these red FPs, since the timescales 
are consistent with these changes (Schenk et al., 2004a). On the other hand, amino acids in 
close proximity of the chromophore can also affect the fluorescence of the latter. The pH-
dependence of the mRFP1 fluorescence, as evidenced here, is most probably a consequence 
of an altered chromophore environment (see next section). Moreover, the looser H-bonding 
network in mRFP1 and mFruits as compared to DsRed might contribute to the 
conformational freedom of the chromophore in the β-barrel (Campbell et al., 2002).  
Our results for the time-resolved fluorescence experiments are consistent with 
conformational rearrangements of the chromophore in mRFP1 and mFruits. Similar 
biexponential decays in other red FPs such as eqFP611 and HcRed have been associated with 
the presence of two different conformers (Loos et al., 2006; Cotlet et al., 2006). Furthermore, 
we showed here with FCS that the conformers interconvert in the excited state, since the 
flickering is light-induced. In the case of DsRed, the pure monoexponential decay is a 
consequence of the reduced conformational mobility in the excited-state.  
As for the blinking of immobilized mRFP1, the fact that the flickering is slowed down in the 
rigid PVA matrix would be consistent with the attribution of the process  to a conformational 
change (Cotlet et al., 2006). It was previously shown that binding of eqFP611 to polyethylene 
glycol-covered glass surfaces did not affect the flickering rates as compared to solution 
(Schenk et al., 2004a), although the latter process was suppressed when eqFP611 was 
deposited on bare glass. The PVA matrix used in our single-molecule experiments might be 
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slightly more rigid than polyethylene glycol, but still allows a certain conformational freedom. 
The slight effect of solvent viscosity on the flickering component observed in FCS is also 
consistent with the above (although viscosity will clearly affect more the diffusion 
component). On the other hand, autocorrelation times in the tens of ms timescale have been 
previously assigned to the interconversion between cis and trans conformations mediated by 
polymer motions in immobilized HcRed (Cotlet et al., 2006). A hybrid quantum 
mechanics/molecular dynamics study might be useful to reveal the mechanisms of cis-trans 
isomerization and/or loss of chromophore planarity that are responsible for the observed 
fluorescence flickering in mRFPs, as was done previously for GFP (Weber et al., 1999). 
By comparing DsRed and eqFP611, the latter which has been shown to have a smaller 
oligomerization tendency than the former, it was already shown by Schenk et al. that 
oligomerization does not influence to a great extent the flickering dynamics observed with 
FCS, although the difference in oligomerization state between the two proteins in their 
experimental conditions is somewhat inconclusive. We have found with single-molecule FCS 
(see section ‘Single-molecule spectroscopy of immobilized mRFP1’) that both immobilized 
mRFP1 and DsRed showed flickering, although for DsRed the flickering is somewhat more 
frequent in the lower intensity levels, after several units have photobleached. This situation 
would resemble that of mRFP1, although we cannot rule out the effect of the photobleached 
units of DsRed acting as ‘traps’. 
7.4.2. Implications for cellular measurements 
To illustrate this, we made a fusion protein of mRFP and eGFP, expressed it inside live 
human HeLaP4 cells and performed FCS measurements, as described in (De Rijck et al., 
2006).  
Since the fluorescence of the fused protein can be monitored in the green and the red 
channel simultaneously (with two-colour excitation and detection), FCS analysis of both 
mRFP1- and eGFP-fluorescence is possible. Table 7.2 summarizes the results after fitting the 
two autocorrelation curves to a model with one exponential and two diffusion components 
(the fast representing free diffusion and the slow representing hindered diffusion). It is clear 
that fitting of the mRFP1 autocorrelation curve gives a non-realistic diffusion time for the 
freely diffusing protein (i.e., 39 µs for mRFPs vs 380 µs for eGFP), despite the fact that the 
flickering process is represented in the fitting. If the protein complex is bigger and diffusion 
is thus slowed down, then the processes can be separated well, as was the case in our in vitro 
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viscosity measurements. On the other hand, the sensitivity of dark state formation on the 
excitation intensity could also be exploited to separate diffusion and dark states. This would 
simplify the use of RFPs in cellular measurements considerably, but requires the RFP to be 
compatible with higher excitation intensities than typically used in cells.  
 
Table 7.2 Fit results for intracellular FCS on mRFP-eGFP – 
Fitting was performed using a 2-component diffusion model with 
one exponential. Goodness-of-fit was judged by looking both at the 
residual δG(τ) curve and the χ²-value.  
FCS channel  τ  (µs) Fraction  (%) 
eGFP Free diffusion 380 ± 70 74.8 ± 13.6 
 Hindered diffusion 16405 ± 2220 25.2 ± 13.6 
 Photophysics (triplet) 4 ± 2 16 ± 2 
mRFP1 Free diffusion 39 ± 17 65.5 ± 8.0 
 Hindered diffusion 2481 ± 840 34.5 ± 8.0 
 Photophysics (flickering) 63 ± 11 43 ± 7 
7.5. Conclusion 
Fluorescence flickering in (m)RFPs seems to be a general behavior that might impair the 
analysis in FCS and FRET experiments. Unveiling the mechanism(s) responsible for this 
light-induced process may assist in the development of new and better mutants. In this work, 
we focused on the presence of this flickering in the monomeric RFPs mRFP1, mCherry and 
mStrawberry and provide insight in the pH-dependence of the fluorescence flickering. Taking 
into account previous results on other RFPs, we offer a global picture of the structural basis 
of fluorescence flickering in (monomeric) RFPs. Further evolution of mRFPs should 
specifically address this problem, since we show that the implications in cellular 
measurements can be serious.  
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Part IV – General conclusions 
Identifying and characterizing intracellular interactions of a protein is typically performed by 
setting up a robust biochemical assay that specifically detects interacting partners in the 
presence of the protein. As with all research techniques, biochemical assays have their 
strengths and limitations. For example, although these assays do allow for the identification 
and characterization of cellular proteins, the biological content and three-dimensional 
architecture of the cell and its subcompartments creates an environment that can hardly be 
imitated in any ex vivo or in vitro assay. Secondly, in many interaction assays such as chromatin 
binding assays, pull-down and co-immunoprecipitation the time dimension is lost, only a 
static non-equilibrium picture of protein behavior and properties is obtained, whereas in vivo 
protein interactions occur dynamically. 
Fluorescence correlation (FCS) and cross-correlation (FCCS) spectroscopy are two classic 
examples of biophysical research techniques that can be used to provide information at 
spatial and temporal scales that no single biochemical technique can approach. These 
techniques allow to measure the concentration, mobility and interactions of proteins inside a 
living functional cell, which opens a new dimension in studying protein function.  
The rationale of this doctoral research project has been to gain insight into the intracellular 
function of a human transcriptional co-activator, LEDGF/p75, in view of its known 
importance for the human immunodeficiency virus, with the specific aim of investigating this 
protein in the time dimension. LEDGF/p75 has been suggested to guide integration towards 
active regions in the genome, through its known strong interaction with HIV-1 integrase, the 
viral enzyme that catalyzes the insertion of the viral genome into that of the infected immune 
cell. How does its strong affinity for chromatin, as suggested from in vitro experiments, relate 
to this?  
We have clearly shown with intracellular FCS that LEDGF/p75 interacts extraordinarily 
dynamically with chromatin, mainly through non-specific interactions. We showed the 
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kinetics of association to be diffusion controlled with a high rate constant for dissociation 
(koff > 38.6 s-1) and a high concentration of (aspecific) binding sites. LEDGF/p75 thus 
continuously scans the genome, and finding a specific binding site amenable to 
transcriptional activation is thus likely a matter of chance. We are the first to demonstrate 
ultrafast chromatin binding kinetics for a transcription factor.  
This dynamic profile changed drastically when HIV-1 integrase is co-expressed in cells. We 
showed order-of-magnitude slower dynamics of the LEDGF/p75-IN complex and pin-
pointed these slow dynamics to the PWWP domain of LEDGF/p75, a known 
DNA/chromatin interacting domain. We finally investigated the stoichiometry of the 
complex and determined that IN can form oligomers independent of the presence of 
LEDGF/p75. 
We have set up a set of intracellular assays to probe for the presence or absence of the 
LEDGF/p75-IN interaction, based on FCCS. Due to a higher order stoichiometry, the 
interacting complex likely contains multiple LEDGF/p75 and IN partners, we had to target 
the protein complex away from chromatin in order to quantify the interaction with FCCS. By 
quantitative analysis, we could calculate for the first time an intracellular dissociation constant 
of LEDGF/p75 and IN of around 400 nM, implying a fairly strong intracellular affinity. In 
the nucleus, competition with other co-factors of LEDGF/p75 and IN, a weaker apparent 
affinity was observed. The slow dynamics of the LEDGF/p75-IN complex may be 
advantageous for the viral integration complex, because it confers more time to IN to 
perform proper integration in the host cell genome. Future work will consist in investigating 
the contribution of the slow dynamics to viral integration efficiency. We speculate that the 
mechanism of the transcriptional co-activator, i.e. aspecific genome scanning followed by 
arrest at defined sites of gene activation, probably through association with the transcription 
machinery, has been hijacked by the lentiviral integration machinery to guarantee both high 
frequency of integration sites and proviral gene activation after integration. Future work on 
HIV will also consist in the quantification of the affinity of IN in cells for other binding 
partners, that could possibly take over the role of LEDGF/p75 when its interaction with IN 
is targeted by inhibitors. The relationship in terms of chromatin and protein binding affinity 
of binding partners, IN and LEDGF/p75 will be further investigated. Furthermore, 
chromatin binding of LEDGF/p75 will be investigated in view of its known roles in 
oncogenesis and autoimmunity. The importance of chromatin binding affinity for the 
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complete viral pre-integration complex will be analysed by studying the dynamics of 
integration complexes in cells depleted for LEDGF/p75. 
Throughout the doctoral research, an important goal has been to verify the performance FCS 
and FCCS for measurements in living cells. The FCS technique was carefully investigated in a 
controlled in vitro environment. We verified the effects of the optical density, cover glass 
thickness, temperature, confocal pinhole, optical saturation and detector afterpulsing and 
provided an adequate method to calibrate a two-color setup. From these measurements we 
conclude that FCS can indeed work well in living cells, provided that are the above 
mentioned experimental parameters are carefully considered. We also studied the complex 
photophysics of monomeric red fluorescent proteins in detail with different approaches and 
showed that light-enhanced dark state formation is related to intra-protein chromophore 
mobility and can sometimes make quantitative FCS analysis difficult.  
Finally, the performance of the FCCS technique for measuring interactions in cells by means 
of double fluorescent protein fusion, was investigated by quantitative analysis of a control 
protein fusion inside living cells. From these experiment, we had to conclude that the red 
fluorescent protein partner, be it mRFP1 or mCherry, suffers from low photostability, which 
renders a vast percentage of the population photobleached, with a negative effect on the 
measurement as a result. We have also experimentally shown that cross-talk of the green 
fluorochrome into the red detection channel and interfluorochrome FRET has a large effect 
on the measurement, and conclude that it is of crucial importance to quantify these effects 
for each protein-protein interaction to be analysed, if FCCS is to be used to calculate 
intracellular binding constants.  Fluorescent protein cross-correlation spectroscopy has the 
potential of becoming the biophysical tool of choice for quantifying protein-protein 
interactions in cells, because the absolute concentrations of both partners and their complex 
can directly be measured. Future work will consist in applying pulsed-interleaved excitation or 
temporal laser switching FCCS on current and new fluorescent proteins. The photophysics of 
red fluorescent proteins and the search for a better fluorescence couple for FCCS will be 
continued, since the method has the potential of becoming an artefact-free quantitative 
technique for measuring protein-protein interactions in cells and can be used, in terms of 
drug-discovery, for the intracellular validation of inhibitors. 
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